rank | geneset | description | N_genes | mut_tally | N | n | npat | nsite | nsil | n1 | n2 | n3 | n4 | n5 | p | q |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GPCRDB_CLASS_B_SECRETIN_ LIKE | 20 | CALCR(2), CRHR1(3), CRHR2(1), ELTD1(9), EMR1(5), EMR2(3), GLP2R(2), GPR64(3) | 70035 | 28 | 22 | 28 | 7 | 6 | 13 | 1 | 4 | 4 | <1.00e-11 | <7.70e-10 | |
2 | STRIATED_MUSCLE_ CONTRACTION | 37 | ACTN3(2), DMD(10), MYBPC3(1), MYH6(8), MYH7(6), MYH8(14), MYOM1(2), NEB(9), TNNT3(1), TTN(173) | 823331 | 226 | 91 | 225 | 69 | 52 | 114 | 20 | 19 | 21 | <1.00e-11 | <7.70e-10 | |
3 | NO1PATHWAY | Shear stress in endothelial cells increases cytoplasmic calcium, which activates nitric oxide synthase III to release NO, which in turn regulates cardiac contractions. | 28 | CHRM1(1), CHRNA1(2), FLT4(1), NOS3(1), RYR2(60), SLC7A1(2) | 268724 | 67 | 41 | 66 | 20 | 12 | 38 | 7 | 3 | 7 | <1.00e-11 | <7.70e-10 |
4 | HSA04720_LONG_TERM_ POTENTIATION | Genes involved in long-term potentiation | 67 | ADCY8(8), ARAF(1), BRAF(4), CACNA1C(14), CAMK2A(2), CAMK2D(1), CAMK4(1), CREBBP(10), EP300(4), GRIA1(5), GRIN2B(11), GRM1(8), ITPR1(1), ITPR2(5), ITPR3(3), KRAS(2), MAPK1(1), MAPK3(1), PLCB1(6), PLCB4(3), PPP3CC(1), PRKCA(3), RAF1(1), RPS6KA2(2) | 461187 | 98 | 57 | 98 | 27 | 29 | 39 | 4 | 10 | 16 | <1.00e-11 | <7.70e-10 |
5 | HSA04730_LONG_TERM_ DEPRESSION | Genes involved in long-term depression | 74 | ARAF(1), BRAF(4), CACNA1A(6), CRHR1(3), GNAS(2), GRIA1(5), GRM1(8), GUCY2C(3), GUCY2D(1), ITPR1(1), ITPR2(5), ITPR3(3), KRAS(2), LYN(1), MAPK1(1), MAPK3(1), NOS3(1), PLA2G4A(4), PLCB1(6), PLCB4(3), PPP2R2A(1), PRKCA(3), RAF1(1), RYR1(23) | 551618 | 89 | 53 | 89 | 25 | 15 | 50 | 3 | 10 | 11 | <1.00e-11 | <7.70e-10 |
6 | HSA04020_CALCIUM_ SIGNALING_PATHWAY | Genes involved in calcium signaling pathway | 169 | ADCY2(11), ADCY3(3), ADCY4(3), ADCY8(8), ATP2A3(2), ATP2B1(4), ATP2B2(4), ATP2B4(1), CACNA1A(6), CACNA1C(14), CACNA1D(1), CACNA1E(14), CACNA1F(3), CACNA1G(4), CACNA1H(1), CACNA1I(7), CAMK2A(2), CAMK2D(1), CAMK4(1), CHRM1(1), EGFR(2), ERBB3(2), GNAL(1), GNAS(2), GRM1(8), ITPR1(1), ITPR2(5), ITPR3(3), MYLK(1), NOS3(1), P2RX4(1), PDE1A(2), PDGFRB(5), PHKG1(1), PHKG2(1), PLCB1(6), PLCB4(3), PLCE1(6), PPP3CC(1), PRKCA(3), RYR1(23), RYR2(60), RYR3(24), SLC8A3(5), TBXA2R(1) | 1662500 | 259 | 92 | 258 | 73 | 60 | 141 | 15 | 18 | 25 | <1.00e-11 | <7.70e-10 |
7 | SMOOTH_MUSCLE_CONTRACTION | 138 | ADCY2(11), ADCY3(3), ADCY4(3), ADCY5(2), ADCY8(8), ATP2A3(2), CAMK2A(2), CAMK2D(1), CREB3(1), CRHR1(3), GRK4(1), IL1B(1), ITPR1(1), ITPR2(5), ITPR3(3), NOS3(1), PRKCA(3), PRKCE(2), PRKCZ(1), RGS6(3), RYR1(23), RYR2(60), RYR3(24), TNXB(12), USP5(1) | 1159895 | 177 | 77 | 176 | 52 | 51 | 89 | 11 | 11 | 15 | <1.00e-11 | <7.70e-10 | |
8 | CALCIUM_REGULATION_ IN_CARDIAC_CELLS | 139 | ADCY2(11), ADCY3(3), ADCY4(3), ADCY5(2), ADCY8(8), ATP1B2(1), ATP2A3(2), ATP2B1(4), ATP2B2(4), CACNA1A(6), CACNA1C(14), CACNA1D(1), CACNA1E(14), CAMK2A(2), CAMK2D(1), CAMK4(1), CHRM1(1), GJB1(1), GRK4(1), ITPR1(1), ITPR2(5), ITPR3(3), PEA15(1), PRKCA(3), PRKCE(2), PRKCZ(1), RGS6(3), RYR1(23), RYR2(60), RYR3(24), SLC8A3(5), USP5(1) | 1466343 | 212 | 88 | 211 | 58 | 59 | 109 | 11 | 13 | 20 | <1.00e-11 | <7.70e-10 | |
9 | HSA04512_ECM_RECEPTOR_ INTERACTION | Genes involved in ECM-receptor interaction | 87 | AGRN(1), CD36(1), CHAD(1), COL11A2(6), COL1A1(4), COL4A1(6), COL4A4(6), COL4A6(2), COL5A3(7), FNDC3A(1), GP1BA(3), GP5(3), HSPG2(4), ITGA1(1), ITGA2(5), ITGA5(1), ITGA7(2), ITGA8(8), ITGB4(2), ITGB6(1), LAMA1(7), LAMA2(10), LAMA3(6), LAMA5(5), LAMB1(5), LAMB2(3), LAMB4(3), RELN(27), TNC(5), TNXB(12), VWF(12) | 1365132 | 160 | 78 | 160 | 51 | 48 | 77 | 5 | 12 | 18 | 1.60e-10 | 1.10e-08 |
10 | LAIRPATHWAY | The local acute inflammatory response is mediated by activated macrophages and mast cells or by complement activation. | 16 | C3(1), C6(11), C7(4), ITGAL(2), SELP(6) | 74494 | 24 | 23 | 24 | 8 | 5 | 10 | 3 | 0 | 6 | 6.75e-10 | 4.16e-08 |
11 | PLCPATHWAY | Phospholipase C hydrolyzes the membrane lipid PIP2 to DAG, which activates protein kinase C, and IP3, which causes calcium influx. | 7 | PLCB1(6), PRKCA(3), VAV1(5) | 27170 | 14 | 12 | 14 | 2 | 4 | 4 | 1 | 4 | 1 | 4.16e-09 | 2.14e-07 |
12 | ST_MYOCYTE_AD_PATHWAY | Cardiac myocytes have a variety of adrenergic receptors that induce subtype-specific signaling effects. | 23 | APC(7), EPHB2(3), ITPR1(1), ITPR2(5), ITPR3(3), KCNJ9(3), MAPK1(1), RHO(1), RYR1(23) | 233311 | 47 | 37 | 47 | 10 | 7 | 28 | 3 | 5 | 4 | 4.16e-09 | 2.14e-07 |
13 | HSA04530_TIGHT_JUNCTION | Genes involved in tight junction | 131 | ACTN3(2), ASH1L(5), CDK4(1), EPB41L1(2), EPB41L3(6), INADL(5), KRAS(2), LLGL1(1), LLGL2(2), MAGI1(3), MPDZ(2), MYH1(9), MYH10(2), MYH11(6), MYH13(11), MYH14(4), MYH2(14), MYH4(11), MYH6(8), MYH7(6), MYH7B(2), MYH8(14), OCLN(1), PARD3(3), PPP2R2A(1), PRKCA(3), PRKCE(2), PRKCZ(1), SPTAN1(2), SYMPK(2), TJAP1(4), YES1(2) | 1160276 | 139 | 75 | 139 | 47 | 42 | 56 | 10 | 15 | 16 | 5.25e-09 | 2.49e-07 |
14 | REELINPATHWAY | Reelin is secreted by neurons and recognized by receptors including cadherin related neuronal receptors, which promote phosphorylation of Dab1. | 7 | RELN(27) | 114849 | 27 | 18 | 27 | 7 | 6 | 9 | 2 | 6 | 4 | 2.97e-08 | 1.31e-06 |
15 | HSA04912_GNRH_SIGNALING_ PATHWAY | Genes involved in GnRH signaling pathway | 95 | ADCY2(11), ADCY3(3), ADCY4(3), ADCY5(2), ADCY8(8), CACNA1C(14), CACNA1D(1), CACNA1F(3), CAMK2A(2), CAMK2D(1), EGFR(2), GNAS(2), ITPR1(1), ITPR2(5), ITPR3(3), KRAS(2), MAP2K6(2), MAP3K1(4), MAPK1(1), MAPK3(1), PLA2G4A(4), PLCB1(6), PLCB4(3), PRKCA(3), RAF1(1), SOS1(3) | 690395 | 91 | 66 | 91 | 30 | 31 | 37 | 4 | 9 | 10 | 3.95e-08 | 1.62e-06 |
16 | ALTERNATIVEPATHWAY | The alternative complement pathway is an antibody-independent mechanism of immune activation that results in cell lysis via the membrane attack complex. | 6 | C3(1), C6(11), C7(4), C9(2) | 57896 | 18 | 17 | 18 | 5 | 3 | 7 | 3 | 0 | 5 | 7.17e-08 | 2.76e-06 |
17 | HSA04510_FOCAL_ADHESION | Genes involved in focal adhesion | 192 | ACTN3(2), BRAF(4), CHAD(1), COL11A2(6), COL1A1(4), COL4A1(6), COL4A4(6), COL4A6(2), COL5A3(7), DOCK1(3), EGFR(2), FARP2(1), FLNA(4), FLNB(3), GRLF1(2), ITGA1(1), ITGA2(5), ITGA5(1), ITGA7(2), ITGA8(8), ITGB4(2), ITGB6(1), LAMA1(7), LAMA2(10), LAMA3(6), LAMA5(5), LAMB1(5), LAMB2(3), LAMB4(3), MAPK1(1), MAPK3(1), MET(2), MYLK(1), PAK1(1), PDGFRB(5), PIK3R5(4), PIP5K1C(1), PRKCA(3), PTK2(2), RAF1(1), RAPGEF1(2), RELN(27), SOS1(3), TLN1(3), TLN2(2), TNC(5), TNXB(12), VAV1(5), VCL(2), VWF(12) | 1988895 | 207 | 88 | 207 | 67 | 54 | 104 | 9 | 17 | 23 | 1.98e-07 | 6.88e-06 |
18 | CK1PATHWAY | Caseine kinase 1 (CK1) and cdk5 phosphorylate DARPP32 in the dopamine signaling pathway. | 17 | GRM1(8), PLCB1(6) | 32130 | 14 | 13 | 14 | 4 | 3 | 6 | 0 | 1 | 4 | 2.01e-07 | 6.88e-06 |
19 | NOS1PATHWAY | Glutamate stimulates NMDA-mediates calcium influx, which promotes nitric oxide synthesis from arginine by neuronal nitric oxide synthase, activating guanylate cyclase. | 21 | GRIN2B(11), PPP3CC(1), PRKCA(3) | 47365 | 15 | 12 | 15 | 4 | 3 | 4 | 1 | 4 | 3 | 2.40e-07 | 7.78e-06 |
20 | GPCRDB_CLASS_C_METABOTROPIC_ GLUTAMATE_PHEROMONE | 13 | CASR(5), GRM1(8), GRM2(3) | 43244 | 16 | 15 | 16 | 5 | 2 | 9 | 0 | 1 | 4 | 2.77e-07 | 8.54e-06 | |
21 | HSA04540_GAP_JUNCTION | Genes involved in gap junction | 92 | ADCY2(11), ADCY3(3), ADCY4(3), ADCY5(2), ADCY8(8), EGFR(2), GNAS(2), GRM1(8), GUCY2C(3), GUCY2D(1), ITPR1(1), ITPR2(5), ITPR3(3), KRAS(2), MAP2K5(1), MAPK1(1), MAPK3(1), PDGFRB(5), PLCB1(6), PLCB4(3), PRKCA(3), RAF1(1), SOS1(3), TUBB2C(1), TUBB4(3) | 610012 | 82 | 56 | 82 | 23 | 19 | 39 | 4 | 9 | 11 | 3.87e-07 | 0.000011 |
22 | PPARGPATHWAY | PPAR-gamma is a nuclear hormone receptor that is activated by fatty acids and regulates transcription through co-activations like Src-1 and Tif2. | 7 | CREBBP(10), EP300(4) | 37855 | 14 | 13 | 14 | 3 | 3 | 6 | 0 | 2 | 3 | 1.58e-06 | 0.000044 |
23 | ARENRF2PATHWAY | Nrf1 and nrf2 are transcription factors that bind to antioxidant response elements (AREs), promoters of genes involved in oxidative damage control. | 13 | KEAP1(13), MAPK1(1), PRKCA(3) | 54418 | 17 | 17 | 17 | 0 | 3 | 10 | 1 | 2 | 1 | 3.02e-06 | 0.000081 |
24 | HSA04664_FC_EPSILON_ RI_SIGNALING_PATHWAY | Genes involved in Fc epsilon RI signaling pathway | 74 | BTK(2), IL4(1), INPP5D(4), KRAS(2), LYN(1), MAP2K6(2), MAPK1(1), MAPK3(1), MS4A2(1), PIK3R5(4), PLA2G4A(4), PRKCA(3), PRKCE(2), RAF1(1), SOS1(3), VAV1(5) | 217583 | 37 | 30 | 37 | 7 | 7 | 18 | 1 | 6 | 5 | 3.20e-06 | 0.000082 |
25 | CARM1PATHWAY | The methyltransferase CARM1 interacts with transcription factors such as CBP/p300 and methylates histones H3 and H4. | 13 | CREBBP(10), EP300(4) | 42669 | 14 | 13 | 14 | 3 | 3 | 6 | 0 | 2 | 3 | 5.88e-06 | 0.00014 |
26 | ST_G_ALPHA_I_PATHWAY | Gi and Go proteins are members of the same family that transduce cellular signals through both their alpha and beta subunits. | 34 | BRAF(4), EGFR(2), EPHB2(3), ITPR1(1), ITPR2(5), ITPR3(3), KCNJ9(3), MAPK1(1), PLCB1(6), PLCB4(3), RAF1(1), SOS1(3) | 183871 | 35 | 27 | 35 | 9 | 11 | 17 | 2 | 2 | 3 | 6.07e-06 | 0.00014 |
27 | HSA04916_MELANOGENESIS | Genes involved in melanogenesis | 99 | ADCY2(11), ADCY3(3), ADCY4(3), ADCY5(2), ADCY8(8), CAMK2A(2), CAMK2D(1), CREB3(1), CREBBP(10), DVL1(1), DVL3(1), EP300(4), FZD2(2), GNAS(2), KRAS(2), MAPK1(1), MAPK3(1), PLCB1(6), PLCB4(3), PRKCA(3), RAF1(1), WNT7A(2), WNT8A(1), WNT9A(1) | 601357 | 72 | 49 | 72 | 20 | 22 | 32 | 2 | 10 | 6 | 6.71e-06 | 0.00015 |
28 | HSA02010_ABC_TRANSPORTERS_ GENERAL | Genes involved in ABC transporters - general | 44 | ABCA10(4), ABCA13(16), ABCA4(8), ABCA6(5), ABCA7(1), ABCB1(9), ABCB5(4), ABCC1(4), ABCC10(1), ABCC12(9), ABCC2(2), ABCC5(1), ABCC8(6), ABCC9(5), ABCG4(1), ABCG8(5) | 616577 | 81 | 56 | 81 | 28 | 18 | 42 | 7 | 6 | 8 | 7.21e-06 | 0.00016 |
29 | BLOOD_CLOTTING_CASCADE | 21 | F12(1), F5(5), FGG(1), LPA(6), VWF(12) | 122623 | 25 | 23 | 25 | 6 | 6 | 13 | 0 | 1 | 5 | 9.29e-06 | 0.00020 | |
30 | NDKDYNAMINPATHWAY | Endocytotic role of NDK, Phosphins and Dynamin | 19 | AMPH(10), PICALM(2), PPP3CC(1), SYNJ2(1) | 49330 | 14 | 14 | 14 | 4 | 4 | 6 | 0 | 0 | 4 | 0.000011 | 0.00022 |
31 | RELAPATHWAY | Acetylated NF-kB proteins are immune to IkB regulation and promote transcription until the histone deacetylase HDAC3 deacetylates the RelA subunit of NF-kB. | 16 | CREBBP(10), EP300(4), RELA(2), TNFRSF1A(2), TNFRSF1B(1) | 81709 | 19 | 17 | 19 | 5 | 5 | 8 | 0 | 3 | 3 | 0.000019 | 0.00037 |
32 | PKCPATHWAY | Gq-coupled receptors promote hydrolysis of PIP2 to DAG and IP3, which causes calcium influx and activates protein kinase C. | 6 | PLCB1(6), PRKCA(3), RELA(2) | 31109 | 11 | 8 | 11 | 3 | 4 | 4 | 0 | 2 | 1 | 0.000029 | 0.00055 |
33 | HSA04340_HEDGEHOG_ SIGNALING_PATHWAY | Genes involved in Hedgehog signaling pathway | 56 | CSNK1G1(2), GLI1(1), LRP2(22), STK36(4), WNT7A(2), WNT8A(1), WNT9A(1) | 190483 | 33 | 26 | 33 | 10 | 8 | 20 | 1 | 2 | 2 | 0.000037 | 0.00068 |
34 | SPPAPATHWAY | Thrombin cleaves protease-activated receptors PAR1 and PAR4 to induce calcium influx and activate platelet aggregation, a process inhibited by aspirin. | 21 | F2RL3(1), ITGA1(1), MAPK1(1), MAPK3(1), PLA2G4A(4), PLCB1(6), PRKCA(3), PTK2(2), RAF1(1) | 99287 | 20 | 16 | 20 | 6 | 7 | 8 | 0 | 3 | 2 | 0.000071 | 0.0013 |
35 | SA_DIACYLGLYCEROL_ SIGNALING | DAG (diacylglycerol) signaling activity | 10 | PDE1A(2), PLCB1(6) | 17214 | 8 | 7 | 8 | 2 | 4 | 3 | 0 | 1 | 0 | 0.000085 | 0.0015 |
36 | PELP1PATHWAY | Pelp1 acts downstream of activated estrogen receptor to promote cell proliferation and is overexpressed in many breast tumors. | 7 | CREBBP(10), EP300(4), MAPK1(1), MAPK3(1) | 68251 | 16 | 15 | 16 | 3 | 3 | 8 | 0 | 2 | 3 | 0.000091 | 0.0016 |
37 | TGFBPATHWAY | The TGF-beta receptor responds to ligand binding by activating the SMAD family of transcriptional regulations, commonly blocking cell growth. | 13 | APC(7), CDH1(1), CREBBP(10), EP300(4), MAPK3(1) | 125820 | 23 | 21 | 23 | 3 | 3 | 12 | 1 | 3 | 4 | 0.000098 | 0.0016 |
38 | ATMPATHWAY | The tumor-suppressing protein kinase ATM responds to radiation-induced DNA damage by blocking cell-cycle progression and activating DNA repair. | 19 | ATM(4), BRCA1(5), RAD50(3), RAD51(1), RELA(2) | 61094 | 15 | 12 | 15 | 2 | 2 | 9 | 0 | 2 | 2 | 0.00012 | 0.0019 |
39 | VITCBPATHWAY | Vitamin C (ascorbic acid), in addition to its role in collagen modification, serves as an antioxidant and is imported into cells by Svct2 in the brain and Svct1 in intestinal epithelium. | 11 | COL4A1(6), COL4A3(2), COL4A4(6), COL4A6(2) | 70228 | 16 | 14 | 16 | 7 | 7 | 7 | 1 | 0 | 1 | 0.00013 | 0.0020 |
40 | NTHIPATHWAY | Hemophilus influenzae infections activate NF-kB via several pathways, inducing the inflammatory response. | 22 | CREBBP(10), EP300(4), IL1B(1), MAP2K6(2), MAP3K14(1), MYD88(1), RELA(2) | 118678 | 21 | 19 | 21 | 8 | 6 | 8 | 0 | 2 | 5 | 0.00013 | 0.0020 |
41 | G_PROTEIN_SIGNALING | 92 | ADCY2(11), ADCY3(3), ADCY4(3), ADCY5(2), ADCY8(8), AKAP11(4), AKAP9(5), GNAL(1), ITPR1(1), KRAS(2), PDE1A(2), PDE4A(1), PDE4C(1), PDE8A(2), PPP3CC(1), PRKCA(3), PRKCE(2), PRKCZ(1), PRKD3(2), USP5(1) | 529834 | 56 | 42 | 56 | 15 | 12 | 24 | 1 | 11 | 8 | 0.00016 | 0.0023 | |
42 | HSA01430_CELL_COMMUNICATION | Genes involved in cell communication | 137 | CHAD(1), COL11A2(6), COL17A1(2), COL1A1(4), COL4A1(6), COL4A4(6), COL4A6(2), COL5A3(7), GJA10(3), GJB1(1), ITGB4(2), KRT13(1), KRT23(3), KRT3(2), KRT6B(3), KRT72(1), KRT74(1), KRT75(1), KRT76(1), KRT79(1), KRT9(1), LAMA1(7), LAMA2(10), LAMA3(6), LAMA5(5), LAMB1(5), LAMB2(3), LAMB4(3), NES(1), RELN(27), TNC(5), TNXB(12), VWF(12) | 1610052 | 151 | 75 | 151 | 48 | 41 | 76 | 5 | 10 | 19 | 0.00016 | 0.0023 |
43 | AMIPATHWAY | Endogenous anti-thrombosis pathways are overwhelmed in plaque-narrowed blood vessels, resulting in potentially lethal myocardial infarction. | 21 | CD3E(1), CREBBP(10), GNAS(2), PTPRC(4) | 77146 | 17 | 14 | 17 | 5 | 4 | 7 | 1 | 2 | 3 | 0.00017 | 0.0023 |
44 | CSKPATHWAY | Csk inhibits T-cell activation by phosphorylating Lck; Csk is regulated by cAMP-dependent kinases and is opposed by the T-cell activator CD45. | 21 | CD3E(1), CREBBP(10), GNAS(2), PTPRC(4) | 77146 | 17 | 14 | 17 | 5 | 4 | 7 | 1 | 2 | 3 | 0.00017 | 0.0023 |
45 | HSA00563_GLYCOSYLPHOSPHATIDYLINOSITOL_ ANCHOR_BIOSYNTHESIS | Genes involved in glycosylphosphatidylinositol(GPI)-anchor biosynthesis | 23 | PIGG(2), PIGO(2), PIGQ(1) | 14857 | 5 | 5 | 5 | 3 | 1 | 0 | 1 | 1 | 2 | 0.00018 | 0.0024 |
46 | P53HYPOXIAPATHWAY | Hypoxia induces p53 accumulation and consequent apoptosis with p53-mediated cell cycle arrest, which is present under conditions of DNA damage. | 19 | ABCB1(9), ATM(4) | 47874 | 13 | 12 | 13 | 2 | 3 | 8 | 0 | 2 | 0 | 0.00021 | 0.0029 |
47 | EDG1PATHWAY | The lipid S1P is an EDG1 ligand promoting chemotaxis via Rac1 and cell survival and proliferation via ERK activation. | 22 | MAPK1(1), MAPK3(1), PLCB1(6), PRKCA(3), PTK2(2), SMPD2(3) | 73231 | 16 | 14 | 16 | 3 | 6 | 6 | 1 | 2 | 1 | 0.00023 | 0.0030 |
48 | ACE2PATHWAY | Angiotensin-converting enzyme 2 (ACE2) digests the blood-pressure regulator angiotensin II (AGT) ultimately to the vasodilator AGT1-7. | 12 | ACE2(2), CMA1(1), COL4A1(6), COL4A3(2), COL4A4(6), COL4A6(2) | 94012 | 19 | 17 | 19 | 7 | 7 | 10 | 1 | 0 | 1 | 0.00028 | 0.0036 |
49 | HSA04080_NEUROACTIVE_ LIGAND_RECEPTOR_ INTERACTION | Genes involved in neuroactive ligand-receptor interaction | 238 | AVPR2(2), CALCR(2), CHRM1(1), CRHR1(3), CRHR2(1), CTSG(2), F2RL3(1), GABRA3(3), GABRG3(5), GABRR1(1), GLP2R(2), GPR156(1), GRIA1(5), GRIK5(2), GRIN2B(11), GRIN3B(1), GRM1(8), GRM2(3), GZMA(3), HTR1D(1), LEPR(8), NPFFR1(1), NPY1R(3), NTSR2(2), P2RX4(1), PARD3(3), PTH2R(4), RXFP1(6), TBXA2R(1), TRPV1(1) | 822037 | 88 | 58 | 88 | 25 | 24 | 42 | 4 | 9 | 9 | 0.00031 | 0.0039 |
50 | HSA04010_MAPK_SIGNALING_ PATHWAY | Genes involved in MAPK signaling pathway | 248 | ACVR1C(1), BRAF(4), CACNA1A(6), CACNA1C(14), CACNA1D(1), CACNA1E(14), CACNA1F(3), CACNA1G(4), CACNA1H(1), CACNA1I(7), CACNA2D2(2), CACNA2D4(1), CACNB2(3), CACNB4(2), CDC25B(2), ECSIT(1), EGFR(2), FLNA(4), FLNB(3), IL1B(1), KRAS(2), MAP2K5(1), MAP2K6(2), MAP3K1(4), MAP3K12(1), MAP3K14(1), MAP4K3(1), MAPK1(1), MAPK3(1), MAPK8IP1(4), MAPK8IP3(3), MAPKAPK5(1), MAX(1), MKNK2(1), NF1(14), NTRK1(5), PAK1(1), PDGFRB(5), PLA2G4A(4), PPP3CC(1), PRKCA(3), RAF1(1), RASA1(2), RASA2(2), RASGRF2(2), RASGRP3(2), RPS6KA2(2), RPS6KA4(2), SOS1(3), TAOK2(2), TNFRSF1A(2) | 1658979 | 153 | 79 | 153 | 43 | 33 | 78 | 6 | 12 | 24 | 0.00032 | 0.0040 |
51 | HSA00902_MONOTERPENOID_ BIOSYNTHESIS | Genes involved in monoterpenoid biosynthesis | 2 | CYP2C19(6) | 11065 | 6 | 6 | 6 | 2 | 2 | 3 | 0 | 0 | 1 | 0.00036 | 0.0043 |
52 | ST_DIFFERENTIATION_ PATHWAY_IN_PC12_ CELLS | Rat-derived PC12 cells respond to nerve growth factor (NGF) and PACAP to differentiate into neuronal cells. | 42 | BRAF(4), CREB3(1), CREBBP(10), MAP1B(4), MAPK1(1), MAPK3(1), MAPK8IP1(4), MAPK8IP3(3), NTRK1(5), OPN1LW(1), PIK3C2G(1) | 251749 | 35 | 33 | 35 | 11 | 11 | 16 | 0 | 3 | 5 | 0.00041 | 0.0048 |
53 | HSA04630_JAK_STAT_ SIGNALING_PATHWAY | Genes involved in Jak-STAT signaling pathway | 152 | CREBBP(10), CSF2RB(4), EP300(4), EPOR(1), IFNA16(2), IL10RA(1), IL11RA(1), IL12RB2(2), IL21R(2), IL22(1), IL22RA2(1), IL4(1), IL5RA(2), JAK2(3), LEPR(8), PIAS1(1), PIAS4(1), PIK3R5(4), PIM1(2), SOS1(3), STAT1(1), STAT5B(1), TPO(5) | 538986 | 61 | 45 | 61 | 18 | 17 | 27 | 2 | 5 | 10 | 0.00041 | 0.0048 |
54 | IL7PATHWAY | IL-7 is required for B and T cell development and proliferation and may contribute to activation of VDJ recombination. | 16 | CREBBP(10), EP300(4), STAT5B(1) | 70404 | 15 | 14 | 15 | 4 | 3 | 7 | 0 | 2 | 3 | 0.00045 | 0.0052 |
55 | HSA04360_AXON_GUIDANCE | Genes involved in axon guidance | 127 | ABLIM1(2), ABLIM3(2), DPYSL5(4), EPHA2(2), EPHA3(5), EPHA6(7), EPHB2(3), KRAS(2), MAPK1(1), MAPK3(1), MET(2), NFAT5(1), NRP1(4), PAK1(1), PLXNA1(2), PLXNA2(1), PLXNB1(1), PLXNC1(2), PPP3CC(1), PTK2(2), RASA1(2), ROBO3(3), SEMA3B(2), SEMA3F(1), SEMA3G(1), SEMA4F(3), SEMA6B(1), SEMA6D(4), SEMA7A(3), SLIT1(4), SLIT3(8), SRGAP3(3) | 731951 | 81 | 51 | 81 | 31 | 20 | 38 | 7 | 5 | 11 | 0.00053 | 0.0060 |
56 | CDMACPATHWAY | Cadmium 2+ promotes cell proliferation in cultured macrophages by entering the cell via calcium channels and activating the MAP kinase pathway. | 15 | MAPK1(1), MAPK3(1), PLCB1(6), PRKCA(3), RAF1(1), RELA(2) | 65690 | 14 | 11 | 14 | 4 | 5 | 6 | 0 | 2 | 1 | 0.00068 | 0.0075 |
57 | EPHA4PATHWAY | Eph Kinases and ephrins support platelet aggregation | 10 | ITGA1(1), LYN(1), SELP(6) | 29128 | 8 | 8 | 8 | 1 | 1 | 4 | 0 | 0 | 3 | 0.00086 | 0.0093 |
58 | UREACYCLEPATHWAY | Ammonia released from amino acid deamination is used to produce carbamoyl phosphate, which is used to convert ornithine to citrulline, from which urea is eventually formed. | 6 | CPS1(9) | 27696 | 9 | 9 | 9 | 1 | 3 | 5 | 0 | 0 | 1 | 0.00093 | 0.0099 |
59 | MYOSINPATHWAY | Myosin light chain kinase phosphorylates myosin and promotes muscle contraction and platelet formation; myosin phosphatase antagonizes these processes. | 13 | MYLK(1), PLCB1(6), PPP1R12B(1), PRKCA(3) | 50901 | 11 | 10 | 11 | 4 | 4 | 4 | 0 | 2 | 1 | 0.0011 | 0.011 |
60 | ST_GRANULE_CELL_ SURVIVAL_PATHWAY | The survival and differentiation of granule cells in the brain is controlled by pro-growth PACAP and pro-apoptotic ceramides. | 25 | APC(7), CREB3(1), EPHB2(3), MAPK1(1), MAPK8IP1(4), MAPK8IP3(3) | 101412 | 19 | 18 | 19 | 1 | 5 | 10 | 1 | 2 | 1 | 0.0011 | 0.011 |
61 | HSA00950_ALKALOID_ BIOSYNTHESIS_I | Genes involved in alkaloid biosynthesis I | 5 | DDC(3), TAT(3) | 13232 | 6 | 6 | 6 | 1 | 2 | 4 | 0 | 0 | 0 | 0.0011 | 0.011 |
62 | PMLPATHWAY | Ring-shaped PML nuclear bodies regulate transcription and are required co-activators in p53- and DAXX-mediated apoptosis. | 13 | CREBBP(10), TNFRSF1A(2), TNFRSF1B(1) | 84465 | 13 | 12 | 13 | 1 | 4 | 3 | 0 | 3 | 3 | 0.0012 | 0.012 |
63 | AKAPCENTROSOMEPATHWAY | Protein Kinase A at the Centrosome | 10 | AKAP9(5), PRKCE(2) | 20276 | 7 | 7 | 7 | 2 | 1 | 5 | 0 | 1 | 0 | 0.0014 | 0.014 |
64 | PPARAPATHWAY | Peroxisome proliferators regulate gene expression via PPAR/RXR heterodimers which bind to peroxisome-proliferator response elements (PPREs). | 50 | CD36(1), CREBBP(10), EP300(4), HSD17B4(1), MAPK1(1), MAPK3(1), NCOR1(4), NCOR2(3), PRKCA(3), RELA(2), STAT5B(1) | 225272 | 31 | 27 | 31 | 9 | 8 | 14 | 1 | 3 | 5 | 0.0015 | 0.014 |
65 | IL12PATHWAY | IL12 and Stat4 Dependent Signaling Pathway in Th1 Development | 20 | CD3E(1), CXCR3(1), IL12RB2(2), JAK2(3), MAP2K6(2) | 40623 | 9 | 8 | 9 | 2 | 1 | 4 | 0 | 1 | 3 | 0.0015 | 0.014 |
66 | SETPATHWAY | Cytotoxic T cells release perforin, which to allow entry into target cells of granzyme B, which activates caspases, and granzyme A, which induces caspase-independent apoptosis. | 11 | CREBBP(10), DFFB(1), GZMA(3) | 84774 | 14 | 13 | 14 | 1 | 5 | 4 | 0 | 2 | 3 | 0.0017 | 0.015 |
67 | SPRYPATHWAY | Four members of the Sprouty protein family block proliferative EGF signals by binding Grb-2, preventing Ras and MAP kinase activation. | 18 | EGFR(2), MAPK1(1), MAPK3(1), PTPRB(9), RAF1(1), RASA1(2), SOS1(3) | 109671 | 19 | 17 | 19 | 4 | 4 | 11 | 0 | 1 | 3 | 0.0019 | 0.017 |
68 | INTRINSICPATHWAY | The intrinsic prothrombin activation pathway is activated by traumatized blood vessels and induces clot formation. | 22 | COL4A1(6), COL4A3(2), COL4A4(6), COL4A6(2), F12(1), F5(5), FGG(1), SERPING1(2) | 174863 | 25 | 20 | 25 | 10 | 8 | 12 | 1 | 0 | 4 | 0.0020 | 0.018 |
69 | TRKAPATHWAY | Nerve growth factor (NGF) promotes neuronal survival and proliferation by binding its receptor TrkA, which activates PI3K/AKT, Ras, and the MAP kinase pathway. | 12 | NTRK1(5), PRKCA(3), SOS1(3) | 61862 | 11 | 11 | 11 | 1 | 0 | 7 | 0 | 2 | 2 | 0.0020 | 0.018 |
70 | GLYCOLYSISPATHWAY | Glycolysis is an evolutionarily conserved pathway by which one glucose molecule is converted to two pyruvate molecules for a gain of 2 ATP. | 9 | GPI(3), HK1(3), PGK1(2) | 37507 | 8 | 7 | 8 | 0 | 5 | 2 | 0 | 0 | 1 | 0.0023 | 0.020 |
71 | PITX2PATHWAY | The bicoid-related transcription factor Pitx2 is activated by Wnt binding to the Frizzled receptor and induces tissue-specific cell proliferation. | 14 | APC(7), CREBBP(10), DVL1(1), EP300(4) | 149767 | 22 | 20 | 22 | 3 | 4 | 10 | 1 | 3 | 4 | 0.0025 | 0.022 |
72 | LEPTINPATHWAY | Leptin is a peptide secreted by adipose tissue that, in skeletal muscle, promotes fatty acid oxidation, decreases cells' lipid content, and promotes insulin sensitivity. | 10 | ACACA(2), LEPR(8), PRKAG2(2) | 57545 | 12 | 12 | 12 | 3 | 5 | 4 | 1 | 1 | 1 | 0.0027 | 0.023 |
73 | TPOPATHWAY | Thrombopoietin binds to its receptor and activates cell growth through the Erk and JNK MAP kinase pathways, protein kinase C, and JAK/STAT activation. | 22 | JAK2(3), MAPK3(1), PRKCA(3), RAF1(1), RASA1(2), SOS1(3), STAT1(1), STAT5B(1) | 108948 | 15 | 15 | 15 | 1 | 1 | 8 | 0 | 2 | 4 | 0.0030 | 0.025 |
74 | HSA04640_HEMATOPOIETIC_ CELL_LINEAGE | Genes involved in hematopoietic cell lineage | 86 | CD19(1), CD1B(3), CD1C(4), CD1E(3), CD22(4), CD36(1), CD3E(1), CD5(1), CR1(2), CSF1R(2), EPOR(1), GP1BA(3), GP5(3), IL11RA(1), IL1B(1), IL4(1), IL5RA(2), ITGA1(1), ITGA2(5), ITGA5(1), ITGAM(2), TPO(5) | 440406 | 48 | 33 | 48 | 16 | 13 | 29 | 2 | 0 | 4 | 0.0030 | 0.025 |
75 | ST_T_CELL_SIGNAL_ TRANSDUCTION | On activation of the T cell receptor, phospholipase C is activated to produce second messengers DAG and PIP3, both required for T cell activation. | 44 | EPHB2(3), GRAP2(1), MAPK1(1), NFAT5(1), NFKBIL2(5), PAK1(1), PTPRC(4), RAF1(1), RASGRP3(2), SOS1(3), VAV1(5) | 240795 | 27 | 22 | 27 | 6 | 9 | 10 | 4 | 4 | 0 | 0.0037 | 0.030 |
76 | PAR1PATHWAY | Activated extracellular thrombin cleaves and activates the G-protein coupled receptors PAR1 and PAR4, which activate platelets. | 19 | F2RL3(1), PLCB1(6), PPP1R12B(1), PRKCA(3) | 67331 | 11 | 9 | 11 | 3 | 5 | 3 | 0 | 2 | 1 | 0.0037 | 0.030 |
77 | ST_ADRENERGIC | Adrenergic receptors respond to epinephrine and norepinephrine signaling. | 34 | APC(7), BRAF(4), EGFR(2), ITPR1(1), ITPR2(5), ITPR3(3), KCNJ9(3), MAPK1(1), RAF1(1) | 191197 | 27 | 24 | 27 | 7 | 7 | 13 | 2 | 1 | 4 | 0.0041 | 0.033 |
78 | ST_INTERLEUKIN_4_ PATHWAY | Like IL-13, IL-4 is produced by Th2 cells on activation of the T cell antigen receptor, and by mast and basophil cells on activation of the IgE receptor. | 26 | IL4(1), INPP5D(4), JAK2(3), SOS1(3) | 56800 | 11 | 11 | 11 | 0 | 1 | 7 | 0 | 2 | 1 | 0.0042 | 0.033 |
79 | HSA03030_DNA_POLYMERASE | Genes involved in DNA polymerase | 24 | POLD1(1), POLQ(6), REV1(4), REV3L(4) | 84785 | 15 | 13 | 15 | 3 | 3 | 10 | 1 | 1 | 0 | 0.0043 | 0.033 |
80 | NO2IL12PATHWAY | Macrophages activate NK cells by releasing IL-12, which induces NK cytotoxic activity in coordination with NO produced by inducible nitric oxide synthase II. | 15 | CD3E(1), CXCR3(1), IL12RB2(2), JAK2(3) | 29013 | 7 | 6 | 7 | 1 | 1 | 3 | 0 | 1 | 2 | 0.0044 | 0.034 |
81 | GPCRDB_OTHER | 53 | CELSR1(10), CELSR2(4), CELSR3(6), CXCR3(1), EMR2(3), EMR3(5), GPR116(4), GPR143(1), GPR61(1), GPR84(1), GRM1(8), LGR6(1) | 451592 | 45 | 31 | 45 | 15 | 6 | 23 | 6 | 2 | 8 | 0.0053 | 0.040 | |
82 | TCRPATHWAY | T cell receptors bind to foreign peptides presented by MHC molecules and induce T cell activation. | 42 | CD3E(1), MAP3K1(4), MAPK3(1), PPP3CC(1), PRKCA(3), RAF1(1), RASA1(2), RELA(2), SOS1(3), VAV1(5) | 185779 | 23 | 22 | 23 | 3 | 5 | 9 | 1 | 3 | 5 | 0.0066 | 0.050 |
83 | MRPPATHWAY | Cancer cells resistant to numerous drugs are called multidrug-resistant (MDR) and express ATP-binding cassette transporter proteins that pump the drugs out of cells. | 6 | ABCB1(9), ABCC1(4) | 69312 | 13 | 12 | 13 | 2 | 4 | 8 | 0 | 1 | 0 | 0.0074 | 0.055 |
84 | HSA04320_DORSO_VENTRAL_ AXIS_FORMATION | Genes involved in dorso-ventral axis formation | 28 | BRAF(4), EGFR(2), KRAS(2), MAPK1(1), MAPK3(1), NOTCH1(6), NOTCH2(2), NOTCH3(3), NOTCH4(4), PIWIL3(2), RAF1(1), SOS1(3) | 257157 | 31 | 26 | 31 | 10 | 4 | 18 | 2 | 2 | 5 | 0.0079 | 0.058 |
85 | AGPCRPATHWAY | G-protein coupled receptors (GPCRs) transduce extracellular signals across the plasma membrane; attenuation occurs by signal molecule degradation or receptor-mediated endocytosis. | 11 | GNAS(2), PRKCA(3) | 19909 | 5 | 5 | 5 | 2 | 0 | 3 | 0 | 1 | 1 | 0.010 | 0.074 |
86 | HSA04610_COMPLEMENT_ AND_COAGULATION_ CASCADES | Genes involved in complement and coagulation cascades | 69 | C1QA(2), C2(2), C3(1), C6(11), C7(4), C9(2), CFB(1), CR1(2), F12(1), F13A1(1), F5(5), FGG(1), MASP2(1), SERPIND1(1), SERPING1(2), VWF(12) | 548617 | 49 | 40 | 49 | 14 | 11 | 22 | 4 | 1 | 11 | 0.011 | 0.076 |
87 | HSA05110_CHOLERA_ INFECTION | Genes involved in cholera - infection | 41 | ACTG2(3), ADCY3(3), ATP6V0A1(3), ATP6V0A2(5), ATP6V1G3(1), ATP6V1H(1), ERO1L(1), GNAS(2), PRKCA(3) | 185836 | 22 | 19 | 22 | 4 | 4 | 11 | 0 | 4 | 3 | 0.013 | 0.092 |
88 | ST_PHOSPHOINOSITIDE_ 3_KINASE_PATHWAY | The phosphoinositide-3 kinase pathway produces the lipid second messenger PIP3 and regulates cell growth, survival, and movement. | 33 | BTK(2), INPP5D(4), RPS6KA2(2), SOS1(3) | 69184 | 11 | 11 | 11 | 0 | 1 | 7 | 0 | 2 | 1 | 0.013 | 0.094 |
89 | NITROGEN_METABOLISM | 21 | CA6(3), CPS1(9) | 70178 | 12 | 12 | 12 | 1 | 4 | 6 | 1 | 0 | 1 | 0.015 | 0.10 | |
90 | BCRPATHWAY | B cell antigen receptors (BCRs) activate tyrosine kinases and transiently increase tyrosine phosphorylation on binding to antigen. | 34 | BLNK(1), BTK(2), LYN(1), MAP3K1(4), MAPK3(1), PPP3CC(1), PRKCA(3), RAF1(1), SOS1(3), VAV1(5) | 181047 | 22 | 21 | 22 | 2 | 4 | 10 | 1 | 3 | 4 | 0.016 | 0.11 |
91 | HSA04670_LEUKOCYTE_ TRANSENDOTHELIAL_ MIGRATION | Genes involved in Leukocyte transendothelial migration | 110 | ACTN3(2), CD99(1), CDH5(1), CTNND1(2), CYBB(2), GRLF1(2), ITGAL(2), ITGAM(2), OCLN(1), PIK3R5(4), PRKCA(3), PTK2(2), RHOH(5), VAV1(5), VCL(2) | 327687 | 36 | 28 | 36 | 21 | 7 | 19 | 1 | 5 | 4 | 0.016 | 0.11 |
92 | METPATHWAY | The hepatocyte growth factor receptor c-Met stimulates proliferation and alters cell motility and adhesion on binding the ligand HGF. | 35 | DOCK1(3), ITGA1(1), MAPK1(1), MAPK3(1), MET(2), PAK1(1), PTK2(2), RAF1(1), RASA1(2), SOS1(3) | 122965 | 17 | 14 | 17 | 4 | 3 | 8 | 2 | 1 | 3 | 0.017 | 0.11 |
93 | C21_STEROID_HORMONE_ METABOLISM | 11 | CYP11B1(5), CYP11B2(3) | 45443 | 8 | 8 | 8 | 1 | 2 | 4 | 0 | 2 | 0 | 0.018 | 0.11 | |
94 | HSA00140_C21_STEROID_ HORMONE_METABOLISM | Genes involved in C21-steroid hormone metabolism | 11 | CYP11B1(5), CYP11B2(3) | 45443 | 8 | 8 | 8 | 1 | 2 | 4 | 0 | 2 | 0 | 0.018 | 0.11 |
95 | UREA_CYCLE_AND_METABOLISM_ OF_AMINO_GROUPS | 20 | CPS1(9), SMS(2) | 60713 | 11 | 10 | 11 | 1 | 3 | 7 | 0 | 0 | 1 | 0.018 | 0.12 | |
96 | CBLPATHWAY | Activated EGF receptors undergo endocytosis into clathrin-coated vesicles, where they are recycled to the membrane or ubiquitinated by Cbl. | 12 | CSF1R(2), EGFR(2), MET(2), PRKCA(3), SH3KBP1(2) | 89437 | 11 | 9 | 11 | 1 | 1 | 5 | 1 | 3 | 1 | 0.019 | 0.12 |
97 | NFATPATHWAY | Cardiac hypertrophy is induced by NF-ATc4 and GATA4, which are stimulated through calcineurin activated by CaMK. | 52 | CAMK4(1), CREBBP(10), ELSPBP1(1), MAPK1(1), MAPK3(1), MYH2(14), PPP3CC(1), RAF1(1) | 268692 | 30 | 25 | 30 | 7 | 8 | 14 | 0 | 3 | 5 | 0.021 | 0.13 |
98 | HSA00534_HEPARAN_ SULFATE_BIOSYNTHESIS | Genes involved in heparan sulfate biosynthesis | 19 | EXT2(1), EXTL1(1), NDST1(3), NDST2(3) | 40965 | 8 | 8 | 8 | 3 | 1 | 5 | 0 | 1 | 1 | 0.021 | 0.13 |
99 | CLASSICPATHWAY | The classic complement pathway is initiated by antibodies and promotes phagocytosis and lysis of foreign cells as well as activating the inflammatory response. | 13 | C1QA(2), C2(2), C3(1), C6(11), C7(4), C9(2) | 250721 | 22 | 20 | 22 | 6 | 3 | 10 | 3 | 0 | 6 | 0.021 | 0.13 |
100 | ST_GA12_PATHWAY | G-alpha-12 promotes cell survival and proliferation, is involved in the stress response, and activates JNK. | 22 | BTK(2), EPHB2(3), F2RL3(1), MAP2K5(1), MAPK1(1), PLD3(1), PTK2(2), RAF1(1), VAV1(5) | 135626 | 17 | 13 | 17 | 2 | 5 | 6 | 1 | 3 | 2 | 0.021 | 0.13 |
101 | ST_DICTYOSTELIUM_ DISCOIDEUM_CAMP_ CHEMOTAXIS_PATHWAY | The fungus Dictyostelium discoideum is a model system for cytoskeletal organization during chemotaxis. | 32 | ETFA(2), ITPR1(1), ITPR2(5), ITPR3(3), MAPK1(1), MAPK3(1), PAK1(1), PIK3C2G(1), RIPK3(1) | 201122 | 16 | 16 | 16 | 7 | 5 | 5 | 0 | 0 | 6 | 0.022 | 0.13 |
102 | TOB1PATHWAY | TGF-beta signaling activates SMADs, which interact with intracellular Tob to maintain unstimulated T cells by repressing IL-2 expression. | 16 | CD3E(1), IL4(1) | 3543 | 2 | 2 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 0.025 | 0.15 |
103 | HSA00760_NICOTINATE_ AND_NICOTINAMIDE_ METABOLISM | Genes involved in nicotinate and nicotinamide metabolism | 22 | ENPP3(3), NNT(4), NT5C2(1), NT5C3(2), NT5E(1) | 71425 | 11 | 11 | 11 | 2 | 2 | 6 | 2 | 0 | 1 | 0.025 | 0.15 |
104 | CCR3PATHWAY | CCR3 is a G-protein coupled receptor that recruits eosinophils to inflammation sites via chemokine ligands. | 21 | GNAS(2), MAPK1(1), MAPK3(1), PIK3C2G(1), PLCB1(6), PPP1R12B(1), PRKCA(3), PTK2(2), RAF1(1) | 140986 | 18 | 16 | 18 | 10 | 6 | 8 | 0 | 2 | 2 | 0.025 | 0.15 |
105 | COMPPATHWAY | Both the classic and alternative immune complement pathways promote inflammation, foreign cell lysis, and phagocytosis. | 16 | C1QA(2), C2(2), C3(1), C6(11), C7(4), C9(2), MASP2(1) | 258752 | 23 | 20 | 23 | 6 | 4 | 10 | 3 | 0 | 6 | 0.026 | 0.15 |
106 | HSA00592_ALPHA_LINOLENIC_ ACID_METABOLISM | Genes involved in alpha-Linolenic acid metabolism | 15 | PLA2G4A(4) | 15172 | 4 | 4 | 4 | 2 | 1 | 2 | 0 | 1 | 0 | 0.028 | 0.16 |
107 | CYSTEINE_METABOLISM | 8 | CARS(3), LDHB(1), LDHC(1) | 28349 | 5 | 5 | 5 | 0 | 0 | 3 | 1 | 0 | 1 | 0.028 | 0.16 | |
108 | HSA00272_CYSTEINE_ METABOLISM | Genes involved in cysteine metabolism | 17 | CARS(3), LDHB(1), LDHC(1) | 28349 | 5 | 5 | 5 | 0 | 0 | 3 | 1 | 0 | 1 | 0.028 | 0.16 |
109 | COMPLEMENT_ACTIVATION_ CLASSICAL | 15 | C1QA(2), C2(2), C3(1), C6(11), C7(4), C9(2) | 260576 | 22 | 20 | 22 | 8 | 3 | 10 | 3 | 0 | 6 | 0.028 | 0.16 | |
110 | HSA04370_VEGF_SIGNALING_ PATHWAY | Genes involved in VEGF signaling pathway | 69 | KRAS(2), MAPK1(1), MAPK3(1), NFAT5(1), NOS3(1), PIK3R5(4), PLA2G4A(4), PPP3CC(1), PRKCA(3), PTK2(2), RAF1(1) | 192376 | 21 | 20 | 21 | 8 | 4 | 10 | 0 | 3 | 4 | 0.029 | 0.17 |
111 | LDLPATHWAY | Low density lipoproteins (LDL) are present in blood plasma, contain cholesterol and triglycerides, and contribute to atherogenic plaque formation. | 6 | LDLR(3) | 11475 | 3 | 3 | 3 | 0 | 1 | 1 | 0 | 1 | 0 | 0.030 | 0.17 |
112 | HSA00061_FATTY_ACID_ BIOSYNTHESIS | Genes involved in fatty acid biosynthesis | 6 | ACACA(2), ACACB(6) | 40666 | 8 | 7 | 8 | 3 | 2 | 6 | 0 | 0 | 0 | 0.032 | 0.18 |
113 | WNTPATHWAY | The Wnt glycoprotein binds to membrane-bound receptors such as Frizzled to activate a number of signaling pathways, including that of beta-catenin. | 23 | APC(7), CREBBP(10), CTBP1(1), DVL1(1) | 178659 | 19 | 17 | 19 | 1 | 4 | 7 | 1 | 3 | 4 | 0.035 | 0.19 |
114 | CCR5PATHWAY | CCR5 is a G-protein coupled receptor expressed in macrophages that recognizes chemokine ligands and is targeted by the HIV envelope protein GP120. | 17 | PRKCA(3) | 15591 | 3 | 3 | 3 | 1 | 0 | 1 | 0 | 1 | 1 | 0.036 | 0.19 |
115 | IONPATHWAY | Activated phospholipase C hydrolyzes the lipid PIP3 into second messengers DAG, which activates protein kinase C, and IP3, which induces calcium influx into the cytoplasm. | 4 | PRKCA(3) | 15591 | 3 | 3 | 3 | 1 | 0 | 1 | 0 | 1 | 1 | 0.036 | 0.19 |
116 | MONOCYTEPATHWAY | Monocytes are a class of immune phagocytes that can develop into macrophages and express LFA-1, CD44, and other surface signaling proteins. | 11 | ITGAL(2), ITGAM(2), SELL(1), SELP(6) | 74250 | 11 | 10 | 11 | 6 | 3 | 6 | 0 | 0 | 2 | 0.037 | 0.20 |
117 | INTEGRIN_MEDIATED_ CELL_ADHESION_KEGG | 90 | CAPN1(2), CAPN11(1), CAPN3(3), CAPN5(3), DOCK1(3), ITGA2(5), ITGA5(1), ITGA7(2), ITGA8(8), ITGAD(7), ITGAL(2), ITGAM(2), ITGB4(2), ITGB6(1), MAP2K6(2), PAK1(1), PTK2(2), RAPGEF1(2), RHO(1), SDCCAG8(5), SORBS1(4), SOS1(3), TLN1(3), VCL(2) | 718652 | 67 | 47 | 67 | 20 | 18 | 36 | 6 | 1 | 6 | 0.038 | 0.20 | |
118 | DNA_POLYMERASE | 7 | POLD1(1), POLQ(6) | 39944 | 7 | 6 | 7 | 1 | 1 | 5 | 0 | 1 | 0 | 0.038 | 0.20 | |
119 | HSA04520_ADHERENS_ JUNCTION | Genes involved in adherens junction | 75 | ACTN3(2), ACVR1C(1), CDH1(1), CREBBP(10), CTNND1(2), EGFR(2), EP300(4), FARP2(1), INSR(2), MAPK1(1), MAPK3(1), MET(2), PARD3(3), PTPRB(9), PTPRF(4), PTPRJ(2), PTPRM(5), PVRL1(4), PVRL3(1), SORBS1(4), VCL(2), WASF3(1), WASL(1), YES1(2) | 763856 | 67 | 45 | 67 | 20 | 13 | 35 | 2 | 9 | 8 | 0.039 | 0.20 |
120 | TIDPATHWAY | On ligand binding, interferon gamma receptors stimulate JAK2 kinase to phosphorylate STAT transcription factors, which promote expression of interferon responsive genes. | 18 | JAK2(3), RELA(2), TNFRSF1A(2), TNFRSF1B(1) | 55018 | 8 | 7 | 8 | 1 | 2 | 3 | 0 | 2 | 1 | 0.040 | 0.21 |
121 | SRCRPTPPATHWAY | Activation of Src by Protein-tyrosine phosphatase alpha | 9 | CDC25B(2), PRKCA(3) | 32755 | 5 | 5 | 5 | 1 | 0 | 2 | 1 | 1 | 1 | 0.044 | 0.22 |
122 | SA_TRKA_RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. | 15 | NTRK1(5), SOS1(3) | 55847 | 8 | 8 | 8 | 1 | 0 | 6 | 0 | 1 | 1 | 0.047 | 0.24 |
123 | PROSTAGLANDIN_AND_ LEUKOTRIENE_METABOLISM | 31 | PLA2G4A(4), PRDX2(1), TPO(5) | 64806 | 10 | 10 | 10 | 4 | 3 | 5 | 0 | 1 | 1 | 0.048 | 0.24 | |
124 | G2PATHWAY | Activated Cdc2-cyclin B kinase regulates the G2/M transition; DNA damage stimulates the DNA-PK/ATM/ATR kinases, which inactivate Cdc2. | 22 | ATM(4), BRCA1(5), CDC25B(2), EP300(4), PRKDC(4) | 158071 | 19 | 17 | 19 | 4 | 3 | 10 | 1 | 2 | 3 | 0.050 | 0.25 |
125 | HSA01040_POLYUNSATURATED_ FATTY_ACID_BIOSYNTHESIS | Genes involved in polyunsaturated fatty acid biosynthesis | 13 | HSD17B12(1) | 3178 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0.052 | 0.26 |
126 | HSA00910_NITROGEN_ METABOLISM | Genes involved in nitrogen metabolism | 24 | CA6(3), CPS1(9) | 85086 | 12 | 12 | 12 | 1 | 4 | 6 | 1 | 0 | 1 | 0.052 | 0.26 |
127 | TSP1PATHWAY | Thrombospondin-1 (TSP-1) inhibits angiogenesis by inducing caspase-dependent apoptosis in microvascular endothelial cells. | 7 | CD36(1) | 6029 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0.053 | 0.26 |
128 | CYTOKINEPATHWAY | Intercellular signaling in the immune system occurs via secretion of cytokines, which promote antigen-dependent B and T cell response. | 20 | IL16(4), IL4(1) | 25265 | 5 | 5 | 5 | 0 | 3 | 2 | 0 | 0 | 0 | 0.055 | 0.26 |
129 | P53PATHWAY | p53 induces cell cycle arrest or apoptosis under conditions of DNA damage. | 16 | ATM(4), CDK4(1) | 28188 | 5 | 5 | 5 | 0 | 2 | 2 | 0 | 1 | 0 | 0.055 | 0.26 |
130 | NFKBPATHWAY | Inactive nuclear factor kB (NF-kB) is inhibited by the IkB family in the cytoplasm; active NF-kB is localized in the nucleus and regulates transcription of a variety of genes. | 22 | IRAK1(4), MAP3K1(4), MAP3K14(1), MYD88(1), RELA(2), TNFRSF1A(2), TNFRSF1B(1) | 148769 | 15 | 13 | 15 | 5 | 6 | 4 | 1 | 2 | 2 | 0.057 | 0.27 |
131 | GABAPATHWAY | Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter whose receptor is regulated by Plic-1, gephyrin, and GABARAP, which promote receptor clustering. | 12 | GABRA3(3) | 10755 | 3 | 3 | 3 | 0 | 0 | 3 | 0 | 0 | 0 | 0.059 | 0.28 |
132 | HSA00680_METHANE_ METABOLISM | Genes involved in methane metabolism | 10 | TPO(5) | 28868 | 5 | 5 | 5 | 1 | 1 | 3 | 0 | 0 | 1 | 0.061 | 0.28 |
133 | HSA00940_PHENYLPROPANOID_ BIOSYNTHESIS | Genes involved in phenylpropanoid biosynthesis | 7 | TPO(5) | 28868 | 5 | 5 | 5 | 1 | 1 | 3 | 0 | 0 | 1 | 0.061 | 0.28 |
134 | FCER1PATHWAY | In mast cells, Fc epsilon receptor 1 activates BTK, PKC, and the MAP kinase pathway to promote degranulation and arachnidonic acid release. | 37 | BTK(2), LYN(1), MAP3K1(4), MAPK1(1), MAPK3(1), PLA2G4A(4), PPP3CC(1), RAF1(1), SOS1(3), VAV1(5) | 204355 | 23 | 21 | 23 | 4 | 5 | 11 | 1 | 3 | 3 | 0.061 | 0.28 |
135 | HSA00401_NOVOBIOCIN_ BIOSYNTHESIS | Genes involved in novobiocin biosynthesis | 3 | TAT(3) | 10582 | 3 | 3 | 3 | 1 | 1 | 2 | 0 | 0 | 0 | 0.062 | 0.28 |
136 | STARCH_AND_SUCROSE_ METABOLISM | 44 | AGL(2), ENPP3(3), GANAB(4), GPI(3), GYS1(1), GYS2(2), HK1(3), MGAM(7), PGM1(1), UGT1A7(1), UGT2B15(2) | 273958 | 29 | 24 | 29 | 10 | 9 | 13 | 1 | 2 | 4 | 0.065 | 0.30 | |
137 | CIRCADIANPATHWAY | A heterodimer composed of Bmal1 and Clock acts as a transcription factor for proteins that regulate circadian rhythms, such as Per and Cry. | 6 | PER1(4) | 18600 | 4 | 3 | 4 | 0 | 1 | 3 | 0 | 0 | 0 | 0.066 | 0.30 |
138 | HSA04150_MTOR_SIGNALING_ PATHWAY | Genes involved in mTOR signaling pathway | 44 | BRAF(4), EIF4B(2), MAPK1(1), MAPK3(1), PIK3R5(4), RPS6KA2(2), TSC2(2), ULK2(1) | 137632 | 17 | 16 | 17 | 6 | 4 | 10 | 0 | 1 | 2 | 0.066 | 0.30 |
139 | HSA04514_CELL_ADHESION_ MOLECULES | Genes involved in cell adhesion molecules (CAMs) | 130 | CD22(4), CD99(1), CDH1(1), CDH3(1), CDH5(1), CNTN1(7), ICAM3(1), ITGA8(8), ITGAL(2), ITGAM(2), MAG(1), NLGN2(1), NRCAM(3), OCLN(1), PTPRC(4), PTPRF(4), PTPRM(5), PVRL1(4), PVRL3(1), SELL(1), SELP(6), VCAN(12) | 802216 | 71 | 46 | 71 | 21 | 15 | 43 | 5 | 1 | 7 | 0.067 | 0.30 |
140 | SIG_PIP3_SIGNALING_ IN_B_LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes | 33 | BTK(2), CD19(1), ITPR1(1), ITPR2(5), ITPR3(3), LYN(1), PTPRC(4), RPS6KA2(2), VAV1(5) | 240800 | 24 | 22 | 24 | 7 | 6 | 9 | 2 | 3 | 4 | 0.069 | 0.30 |
141 | HSA04330_NOTCH_SIGNALING_ PATHWAY | Genes involved in Notch signaling pathway | 43 | CREBBP(10), CTBP1(1), CTBP2(1), DLL3(2), DTX2(1), DVL1(1), DVL3(1), EP300(4), HDAC2(1), NCOR2(3), NCSTN(3), NOTCH1(6), NOTCH2(2), NOTCH3(3), NOTCH4(4) | 444984 | 43 | 32 | 43 | 11 | 8 | 23 | 2 | 4 | 6 | 0.070 | 0.31 |
142 | PANTOTHENATE_AND_ COA_BIOSYNTHESIS | 12 | DPYS(2), ENPP3(3), PANK3(1), PANK4(2) | 59870 | 8 | 8 | 8 | 0 | 2 | 4 | 0 | 2 | 0 | 0.071 | 0.31 | |
143 | SA_B_CELL_RECEPTOR_ COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. | 24 | BLNK(1), LYN(1), MAP3K1(4), MAPK1(1), MAPK3(1), MAPK8IP3(3), SOS1(3), VAV1(5) | 152605 | 19 | 19 | 19 | 2 | 5 | 10 | 1 | 2 | 1 | 0.072 | 0.31 |
144 | NKTPATHWAY | T cell differentiation into Th1 and Th2 cells occurs by differential chemokine receptor expression, which mediates tissue localization and immune response. | 28 | CXCR3(1), IL12RB2(2), IL4(1) | 19709 | 4 | 4 | 4 | 1 | 1 | 2 | 0 | 0 | 1 | 0.075 | 0.32 |
145 | S1PPATHWAY | At low cholesterol concentrations, sterol-regulatory element binding proteins (SREBPs) act as transcription factors to promote cholesterol uptake and biosynthesis. | 7 | LDLR(3) | 17745 | 3 | 3 | 3 | 0 | 1 | 1 | 0 | 1 | 0 | 0.078 | 0.33 |
146 | HSA04740_OLFACTORY_ TRANSDUCTION | Genes involved in olfactory transduction | 30 | ADCY3(3), CAMK2A(2), CAMK2D(1), CLCA4(2), CNGB1(3), GNAL(1) | 145273 | 12 | 12 | 12 | 2 | 6 | 2 | 0 | 2 | 2 | 0.080 | 0.34 |
147 | FLUMAZENILPATHWAY | Flumazenil is a benzodiazepine receptor antagonist that may induce protective preconditioning in ischemic cardiomyocytes. | 9 | GABRA3(3), PRKCE(2) | 23876 | 5 | 5 | 5 | 0 | 1 | 4 | 0 | 0 | 0 | 0.083 | 0.35 |
148 | PLK3PATHWAY | Active Plk3 phosphorylates CDC25c, blocking the G2/M transition, and phosphorylates p53 to induce apoptosis. | 7 | ATM(4) | 21839 | 4 | 4 | 4 | 0 | 1 | 2 | 0 | 1 | 0 | 0.086 | 0.35 |
149 | KERATINOCYTEPATHWAY | Keratinocyte differentiation, which models the differentiation of epidermal cells, requires the four main MAP kinase pathways. | 43 | EGFR(2), MAP2K6(2), MAP3K1(4), MAP3K14(1), MAPK1(1), MAPK3(1), PRKCA(3), PRKCE(2), RAF1(1), RELA(2), TNFRSF1A(2), TNFRSF1B(1) | 226611 | 22 | 20 | 22 | 7 | 7 | 9 | 0 | 2 | 4 | 0.086 | 0.35 |
150 | AKAP13PATHWAY | A-kinase anchor protein 13 (AKAP13) localizes protein kinase A holoenzyme and is a nucleotide exchange factor for Rho/Rac. | 7 | AKAP13(4) | 22005 | 4 | 4 | 4 | 1 | 1 | 2 | 0 | 1 | 0 | 0.086 | 0.35 |
151 | EXTRINSICPATHWAY | The extrinsic prothrombin activation pathway requires the release of thromboplastin from damaged tissues to activate the blood clotting cascade. | 13 | F5(5), FGG(1) | 41492 | 6 | 6 | 6 | 2 | 1 | 3 | 0 | 0 | 2 | 0.087 | 0.35 |
152 | ST_ERK1_ERK2_MAPK_ PATHWAY | The Erk1 and Erk2 MAP kinase pathways are regulated by Raf, Mos, and Tpl-2. | 29 | BRAF(4), CREB3(1), MAPK1(1), MAPK3(1), MKNK2(1), RPS6KA2(2), SOS1(3) | 128758 | 13 | 13 | 13 | 3 | 1 | 11 | 0 | 1 | 0 | 0.088 | 0.36 |
153 | CARM_ERPATHWAY | Methyltransferase CARM1 methylates CBP and co-activates estrogen receptors via Grip1. | 26 | BRCA1(5), CREBBP(10), EP300(4), HDAC2(1), NCOR2(3), NR0B1(1), POLR2A(2) | 349597 | 26 | 22 | 26 | 5 | 6 | 10 | 0 | 5 | 5 | 0.089 | 0.36 |
154 | TH1TH2PATHWAY | Helper T subtype Th1 produces pro-inflammatory cytokines that stimulate phagocytosis, while Th2 cells promote antibody production and activate eosinophils. | 17 | IL12RB2(2), IL4(1) | 16272 | 3 | 3 | 3 | 1 | 0 | 2 | 0 | 0 | 1 | 0.089 | 0.36 |
155 | APOPTOSIS_GENMAPP | 42 | BAK1(1), MAP3K1(4), MAP3K14(1), PARP1(2), RELA(2), TNFRSF1A(2), TNFRSF1B(1) | 136283 | 13 | 12 | 13 | 6 | 5 | 4 | 0 | 1 | 3 | 0.091 | 0.36 | |
156 | GLUCOCORTICOID_MINERALOCORTICOID_ METABOLISM | 8 | CYP11B2(3) | 26788 | 3 | 3 | 3 | 1 | 0 | 1 | 0 | 2 | 0 | 0.092 | 0.36 | |
157 | ST_INTERFERON_GAMMA_ PATHWAY | The interferon gamma pathway resembles the JAK-STAT pathway and activates STAT transcription factors. | 9 | JAK2(3), PTPRU(3), STAT1(1) | 54370 | 7 | 6 | 7 | 1 | 0 | 5 | 0 | 1 | 1 | 0.093 | 0.36 |
158 | OVARIAN_INFERTILITY_ GENES | 25 | ATM(4), CDK4(1), INHA(3), MLH1(2), MSH5(1), NCOR1(4), ZP2(3) | 157012 | 18 | 15 | 18 | 1 | 5 | 8 | 2 | 1 | 2 | 0.093 | 0.36 | |
159 | SIG_CHEMOTAXIS | Genes related to chemotaxis | 44 | ARHGEF11(7), BTK(2), ITPR1(1), ITPR2(5), ITPR3(3), MYLK(1), PAK1(1), RHO(1), WASL(1) | 286271 | 22 | 18 | 22 | 6 | 8 | 8 | 1 | 0 | 5 | 0.094 | 0.36 |
160 | CALCINEURINPATHWAY | Increased intracellular calcium activates the phosphatase calcineurin in differentiating keratinocytes. | 18 | PPP3CC(1), PRKCA(3) | 52885 | 4 | 4 | 4 | 0 | 0 | 1 | 0 | 1 | 2 | 0.095 | 0.36 |
161 | SIG_CD40PATHWAYMAP | Genes related to CD40 signaling | 33 | MAPK1(1), MAPK3(1), MAPK8IP1(4), MAPK8IP3(3), MAPKAPK5(1), NFKBIL2(5) | 137448 | 15 | 15 | 15 | 3 | 6 | 6 | 1 | 1 | 1 | 0.095 | 0.36 |
162 | BIOGENIC_AMINE_SYNTHESIS | 15 | DDC(3), PAH(2) | 30650 | 5 | 5 | 5 | 0 | 3 | 2 | 0 | 0 | 0 | 0.096 | 0.36 | |
163 | ST_INTEGRIN_SIGNALING_ PATHWAY | Integrins are transmembrane receptors that mediate cell growth, survival, and migration by binding to ligands in the extracellular matrix. | 78 | ARHGEF6(1), BRAF(4), DOCK1(3), EPHB2(3), GRLF1(2), ITGA1(1), ITGA2(5), ITGA5(1), ITGA7(2), ITGA8(8), MAP3K11(1), MAPK1(1), MAPK8IP1(4), MAPK8IP3(3), MYLK(1), PAK1(1), PTK2(2), RAF1(1), RHO(1), SOS1(3), TLN1(3), TLN2(2) | 625106 | 53 | 41 | 53 | 22 | 17 | 30 | 2 | 1 | 3 | 0.098 | 0.37 |
164 | GALACTOSE_METABOLISM | 24 | GALT(1), GANAB(4), HK1(3), MGAM(7), PFKP(2), PGM1(1) | 162622 | 18 | 16 | 18 | 5 | 5 | 10 | 0 | 1 | 2 | 0.099 | 0.37 | |
165 | ASBCELLPATHWAY | B cells require interaction with helper T cells to produce antigen-specific immunoglobulins as a key element of the human immune response. | 8 | IL4(1) | 1601 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.10 | 0.38 |
166 | GATA3PATHWAY | GATA-3 is a transcription factor that promotes differentiation of helper T cells into Th2 cells, which secrete cytokines IL4, IL5, and IL13. | 16 | IL4(1) | 1601 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.10 | 0.38 |
167 | INFLAMPATHWAY | Interleukins and TNF serve as signals to coordinate the inflammatory response, in which macrophages recruit and activate neutrophils, fibroblasts, and T cells. | 29 | IL4(1) | 1601 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.10 | 0.38 |
168 | STEMPATHWAY | In the absence of infection, bone marrow stromal cells release hematopoietic cytokines; activated macrophages and Th cells induce hematopoiesis during infection. | 15 | IL4(1) | 1601 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.10 | 0.38 |
169 | ERBB4PATHWAY | ErbB4 (aka HER4) is a receptor tyrosine kinase that binds neuregulins as well as members of the EGF family, which also target EGF receptors. | 6 | NRG2(2), PRKCA(3) | 39039 | 5 | 5 | 5 | 0 | 0 | 3 | 0 | 1 | 1 | 0.10 | 0.38 |
170 | ST_WNT_CA2_CYCLIC_ GMP_PATHWAY | Some Wnt glycoprotein/Frizzled receptor interactions increase intracellular calcium and decrease cGMP. | 19 | CAMK2A(2), CAMK2D(1), ITPR1(1), ITPR2(5), ITPR3(3), NFAT5(1), PDE6A(2), PDE6B(1) | 178205 | 16 | 16 | 16 | 5 | 7 | 5 | 1 | 0 | 3 | 0.11 | 0.38 |
171 | ST_STAT3_PATHWAY | The transcription factor STAT3 is involved in cell growth regulation and is commonly upregulated in tumors. | 11 | JAK2(3), PTPRU(3) | 46377 | 6 | 6 | 6 | 1 | 0 | 4 | 0 | 1 | 1 | 0.11 | 0.38 |
172 | METHANE_METABOLISM | 13 | PRDX2(1), TPO(5) | 43333 | 6 | 6 | 6 | 2 | 2 | 3 | 0 | 0 | 1 | 0.11 | 0.38 | |
173 | STILBENE_COUMARINE_ AND_LIGNIN_BIOSYNTHESIS | 10 | PRDX2(1), TPO(5) | 43333 | 6 | 6 | 6 | 2 | 2 | 3 | 0 | 0 | 1 | 0.11 | 0.38 | |
174 | ST_JAK_STAT_PATHWAY | The Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway transduces extracellular signals to promote gene activation. | 9 | JAK2(3), PIAS1(1), PTPRU(3) | 48492 | 7 | 7 | 7 | 1 | 1 | 4 | 0 | 1 | 1 | 0.11 | 0.38 |
175 | FMLPPATHWAY | The fMLP receptor is a G-protein coupled receptor in neutrophils that recognizes formylated bacterial peptides and activates NADPH oxidase. | 37 | MAP2K6(2), MAP3K1(4), MAPK1(1), MAPK3(1), PAK1(1), PIK3C2G(1), PLCB1(6), PPP3CC(1), RAF1(1), RELA(2) | 227565 | 20 | 17 | 20 | 9 | 8 | 7 | 0 | 1 | 4 | 0.11 | 0.38 |
176 | PLCDPATHWAY | Phospholipase C (PLC-d1) hydrolyzes the membrane lipid PIP2 to DAG and IP3, which induce calcium influx and activates protein kinase C. | 4 | PRKCA(3) | 23703 | 3 | 3 | 3 | 1 | 0 | 1 | 0 | 1 | 1 | 0.11 | 0.38 |
177 | ST_GAQ_PATHWAY | G-alpha-q activates phospholipase C, resulting in calcium influx and increasing protein kinase C activity. | 27 | ITPR1(1), ITPR2(5), ITPR3(3), NFKBIL2(5), PLD3(1) | 177118 | 15 | 15 | 15 | 5 | 6 | 4 | 1 | 1 | 3 | 0.11 | 0.39 |
178 | CHREBPPATHWAY | Carbohydrate responsive element binding protein (chREBP) is a transcription factor inhibited by cAMP and activated by high carbohydrate levels. | 17 | GNAS(2), PRKAG2(2) | 22804 | 4 | 4 | 4 | 2 | 1 | 2 | 0 | 0 | 1 | 0.11 | 0.39 |
179 | HIVNEFPATHWAY | HIV-infected CD4 helper T cells may express Fas ligand, which binds to the Fas receptors of uninfected cells and induces apoptosis. | 52 | BAG4(1), CFLAR(1), DFFB(1), MAP3K1(4), MAP3K14(1), PRKDC(4), PTK2(2), RASA1(2), RELA(2), SPTAN1(2), TNFRSF1A(2), TNFRSF1B(1) | 331822 | 23 | 21 | 23 | 7 | 8 | 8 | 0 | 1 | 6 | 0.12 | 0.41 |
180 | IL3PATHWAY | IL-3 promotes proliferation and differentiation of hematopoietic cells via a heterodimeric receptor that activates the Stat5 and MAP kinase pathways. | 15 | CSF2RB(4), JAK2(3), MAPK3(1), RAF1(1), SOS1(3), STAT5B(1) | 106400 | 13 | 13 | 13 | 3 | 3 | 8 | 0 | 1 | 1 | 0.12 | 0.41 |
181 | ST_B_CELL_ANTIGEN_ RECEPTOR | B cell receptors bind antigens and promote B cell activation. | 39 | BLNK(1), BTK(2), CD19(1), EPHB2(3), LYN(1), MAPK1(1), NFAT5(1), NFKBIL2(5), RAF1(1), SOS1(3), VAV1(5) | 251198 | 24 | 20 | 24 | 5 | 5 | 12 | 2 | 4 | 1 | 0.12 | 0.41 |
182 | CTLA4PATHWAY | T cell activation requires interaction with an antigen-MHC-I complex on an antigen-presenting cell (APC), as well as CD28 interaction with the APC's CD80 or 86. | 17 | CD3E(1) | 1942 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.12 | 0.41 |
183 | IL17PATHWAY | Activated T cells secrete IL-17, which stimulates fibroblasts and other cells to secrete inflammatory and hematopoietic cytokines. | 13 | CD3E(1) | 1942 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.12 | 0.41 |
184 | TCAPOPTOSISPATHWAY | HIV infection upregulates Fas ligand in macrophages and CD4 in helper T cells, leading to widespread Fas-induced T cell apoptosis. | 6 | CD3E(1) | 1942 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.12 | 0.41 |
185 | TCRMOLECULE | T Cell Receptor and CD3 Complex | 3 | CD3E(1) | 1942 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.12 | 0.41 |
186 | SIG_BCR_SIGNALING_ PATHWAY | Members of the BCR signaling pathway | 46 | BLNK(1), BTK(2), CD19(1), CD22(4), INPP5D(4), ITPR1(1), ITPR2(5), ITPR3(3), LYN(1), MAPK1(1), MAPK3(1), PPP3CC(1), PTPRC(4), RAF1(1), SOS1(3), VAV1(5) | 395007 | 38 | 33 | 38 | 9 | 10 | 17 | 3 | 3 | 5 | 0.13 | 0.42 |
187 | ST_IL_13_PATHWAY | Like IL-4, IL-13 is produced by Th2 cells on activation of the T cell antigen receptor, and by mast and basophil cells on activation of the IgE receptor. | 7 | JAK2(3) | 29641 | 3 | 3 | 3 | 0 | 0 | 1 | 0 | 1 | 1 | 0.14 | 0.44 |
188 | ST_INTERLEUKIN_13_ PATHWAY | IL-13 is produced by Th2 cells on activation of the T cell antigen receptor, and by mast and basophil cells on activation of the IgE receptor. | 7 | JAK2(3) | 29641 | 3 | 3 | 3 | 0 | 0 | 1 | 0 | 1 | 1 | 0.14 | 0.44 |
189 | CFTRPATHWAY | The cAMP-regulated chloride channel CFTR (deficient in cystic fibrosis) is regulated by the surface-localized beta-adrenergic receptor. | 11 | GNAS(2) | 9709 | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 0 | 0.14 | 0.44 |
190 | PHENYLALANINE_METABOLISM | 22 | ALDH3A1(1), AOC2(1), DDC(3), PRDX2(1), TAT(3), TPO(5) | 129129 | 14 | 13 | 14 | 5 | 4 | 7 | 1 | 0 | 2 | 0.14 | 0.44 | |
191 | HSA04110_CELL_CYCLE | Genes involved in cell cycle | 110 | ANAPC4(2), ATM(4), CDC25B(2), CDK4(1), CREBBP(10), EP300(4), HDAC2(1), ORC3L(1), PRKDC(4), RBL1(4), SMC1A(2) | 406210 | 35 | 27 | 35 | 10 | 9 | 14 | 3 | 4 | 5 | 0.14 | 0.44 |
192 | SELENOAMINO_ACID_ METABOLISM | 12 | MARS(1), MAT1A(1), PAPSS2(1), SCLY(1) | 29022 | 4 | 3 | 4 | 1 | 1 | 2 | 0 | 1 | 0 | 0.15 | 0.47 | |
193 | GLEEVECPATHWAY | The drug Gleevec specifically targets the abnormal bcr-abl protein, an apoptosis inhibitor present in chronic myeloid leukemia. | 22 | JAK2(3), MAP3K1(4), MAPK3(1), RAF1(1), SOS1(3), STAT1(1), STAT5B(1) | 118969 | 14 | 14 | 14 | 2 | 3 | 8 | 0 | 1 | 2 | 0.15 | 0.47 |
194 | FEEDERPATHWAY | Sugars such as mannose, galactose, and fructose are enzymatically converted to glucose via feeder pathways that lead to glycolysis. | 9 | HK1(3), PGM1(1) | 56996 | 4 | 4 | 4 | 0 | 4 | 0 | 0 | 0 | 0 | 0.15 | 0.47 |
195 | HSA00591_LINOLEIC_ ACID_METABOLISM | Genes involved in linoleic acid metabolism | 31 | CYP2C19(6), PLA2G4A(4) | 78868 | 10 | 10 | 10 | 8 | 3 | 5 | 0 | 1 | 1 | 0.15 | 0.47 |
196 | EPONFKBPATHWAY | The cytokine erythropoietin (Epo) prevents stress-induced neuronal apoptosis by stimulating anti-apoptotic pathways through JAK2 kinase and NF-kB. | 11 | EPOR(1), JAK2(3), RELA(2) | 62158 | 6 | 4 | 6 | 1 | 1 | 2 | 0 | 1 | 2 | 0.15 | 0.48 |
197 | HSA04012_ERBB_SIGNALING_ PATHWAY | Genes involved in ErbB signaling pathway | 85 | ARAF(1), BRAF(4), CAMK2A(2), CAMK2D(1), EGFR(2), ERBB3(2), KRAS(2), MAPK1(1), MAPK3(1), NRG2(2), PAK1(1), PIK3R5(4), PRKCA(3), PTK2(2), RAF1(1), SOS1(3), STAT5B(1) | 350789 | 33 | 29 | 33 | 11 | 9 | 18 | 0 | 2 | 4 | 0.16 | 0.48 |
198 | LYSINE_DEGRADATION | 31 | ALDH3A1(1), DLST(1), DOT1L(2), GCDH(1) | 137776 | 5 | 5 | 5 | 2 | 0 | 0 | 3 | 1 | 1 | 0.16 | 0.48 | |
199 | HSA00271_METHIONINE_ METABOLISM | Genes involved in methionine metabolism | 17 | DNMT1(3), MARS(1), MAT1A(1), TAT(3) | 64416 | 8 | 8 | 8 | 2 | 1 | 6 | 0 | 1 | 0 | 0.16 | 0.48 |
200 | HSA04070_PHOSPHATIDYLINOSITOL_ SIGNALING_SYSTEM | Genes involved in phosphatidylinositol signaling system | 73 | INPP5B(2), INPP5D(4), ITPR1(1), ITPR2(5), ITPR3(3), PI4KA(3), PIK3C2A(1), PIK3C2B(5), PIK3C2G(1), PIK3R5(4), PIP5K1C(1), PLCB1(6), PLCB4(3), PLCE1(6), PRKCA(3), SYNJ2(1) | 566037 | 49 | 37 | 49 | 15 | 12 | 25 | 1 | 4 | 7 | 0.16 | 0.48 |
201 | 1_2_DICHLOROETHANE_ DEGRADATION | 8 | ALDH3A1(1) | 7017 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0.16 | 0.48 | |
202 | ASCORBATE_AND_ALDARATE_ METABOLISM | 8 | ALDH3A1(1) | 7017 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0.16 | 0.48 | |
203 | HSA00053_ASCORBATE_ AND_ALDARATE_METABOLISM | Genes involved in ascorbate and aldarate metabolism | 9 | ALDH3A1(1) | 7017 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0.16 | 0.48 |
204 | HSA04350_TGF_BETA_ SIGNALING_PATHWAY | Genes involved in TGF-beta signaling pathway | 89 | ACVR1C(1), ACVRL1(2), BMPR1A(2), CREBBP(10), EP300(4), INHBC(1), MAPK1(1), MAPK3(1), NODAL(2), PPP2R2A(1), RBL1(4), SMURF2(1), ZFYVE16(1) | 418180 | 31 | 29 | 31 | 4 | 6 | 13 | 2 | 5 | 5 | 0.16 | 0.49 |
205 | P35ALZHEIMERSPATHWAY | p35, a neuron-specific activator of cyclin-dependent kinase 5, is cleaved to p25 in Alzheimer's disease and promotoes hyperphosphorylated tau formation and apoptosis. | 11 | CAPN1(2) | 9989 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 0.17 | 0.51 |
206 | HSA00150_ANDROGEN_ AND_ESTROGEN_METABOLISM | Genes involved in androgen and estrogen metabolism | 54 | ARSE(2), CYP11B1(5), CYP11B2(3), CYP19A1(3), HSD17B12(1), UGT1A7(1), UGT2B15(2), WBSCR22(1) | 192556 | 18 | 17 | 18 | 2 | 7 | 7 | 1 | 2 | 1 | 0.17 | 0.52 |
207 | CXCR4PATHWAY | CXCR4 is a G-protein coupled receptor that responds to the ligand SDF-1 by activating Ras and PI3 kinase to promote lymphocyte chemotaxis. | 23 | MAPK1(1), MAPK3(1), PIK3C2G(1), PRKCA(3), PTK2(2), RAF1(1), RELA(2) | 98923 | 11 | 9 | 11 | 7 | 3 | 5 | 0 | 1 | 2 | 0.18 | 0.52 |
208 | IFNGPATHWAY | IFN gamma signaling pathway | 6 | JAK2(3), STAT1(1) | 37634 | 4 | 4 | 4 | 0 | 0 | 2 | 0 | 1 | 1 | 0.18 | 0.52 |
209 | IL22BPPATHWAY | IL-22 is produced by T cells and induces the acute phase inflammatory response in hepatocytes. | 13 | IL10RA(1), IL22(1), IL22RA2(1), JAK2(3), STAT1(1), STAT5B(1) | 77011 | 8 | 8 | 8 | 3 | 1 | 4 | 0 | 1 | 2 | 0.18 | 0.53 |
210 | HSA00400_PHENYLALANINE_ TYROSINE_AND_TRYPTOPHAN_ BIOSYNTHESIS | Genes involved in phenylalanine, tyrosine and tryptophan biosynthesis | 9 | PAH(2), TAT(3) | 38582 | 5 | 5 | 5 | 1 | 3 | 2 | 0 | 0 | 0 | 0.19 | 0.54 |
211 | ANDROGEN_AND_ESTROGEN_ METABOLISM | 30 | ARSE(2), CYP11B1(5), CYP11B2(3), UGT1A7(1), UGT2B15(2) | 148732 | 13 | 13 | 13 | 1 | 5 | 5 | 1 | 2 | 0 | 0.19 | 0.54 | |
212 | PYK2PATHWAY | Pyk2 and Rac1 stimulate the JNK cascade and activate MKK3, which activates p38. | 28 | MAP3K1(4), MAPK1(1), MAPK3(1), PAK1(1), PRKCA(3), RAF1(1), SOS1(3) | 124133 | 14 | 14 | 14 | 3 | 4 | 7 | 0 | 1 | 2 | 0.19 | 0.54 |
213 | HSA04810_REGULATION_ OF_ACTIN_CYTOSKELETON | Genes involved in regulation of actin cytoskeleton | 203 | ACTN3(2), APC(7), ARAF(1), ARHGEF4(1), ARHGEF6(1), BRAF(4), CHRM1(1), CYFIP2(3), DOCK1(3), EGFR(2), FGD1(2), FGD3(4), GRLF1(2), ITGA1(1), ITGA2(5), ITGA5(1), ITGA7(2), ITGA8(8), ITGAD(7), ITGAL(2), ITGAM(2), ITGB4(2), ITGB6(1), KRAS(2), MAPK1(1), MAPK3(1), MYH10(2), MYH14(4), MYLK(1), NCKAP1L(4), PAK1(1), PDGFRB(5), PIK3R5(4), PIP5K1C(1), PPP1R12B(1), PTK2(2), RAF1(1), SOS1(3), TIAM2(1), TMSL3(1), VAV1(5), VCL(2), WASL(1) | 1322909 | 107 | 68 | 107 | 36 | 28 | 53 | 6 | 8 | 12 | 0.19 | 0.54 |
214 | ST_G_ALPHA_S_PATHWAY | The G-alpha-s protein activates adenylyl cyclases, which catalyze cAMP formation. | 12 | BRAF(4), CREB3(1), MAPK1(1), RAF1(1) | 50774 | 7 | 7 | 7 | 3 | 2 | 5 | 0 | 0 | 0 | 0.19 | 0.55 |
215 | PEPTIDE_GPCRS | 66 | ATP8A1(5), AVPR2(2), CXCR3(1), GALT(1), NPY1R(3), NTSR2(2) | 135133 | 14 | 13 | 14 | 2 | 2 | 10 | 0 | 1 | 1 | 0.20 | 0.57 | |
216 | CARDIACEGFPATHWAY | Cardiac hypertrophy, a response to high blood pressure, is stimulated by GPCR ligands such as angiotensin II that activate the EGF pathway. | 16 | ADAM12(2), EGFR(2), PRKCA(3), RELA(2) | 81809 | 9 | 8 | 9 | 3 | 2 | 4 | 1 | 1 | 1 | 0.20 | 0.57 |
217 | HSA04210_APOPTOSIS | Genes involved in apoptosis | 82 | ATM(4), CAPN1(2), CASP10(2), CFLAR(1), CSF2RB(4), DFFB(1), IL1B(1), IRAK1(4), MAP3K14(1), MYD88(1), NTRK1(5), PIK3R5(4), PPP3CC(1), RELA(2), TNFRSF1A(2) | 386919 | 35 | 28 | 35 | 13 | 10 | 17 | 1 | 3 | 4 | 0.20 | 0.57 |
218 | NICOTINATE_AND_NICOTINAMIDE_ METABOLISM | 13 | ENPP3(3), NNT(4), NT5E(1) | 63666 | 8 | 8 | 8 | 2 | 2 | 5 | 0 | 0 | 1 | 0.20 | 0.57 | |
219 | IL5PATHWAY | Pro-inflammatory IL-5 is secretes by activated T cells, eosinophils, and mast cells, and stimulates the proliferation and activation of eosinophils in bone marrow. | 10 | IL1B(1), IL4(1), IL5RA(2) | 24551 | 4 | 4 | 4 | 1 | 1 | 3 | 0 | 0 | 0 | 0.20 | 0.57 |
220 | RAC1PATHWAY | Rac-1 is a Rho family G protein that stimulates formation of actin-dependent structures such as filopodia and lamellopodia. | 22 | MAP3K1(4), MYLK(1), PAK1(1), PPP1R12B(1), RALBP1(1), TRIO(3), VAV1(5) | 183219 | 16 | 14 | 16 | 6 | 5 | 6 | 1 | 3 | 1 | 0.21 | 0.57 |
221 | APOPTOSIS_KEGG | 48 | CASP10(2), DFFB(1), NTRK1(5), PTPN13(2), SFRS2IP(1), TNFRSF1A(2), TNFRSF1B(1) | 144217 | 14 | 14 | 14 | 2 | 2 | 8 | 0 | 2 | 2 | 0.21 | 0.57 | |
222 | HSA00565_ETHER_LIPID_ METABOLISM | Genes involved in ether lipid metabolism | 30 | AGPAT4(1), ENPP2(3), PLA2G4A(4) | 69005 | 8 | 8 | 8 | 8 | 1 | 5 | 0 | 1 | 1 | 0.21 | 0.57 |
223 | METHIONINE_METABOLISM | 12 | DNMT1(3), MARS(1), MAT1A(1) | 45467 | 5 | 5 | 5 | 1 | 0 | 4 | 0 | 1 | 0 | 0.21 | 0.57 | |
224 | BIOPEPTIDESPATHWAY | Extracellular signaling peptides exert biological effects via G-protein coupled receptors (GPCRs), which activate intracellular GTPases. | 37 | CAMK2A(2), CAMK2D(1), JAK2(3), MAPK1(1), MAPK3(1), MYLK(1), PRKCA(3), RAF1(1), SOS1(3), STAT1(1) | 169961 | 17 | 17 | 17 | 6 | 4 | 9 | 0 | 2 | 2 | 0.21 | 0.57 |
225 | HSA00310_LYSINE_ DEGRADATION | Genes involved in lysine degradation | 47 | ALDH3A1(1), DLST(1), DOT1L(2), GCDH(1), HSD17B4(1), SETD1A(5) | 227317 | 11 | 11 | 11 | 5 | 1 | 4 | 4 | 1 | 1 | 0.21 | 0.57 |
226 | FREEPATHWAY | Neutrophils release superoxide to induce lysis in invading bacteria; in neighboring endothelial cells, superoxide dismutase scavenges radicals but produces pro-apoptotic peroxides. | 10 | GSR(2), RELA(2) | 53442 | 4 | 3 | 4 | 1 | 1 | 1 | 0 | 2 | 0 | 0.21 | 0.58 |
227 | HSA00520_NUCLEOTIDE_ SUGARS_METABOLISM | Genes involved in nucleotide sugars metabolism | 6 | GALT(1) | 3300 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.21 | 0.58 |
228 | NUCLEOTIDE_SUGARS_ METABOLISM | 5 | GALT(1) | 3300 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.21 | 0.58 | |
229 | TOLLPATHWAY | Toll-like receptors are activated by bacterial lipoproteins, lipopolysaccharides, and other surface molecules, and activate pro-inflammatory factors such as NF-kB. | 32 | IRAK1(4), MAP2K6(2), MAP3K1(4), MAP3K14(1), MYD88(1), RELA(2), TLR9(1), TOLLIP(1) | 201970 | 16 | 14 | 16 | 6 | 6 | 5 | 1 | 1 | 3 | 0.22 | 0.60 |
230 | ERKPATHWAY | Cell growth is promoted by Ras activation of the anti-apoptotic p44/42 MAP kinase pathway. | 29 | EGFR(2), GNAS(2), MAPK1(1), MAPK3(1), MKNK2(1), RAF1(1), SOS1(3) | 112885 | 11 | 11 | 11 | 5 | 2 | 9 | 0 | 0 | 0 | 0.23 | 0.60 |
231 | HIFPATHWAY | Under normal conditions, hypoxia inducible factor HIF-1 is degraded; under hypoxic conditions, it activates transcription of genes controlled by hpoxic response elements (HREs). | 13 | EP300(4), NOS3(1) | 45322 | 5 | 5 | 5 | 3 | 0 | 5 | 0 | 0 | 0 | 0.23 | 0.60 |
232 | CERAMIDEPATHWAY | Ceramide is a lipid signaling molecule that can activate proliferative or apoptotic pathways, depending on signaling context, localization, and cell type. | 21 | MAP3K1(4), MAPK1(1), MAPK3(1), RAF1(1), RELA(2), TNFRSF1A(2) | 103899 | 11 | 10 | 11 | 3 | 5 | 5 | 0 | 0 | 1 | 0.23 | 0.60 |
233 | ATRBRCAPATHWAY | BRCA1 and 2 block cell cycle progression in response to DNA damage and promote double-stranded break repair; mutations induce breast cancer susceptibility. | 21 | ATM(4), BRCA1(5), RAD1(1), RAD50(3), RAD51(1) | 163542 | 14 | 12 | 14 | 1 | 1 | 9 | 0 | 2 | 2 | 0.23 | 0.60 |
234 | MEF2DPATHWAY | Mef2 transcription factors promote calcium-induced apoptosis in T cells and are regulated by MAP kinases and histone deacetylases. | 18 | EP300(4), HDAC2(1), PPP3CC(1), PRKCA(3) | 121933 | 9 | 9 | 9 | 5 | 0 | 5 | 0 | 2 | 2 | 0.23 | 0.60 |
235 | PURINE_METABOLISM | 110 | ADA(1), ADCY2(11), ADCY3(3), ADCY4(3), ADCY5(2), ADCY8(8), ENPP3(3), GUCY2C(3), GUCY2D(1), NT5E(1), PAPSS2(1), PDE1A(2), PDE4A(1), PDE4C(1), PDE6B(1), PDE8A(2), PFAS(5), POLD1(1), POLQ(6), POLR2A(2), POLR2F(1), RRM1(1) | 903203 | 60 | 42 | 59 | 18 | 14 | 30 | 3 | 10 | 3 | 0.24 | 0.62 | |
236 | CIRCADIAN_EXERCISE | 40 | HERPUD1(1), PER1(4), ZFR(4) | 81059 | 9 | 8 | 9 | 1 | 2 | 5 | 0 | 1 | 1 | 0.24 | 0.62 | |
237 | HSA00670_ONE_CARBON_ POOL_BY_FOLATE | Genes involved in one carbon pool by folate | 16 | ALDH1L1(2), MTHFD1L(1) | 28439 | 3 | 3 | 3 | 1 | 0 | 2 | 0 | 1 | 0 | 0.24 | 0.62 |
238 | ONE_CARBON_POOL_ BY_FOLATE | 15 | ALDH1L1(2), MTHFD1L(1) | 28439 | 3 | 3 | 3 | 1 | 0 | 2 | 0 | 1 | 0 | 0.24 | 0.62 | |
239 | BLYMPHOCYTEPATHWAY | B cells express the major histocompatibility complex (class II MHC), immunoglobulins, adhesion proteins, and other factors on their cell surface. | 10 | CR1(2), FCGR2B(2), ITGAL(2), PTPRC(4) | 98937 | 10 | 10 | 10 | 4 | 4 | 5 | 1 | 0 | 0 | 0.24 | 0.62 |
240 | GPCRPATHWAY | G-protein coupled receptors activate adenylyl cyclase, which converts ATP to cAMP, to activate second messenger pathways. | 34 | GNAS(2), MAPK3(1), PPP3CC(1), PRKCA(3), RAF1(1) | 87694 | 8 | 8 | 8 | 3 | 1 | 4 | 0 | 1 | 2 | 0.24 | 0.62 |
241 | SA_MMP_CYTOKINE_ CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. | 15 | FCGR3A(2), IL1B(1), SELL(1), TNFRSF1A(2), TNFRSF1B(1) | 76010 | 7 | 7 | 7 | 1 | 3 | 2 | 0 | 1 | 1 | 0.24 | 0.62 |
242 | VIPPATHWAY | Apoptosis of activated T cells is inhibited by vasoactive intestinal peptide (VIP) and its relative PACAP. | 27 | MAP3K1(4), PPP3CC(1), RELA(2) | 80041 | 7 | 6 | 7 | 3 | 3 | 2 | 0 | 0 | 2 | 0.24 | 0.62 |
243 | NKCELLSPATHWAY | Natural killer (NK) lymphocytes are inhibited by MHC and activated by surface glycoproteins on tumor or virus-infected cells, which undergo perforin-mediated lysis. | 20 | KLRC3(1), MAPK3(1), PAK1(1), VAV1(5) | 98338 | 8 | 7 | 8 | 1 | 2 | 3 | 1 | 2 | 0 | 0.25 | 0.64 |
244 | HSA04710_CIRCADIAN_ RHYTHM | Genes involved in circadian rhythm | 11 | PER1(4), PER3(2) | 56477 | 6 | 5 | 6 | 3 | 2 | 3 | 0 | 1 | 0 | 0.25 | 0.64 |
245 | 41BBPATHWAY | TNF-type receptor 4-1BB is bound by TRAF1 to activate the MAP kinase pathway in activated T cells. | 18 | IL4(1), MAP3K1(4), RELA(2) | 60131 | 7 | 5 | 7 | 3 | 3 | 3 | 0 | 0 | 1 | 0.26 | 0.64 |
246 | TNFR2PATHWAY | Tumor necrosis factor beta, produced by activated lymphocytes, binds to its receptor TNFR2 to induce activation in immune cells and apoptosis in many other cells. | 18 | MAP3K1(4), MAP3K14(1), RELA(2), TNFRSF1B(1) | 103223 | 8 | 7 | 8 | 4 | 3 | 2 | 0 | 1 | 2 | 0.26 | 0.64 |
247 | PDGFPATHWAY | Platelet-derived growth factor (PDGF) receptor is phosphorylated on ligand binding and promotes cell proliferation. | 26 | MAP3K1(4), MAPK3(1), PRKCA(3), RAF1(1), RASA1(2), SOS1(3), STAT1(1) | 201694 | 15 | 15 | 15 | 2 | 3 | 7 | 0 | 1 | 4 | 0.26 | 0.65 |
248 | TCRAPATHWAY | The kinases Lck and Fyn phosphorylate and activate the T cell receptor, which recognizes antigen-bound MHCII and leads to T cell activation. | 10 | CD3E(1), PTPRC(4) | 44710 | 5 | 5 | 5 | 2 | 1 | 3 | 1 | 0 | 0 | 0.26 | 0.65 |
249 | SA_PROGRAMMED_CELL_ DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. | 12 | BAK1(1) | 8259 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0.26 | 0.65 |
250 | IL1RPATHWAY | The cytokine IL-1 stimulates its primary receptor, IL-1R1, which induces transcription of inflammation-related genes such as interferons. | 31 | IL1B(1), IRAK1(4), MAP2K6(2), MAP3K1(4), MAP3K14(1), MYD88(1), RELA(2), TOLLIP(1) | 230805 | 16 | 14 | 16 | 8 | 7 | 4 | 1 | 1 | 3 | 0.27 | 0.65 |
251 | CREBPATHWAY | CREB is a transcription factor that binds to cAMP-responsive elements (CREs) to activate transcription in response to extracellular signaling. | 26 | CAMK2A(2), CAMK2D(1), GNAS(2), MAPK1(1), MAPK3(1), PRKCA(3), SOS1(3) | 122035 | 13 | 13 | 13 | 4 | 3 | 8 | 0 | 1 | 1 | 0.27 | 0.66 |
252 | RIBOFLAVIN_METABOLISM | 10 | ACPP(1), ENPP3(3) | 30603 | 4 | 4 | 4 | 0 | 2 | 2 | 0 | 0 | 0 | 0.27 | 0.67 | |
253 | HSA04920_ADIPOCYTOKINE_ SIGNALING_PATHWAY | Genes involved in adipocytokine signaling pathway | 71 | ACACB(6), ACSL3(1), ADIPOR1(2), CAMKK1(2), CD36(1), IRS4(3), JAK2(3), LEPR(8), PRKAG2(2), RELA(2), SLC2A4(1), TNFRSF1A(2), TNFRSF1B(1) | 412001 | 34 | 27 | 34 | 6 | 11 | 15 | 3 | 3 | 2 | 0.28 | 0.68 |
254 | HSA04310_WNT_SIGNALING_ PATHWAY | Genes involved in Wnt signaling pathway | 146 | APC(7), CAMK2A(2), CAMK2D(1), CHD8(6), CREBBP(10), CTBP1(1), CTBP2(1), DAAM1(2), DVL1(1), DVL3(1), EP300(4), FZD2(2), LRP5(3), LRP6(1), NFAT5(1), PLCB1(6), PLCB4(3), PPP2R2A(1), PPP3CC(1), PRKCA(3), SENP2(1), WNT7A(2), WNT8A(1), WNT9A(1) | 836151 | 62 | 42 | 62 | 17 | 15 | 28 | 3 | 7 | 9 | 0.28 | 0.68 |
255 | HBXPATHWAY | Hbx is a hepatitis B protein that activates a number of transcription factors, possibly by inducing calcium release from the mitochondrion to the cytoplasm. | 8 | SOS1(3) | 21786 | 3 | 3 | 3 | 1 | 0 | 3 | 0 | 0 | 0 | 0.29 | 0.69 |
256 | GSK3PATHWAY | Bacterial lipopolysaccharide activates AKT to promote the survival and activation of macrophages and inhibits Gsk3-beta to promote beta-catenin accumulation in the nucleus. | 26 | APC(7), DVL1(1), IRAK1(4), MYD88(1), RELA(2), TOLLIP(1) | 193783 | 16 | 15 | 16 | 2 | 5 | 6 | 2 | 2 | 1 | 0.29 | 0.69 |
257 | GLYCINE_SERINE_AND_ THREONINE_METABOLISM | 37 | AGXT2(3), AOC2(1), DLD(1), GLDC(3), SARDH(3) | 177000 | 11 | 11 | 11 | 4 | 3 | 5 | 3 | 0 | 0 | 0.29 | 0.69 | |
258 | HSA04662_B_CELL_ RECEPTOR_SIGNALING_ PATHWAY | Genes involved in B cell receptor signaling pathway | 63 | BLNK(1), BTK(2), CD19(1), CD22(4), FCGR2B(2), INPP5D(4), KRAS(2), LYN(1), NFAT5(1), PIK3R5(4), PPP3CC(1), RASGRP3(2), VAV1(5) | 392519 | 30 | 26 | 30 | 8 | 7 | 12 | 3 | 4 | 4 | 0.29 | 0.69 |
259 | ST_GA13_PATHWAY | G-alpha-13 influences the actin cytoskeleton and activates protein kinase D, PI3K, and Pyk2. | 35 | ARHGEF11(7), LPA(6), MAP3K1(4), NFKBIL2(5), PLD3(1), PTK2(2), TBXA2R(1) | 312077 | 26 | 20 | 26 | 7 | 9 | 12 | 2 | 1 | 2 | 0.29 | 0.69 |
260 | ARGININE_AND_PROLINE_ METABOLISM | 43 | ALDH3A1(1), AOC2(1), CPS1(9), NOS3(1), SMS(2) | 142334 | 14 | 12 | 14 | 4 | 3 | 8 | 1 | 0 | 2 | 0.29 | 0.69 | |
261 | CD40PATHWAY | The CD40 receptor is a TNF-type receptor that regulates immunoglobulin expression in B cells and moderates T cell activation via T-cell expression of its ligand. | 13 | MAP3K1(4), MAP3K14(1), RELA(2) | 92143 | 7 | 6 | 7 | 4 | 3 | 2 | 0 | 0 | 2 | 0.30 | 0.70 |
262 | HCMVPATHWAY | Cytomegalovirus activates MAP kinase pathways in the host cell, inducing transcription of viral genes. | 16 | MAP2K6(2), MAP3K1(4), MAPK1(1), MAPK3(1), RELA(2) | 100137 | 10 | 9 | 10 | 3 | 3 | 5 | 0 | 0 | 2 | 0.30 | 0.71 |
263 | STAT3PATHWAY | The STAT transcription factors are phosphorylated and activated by JAK kinases in response to cytokine signaling. | 7 | JAK2(3), MAPK1(1), MAPK3(1) | 60037 | 5 | 5 | 5 | 0 | 0 | 3 | 0 | 1 | 1 | 0.30 | 0.71 |
264 | CALCINEURIN_NF_AT_ SIGNALING | Mouse genes associated with signal transduction through calcium, calcineurin, and NF-AT. | 92 | CAMK4(1), CD3E(1), CREBBP(10), EP300(4), FCGR3A(2), GRLF1(2), IL1B(1), IL4(1), NFAT5(1), PAK1(1), PPP3CC(1), PTPRC(4), RELA(2), VAV1(5), XPO5(1) | 496441 | 37 | 26 | 37 | 15 | 10 | 15 | 2 | 4 | 6 | 0.30 | 0.71 |
265 | INOSITOL_PHOSPHATE_ METABOLISM | 23 | PIK3C2A(1), PIK3C2B(5), PIK3C2G(1), PLCB1(6), PLCB4(3) | 155169 | 16 | 15 | 16 | 7 | 4 | 8 | 1 | 1 | 2 | 0.30 | 0.71 | |
266 | HISTONE_METHYLTRANSFERASE | Genes with HMT activity | 57 | ASH1L(5), ASH2L(1), DOT1L(2), EZH1(2), JMJD6(1), KDM6A(4), MEN1(1), MLL(2), MLL4(3), OGT(2), SETD1A(5), SETD2(4), WHSC1L1(3) | 538096 | 35 | 27 | 35 | 9 | 3 | 18 | 3 | 4 | 7 | 0.31 | 0.71 |
267 | HSA01031_GLYCAN_ STRUCTURES_BIOSYNTHESIS_ 2 | Genes involved in glycan structures - biosynthesis 2 | 60 | B4GALT3(1), FUT6(2), PIGG(2), PIGO(2), PIGQ(1), ST3GAL4(1), UGCG(1) | 147244 | 10 | 10 | 10 | 5 | 2 | 3 | 1 | 2 | 2 | 0.31 | 0.71 |
268 | HSA00521_STREPTOMYCIN_ BIOSYNTHESIS | Genes involved in streptomycin biosynthesis | 10 | HK1(3), PGM1(1) | 85505 | 4 | 4 | 4 | 1 | 4 | 0 | 0 | 0 | 0 | 0.31 | 0.71 |
269 | STREPTOMYCIN_BIOSYNTHESIS | 8 | HK1(3), PGM1(1) | 85505 | 4 | 4 | 4 | 1 | 4 | 0 | 0 | 0 | 0 | 0.31 | 0.71 | |
270 | HSA00562_INOSITOL_ PHOSPHATE_METABOLISM | Genes involved in inositol phosphate metabolism | 47 | INPP5B(2), PI4KA(3), PIP5K1C(1), PLCB1(6), PLCB4(3), PLCE1(6), SYNJ2(1) | 250659 | 22 | 18 | 22 | 5 | 5 | 14 | 1 | 2 | 0 | 0.31 | 0.72 |
271 | ALKPATHWAY | Activin receptor-like kinase 3 (ALK3) is required during gestation for cardiac muscle development. | 32 | APC(7), BMPR1A(2), DVL1(1) | 119877 | 10 | 10 | 10 | 0 | 2 | 4 | 1 | 2 | 1 | 0.32 | 0.72 |
272 | HSA04660_T_CELL_ RECEPTOR_SIGNALING_ PATHWAY | Genes involved in T cell receptor signaling pathway | 93 | CD3E(1), CDK4(1), GRAP2(1), IL4(1), KRAS(2), MAP3K14(1), NFAT5(1), PAK1(1), PIK3R5(4), PPP3CC(1), PTPRC(4), SOS1(3), VAV1(5) | 324271 | 26 | 25 | 26 | 7 | 6 | 11 | 2 | 3 | 4 | 0.32 | 0.72 |
273 | HSA00512_O_GLYCAN_ BIOSYNTHESIS | Genes involved in O-glycan biosynthesis | 30 | B4GALT5(1), GALNT2(2), GALNT6(3), GALNT7(2), GALNT8(1), GALNTL1(2), OGT(2) | 156141 | 13 | 13 | 13 | 3 | 1 | 11 | 0 | 0 | 1 | 0.33 | 0.73 |
274 | CHONDROITIN | 8 | XYLT2(1) | 10142 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0.33 | 0.73 | |
275 | HEPARAN_SULFATE_ BIOSYNTHESIS | 8 | XYLT2(1) | 10142 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0.33 | 0.73 | |
276 | AT1RPATHWAY | Binding of angiotensin II to AT1-R activates Ca2+ signaling and the JNK pathway. | 33 | EGFR(2), MAP3K1(4), MAPK1(1), MAPK3(1), PAK1(1), PRKCA(3), PTK2(2), RAF1(1), SOS1(3) | 185598 | 18 | 17 | 18 | 5 | 6 | 9 | 0 | 1 | 2 | 0.33 | 0.73 |
277 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. | 7 | CDC25B(2) | 26740 | 2 | 2 | 2 | 1 | 0 | 1 | 1 | 0 | 0 | 0.33 | 0.74 |
278 | HSA00052_GALACTOSE_ METABOLISM | Genes involved in galactose metabolism | 32 | GALT(1), HK1(3), MGAM(7), PFKP(2), PGM1(1) | 158349 | 14 | 12 | 14 | 5 | 5 | 7 | 0 | 1 | 1 | 0.33 | 0.74 |
279 | PLCEPATHWAY | Gs-coupled receptors activate adenylyl cyclase, which activates Epac1, leading to the stimulation of PLC and subsequent DAG and IP3 production. | 12 | GNAS(2), PLCE1(6) | 83615 | 8 | 8 | 8 | 3 | 1 | 6 | 0 | 1 | 0 | 0.34 | 0.74 |
280 | FXRPATHWAY | The nuclear receptor transcription factors FXR and LXR are activated by cholesterol metabolites and regulate cholesterol homeostasis. | 6 | LDLR(3) | 38263 | 3 | 3 | 3 | 0 | 1 | 1 | 0 | 1 | 0 | 0.35 | 0.78 |
281 | HSA00600_SPHINGOLIPID_ METABOLISM | Genes involved in sphingolipid metabolism | 36 | ARSE(2), NEU1(2), SMPD2(3), SMPD3(2), UGCG(1) | 181332 | 10 | 8 | 10 | 0 | 6 | 2 | 1 | 1 | 0 | 0.36 | 0.80 |
282 | ST_FAS_SIGNALING_ PATHWAY | The Fas receptor induces apoptosis and NF-kB activation when bound to Fas ligand. | 59 | BAK1(1), BTK(2), CAD(2), CASP10(2), EGFR(2), EPHB2(3), FAIM2(1), MAP3K1(4), MAPK1(1), MAPK8IP1(4), MAPK8IP3(3), MET(2), NFAT5(1), NFKBIL2(5), PTPN13(2), RALBP1(1) | 439439 | 36 | 27 | 36 | 6 | 11 | 16 | 2 | 4 | 3 | 0.37 | 0.80 |
283 | EGFPATHWAY | The epidermal growth factor (EGF) peptide stimulates the EGF receptor to promote cell proliferation via the MAP kinase and Ras pathways. | 26 | EGFR(2), MAP3K1(4), MAPK3(1), PRKCA(3), RAF1(1), RASA1(2), SOS1(3), STAT1(1) | 239569 | 17 | 17 | 17 | 3 | 4 | 8 | 0 | 1 | 4 | 0.37 | 0.80 |
284 | SIG_REGULATION_OF_ THE_ACTIN_CYTOSKELETON_ BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton | 35 | ACTG2(3), FLNA(4), MYH2(14), MYLK(1), PAK1(1), RHO(1), WASL(1) | 290075 | 25 | 21 | 25 | 6 | 6 | 14 | 0 | 2 | 3 | 0.37 | 0.80 |
285 | ST_TUMOR_NECROSIS_ FACTOR_PATHWAY | Tumor necrosis factor is a pro-inflammatory cytokine that activates NF-kB and c-Jun. | 28 | BAG4(1), CFLAR(1), NFKBIL2(5), RALBP1(1), TNFRSF1A(2), TNFRSF1B(1) | 187906 | 11 | 11 | 11 | 2 | 3 | 3 | 1 | 3 | 1 | 0.37 | 0.80 |
286 | NOTCHPATHWAY | Proteolysis and Signaling Pathway of Notch | 5 | NOTCH1(6) | 69622 | 6 | 5 | 6 | 1 | 0 | 5 | 0 | 0 | 1 | 0.37 | 0.80 |
287 | RASPATHWAY | Ras activation stimulates many signaling cascades, including PI3K/AKT activation to inhibit apoptosis. | 21 | MAPK3(1), RAF1(1), RALBP1(1), RELA(2) | 59969 | 5 | 4 | 5 | 3 | 2 | 2 | 0 | 1 | 0 | 0.37 | 0.80 |
288 | HSA00360_PHENYLALANINE_ METABOLISM | Genes involved in phenylalanine metabolism | 27 | ALDH3A1(1), AOC2(1), DDC(3), TAT(3), TPO(5) | 143409 | 13 | 12 | 13 | 7 | 3 | 7 | 1 | 0 | 2 | 0.38 | 0.80 |
289 | P38MAPKPATHWAY | The Rho family GTPases activate the p38 MAPKs under environmental stress or in the presence of pro-inflammatory cytokines. | 39 | MAP2K6(2), MAP3K1(4), MAPKAPK5(1), MAX(1), PLA2G4A(4), STAT1(1) | 165215 | 13 | 13 | 13 | 5 | 3 | 6 | 0 | 1 | 3 | 0.38 | 0.81 |
290 | BADPATHWAY | When phosphorylated, BAD is inhibited by sequestration; when non-phosphorylated, it promotes apoptosis by inactivating pro-survival BCL-XL and BCL-2. | 22 | CSF2RB(4) | 38474 | 4 | 4 | 4 | 2 | 2 | 2 | 0 | 0 | 0 | 0.38 | 0.81 |
291 | EIF4PATHWAY | The eIF-4F complex recognizes 5' mRNA caps, recruits RNA helicases, and maintains mRNA-ribosome bridging. | 22 | EIF4A1(1), EIF4G3(2), MAPK1(1), MAPK3(1), PRKCA(3) | 112777 | 8 | 8 | 8 | 2 | 0 | 5 | 0 | 1 | 2 | 0.38 | 0.81 |
292 | HSA04060_CYTOKINE_ CYTOKINE_RECEPTOR_ INTERACTION | Genes involved in cytokine-cytokine receptor interaction | 252 | BMPR1A(2), CSF1R(2), CSF2RB(4), CXCR3(1), EGFR(2), EPOR(1), FLT4(1), IFNA16(2), IL10RA(1), IL11RA(1), IL12RB2(2), IL18RAP(3), IL1B(1), IL21R(2), IL22(1), IL22RA2(1), IL4(1), IL5RA(2), INHBC(1), LEPR(8), MET(2), PDGFRB(5), PLEKHO2(3), TNFRSF1A(2), TNFRSF1B(1), TPO(5) | 763845 | 57 | 45 | 57 | 18 | 18 | 25 | 5 | 4 | 5 | 0.39 | 0.82 |
293 | HSA04650_NATURAL_ KILLER_CELL_MEDIATED_ CYTOTOXICITY | Genes involved in natural killer cell mediated cytotoxicity | 126 | ARAF(1), BRAF(4), FCGR3A(2), IFNA16(2), ITGAL(2), KLRC3(1), KRAS(2), MAPK1(1), MAPK3(1), NFAT5(1), PAK1(1), PIK3R5(4), PPP3CC(1), PRKCA(3), RAF1(1), SOS1(3), VAV1(5) | 449244 | 35 | 33 | 35 | 11 | 7 | 17 | 2 | 4 | 5 | 0.39 | 0.82 |
294 | PTDINSPATHWAY | Phosphoinositide 3 kinase (PI3K) phosphorylate inositol rings of phosphoinositide lipids, influencing vesicle trafficking, cell proliferation, and migration. | 22 | BTK(2), LYN(1), PFKP(2), PRKCE(2), PRKCZ(1), RAB5A(1) | 88235 | 9 | 8 | 9 | 1 | 2 | 6 | 0 | 0 | 1 | 0.40 | 0.83 |
295 | HSA00330_ARGININE_ AND_PROLINE_METABOLISM | Genes involved in arginine and proline metabolism | 34 | CPS1(9), NOS3(1) | 104376 | 10 | 9 | 10 | 2 | 3 | 6 | 0 | 0 | 1 | 0.40 | 0.83 |
296 | GSPATHWAY | Activated G-protein coupled receptors stimulate cAMP production and thus activate protein kinase A, involved in a number of signal transduction pathways. | 6 | GNAS(2) | 16178 | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 0 | 0.40 | 0.83 |
297 | G1PATHWAY | CDK4/6-cyclin D and CDK2-cyclin E phosphorylate Rb, which allows the transcription of genes needed for the G1/S cell cycle transition. | 25 | ATM(4), CDK4(1) | 56264 | 5 | 5 | 5 | 0 | 2 | 2 | 0 | 1 | 0 | 0.40 | 0.83 |
298 | HSA00430_TAURINE_ AND_HYPOTAURINE_ METABOLISM | Genes involved in taurine and hypotaurine metabolism | 6 | CSAD(1) | 13358 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0.40 | 0.83 |
299 | GLUTAMATE_METABOLISM | 24 | CAD(2), CPS1(9) | 112678 | 11 | 10 | 11 | 2 | 3 | 7 | 0 | 0 | 1 | 0.41 | 0.84 | |
300 | HSA00650_BUTANOATE_ METABOLISM | Genes involved in butanoate metabolism | 45 | AACS(2), ACSM1(3), ALDH3A1(1), HSD17B4(1) | 91858 | 7 | 7 | 7 | 3 | 1 | 3 | 1 | 1 | 1 | 0.41 | 0.84 |
301 | FASPATHWAY | Binding of the Fas ligand to the Fas receptor induces caspase activation and consequent apoptosis in the Fas-expressing cell. | 27 | CASP10(2), CFLAR(1), DFFB(1), MAP3K1(4), PAK1(1), PRKDC(4), PTPN13(2), SPTAN1(2) | 230379 | 17 | 15 | 17 | 4 | 6 | 8 | 0 | 0 | 3 | 0.41 | 0.84 |
302 | RACCYCDPATHWAY | Ras, Rac, and Rho coordinate to induce cyclin D1 expression and activate cdk2 to promote the G1/S transition. | 22 | CDK4(1), MAPK1(1), MAPK3(1), PAK1(1), RAF1(1), RELA(2) | 87189 | 7 | 6 | 7 | 2 | 4 | 3 | 0 | 0 | 0 | 0.41 | 0.85 |
303 | HSA00230_PURINE_ METABOLISM | Genes involved in purine metabolism | 142 | ADA(1), ADCY2(11), ADCY3(3), ADCY4(3), ADCY5(2), ADCY8(8), AK7(1), ENPP3(3), GUCY2C(3), GUCY2D(1), NT5C2(1), NT5C3(2), NT5E(1), PAPSS2(1), PDE10A(4), PDE1A(2), PDE4A(1), PDE4C(1), PDE8A(2), PFAS(5), POLD1(1), POLR2A(2), POLR2F(1), RRM1(1), RRM2B(2) | 943978 | 63 | 44 | 62 | 23 | 14 | 32 | 4 | 9 | 4 | 0.42 | 0.86 |
304 | CELL2CELLPATHWAY | Epithelial cell adhesion proteins such as cadherins transduce signals into the cell via catenins, which alter cell shape and motility. | 13 | ACTN3(2), PTK2(2), VCL(2) | 106692 | 6 | 6 | 6 | 2 | 2 | 2 | 0 | 2 | 0 | 0.43 | 0.86 |
305 | HSA04115_P53_SIGNALING_ PATHWAY | Genes involved in p53 signaling pathway | 65 | ATM(4), BAI1(5), CDK4(1), DDB2(1), RRM2B(2), TSC2(2) | 166324 | 15 | 12 | 15 | 2 | 3 | 8 | 1 | 2 | 1 | 0.43 | 0.86 |
306 | ATP_SYNTHESIS | 21 | ATP6V0A1(3), ATP6V1B1(2), ATP6V1G3(1), ATP6V1H(1) | 166301 | 7 | 6 | 7 | 0 | 2 | 2 | 0 | 0 | 3 | 0.43 | 0.86 | |
307 | FLAGELLAR_ASSEMBLY | 21 | ATP6V0A1(3), ATP6V1B1(2), ATP6V1G3(1), ATP6V1H(1) | 166301 | 7 | 6 | 7 | 0 | 2 | 2 | 0 | 0 | 3 | 0.43 | 0.86 | |
308 | PHOTOSYNTHESIS | 22 | ATP6V0A1(3), ATP6V1B1(2), ATP6V1G3(1), ATP6V1H(1) | 166301 | 7 | 6 | 7 | 0 | 2 | 2 | 0 | 0 | 3 | 0.43 | 0.86 | |
309 | TYPE_III_SECRETION_ SYSTEM | 21 | ATP6V0A1(3), ATP6V1B1(2), ATP6V1G3(1), ATP6V1H(1) | 166301 | 7 | 6 | 7 | 0 | 2 | 2 | 0 | 0 | 3 | 0.43 | 0.86 | |
310 | STRESSPATHWAY | Tumor necrosis factor receptor TNFR1 promotes apoptosis and activates the pro-inflammatory NF-kB, while TNFR2 activates stress-activated protein kinases (SAPKs). | 25 | MAP2K6(2), MAP3K1(4), MAP3K14(1), RELA(2), TNFRSF1A(2) | 186672 | 11 | 10 | 11 | 6 | 4 | 4 | 0 | 0 | 3 | 0.43 | 0.86 |
311 | GLYOXYLATE_AND_DICARBOXYLATE_ METABOLISM | 12 | ACO1(1), GRHPR(1), MTHFD1L(1) | 60672 | 3 | 3 | 3 | 0 | 2 | 0 | 0 | 1 | 0 | 0.43 | 0.86 | |
312 | HSA00750_VITAMIN_ B6_METABOLISM | Genes involved in vitamin B6 metabolism | 5 | PDXK(1) | 15525 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0.45 | 0.89 |
313 | HSA00630_GLYOXYLATE_ AND_DICARBOXYLATE_ METABOLISM | Genes involved in glyoxylate and dicarboxylate metabolism | 13 | ACO1(1), GRHPR(1), MTHFD1L(1) | 63326 | 3 | 3 | 3 | 0 | 2 | 0 | 0 | 1 | 0 | 0.45 | 0.89 |
314 | GLYCOSPHINGOLIPID_ METABOLISM | 23 | ARSE(2), NEU1(2), SMPD2(3), UGCG(1) | 165743 | 8 | 6 | 8 | 0 | 5 | 1 | 1 | 1 | 0 | 0.45 | 0.89 | |
315 | BENZOATE_DEGRADATION_ VIA_COA_LIGATION | 10 | GCDH(1) | 37433 | 1 | 1 | 1 | 2 | 0 | 0 | 1 | 0 | 0 | 0.45 | 0.89 | |
316 | SA_REG_CASCADE_OF_ CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. | 13 | CDK4(1) | 14436 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0.46 | 0.90 |
317 | HSA00770_PANTOTHENATE_ AND_COA_BIOSYNTHESIS | Genes involved in pantothenate and CoA biosynthesis | 16 | BCAT2(2), DPYS(2), ENPP3(3), PANK3(1), PANK4(2) | 138477 | 10 | 9 | 10 | 0 | 3 | 5 | 0 | 2 | 0 | 0.47 | 0.91 |
318 | IGF1RPATHWAY | Insulin-like growth factor receptor IGF-1R promotes cell growth and inhibits apoptosis on binding of ligands IGF-1 and 2 via Ras activation and the AKT pathway. | 15 | MAPK1(1), MAPK3(1), RAF1(1), SOS1(3) | 63146 | 6 | 6 | 6 | 1 | 1 | 5 | 0 | 0 | 0 | 0.47 | 0.91 |
319 | PENTOSE_AND_GLUCURONATE_ INTERCONVERSIONS | 18 | UGT1A7(1), UGT2B15(2) | 52538 | 3 | 3 | 3 | 0 | 1 | 1 | 1 | 0 | 0 | 0.47 | 0.91 | |
320 | TCYTOTOXICPATHWAY | Cytotoxic T cells release perforin and granzyme to lyse foreign cell targets and express Fas ligand to promote Fas-induced apoptosis. | 11 | CD3E(1), ITGAL(2), PTPRC(4) | 80883 | 7 | 7 | 7 | 4 | 2 | 4 | 1 | 0 | 0 | 0.47 | 0.91 |
321 | THELPERPATHWAY | Helper T cells coordinate the actions of B cells, macrophages, and other immune cells via surface molecules such as T cell receptor/CD3 and their characteristic marker CD4. | 11 | CD3E(1), ITGAL(2), PTPRC(4) | 80883 | 7 | 7 | 7 | 4 | 2 | 4 | 1 | 0 | 0 | 0.47 | 0.91 |
322 | ERK5PATHWAY | Signaling between a tissue and its innervating axon stimulates retrograde transport via Trk receptors, which activate Erk5, which induces transcription of anti-apoptotic factors. | 17 | MAPK1(1), MAPK3(1), NTRK1(5) | 92976 | 7 | 7 | 7 | 1 | 0 | 5 | 0 | 1 | 1 | 0.48 | 0.91 |
323 | HSA04612_ANTIGEN_ PROCESSING_AND_PRESENTATION | Genes involved in antigen processing and presentation | 73 | IFNA16(2), KLRC3(1), LGMN(1), TAPBP(2) | 251611 | 6 | 6 | 6 | 0 | 0 | 2 | 3 | 0 | 1 | 0.48 | 0.91 |
324 | MTORPATHWAY | Mammalian target of rapamycin (mTOR) senses mitogenic factors and nutrients, including ATP, and induces cell proliferation. | 21 | EIF4A1(1), EIF4B(2), EIF4G3(2), TSC2(2) | 99694 | 7 | 7 | 7 | 2 | 1 | 4 | 0 | 0 | 2 | 0.49 | 0.93 |
325 | RNAPATHWAY | dsRNA-activated protein kinase phosphorylates elF2a, which generally inhibits translation, and activates NF-kB to provoke inflammation. | 9 | MAP3K14(1), RELA(2) | 45442 | 3 | 2 | 3 | 3 | 1 | 1 | 0 | 0 | 1 | 0.50 | 0.94 |
326 | HSA00530_AMINOSUGARS_ METABOLISM | Genes involved in aminosugars metabolism | 29 | AMDHD2(1), CHIA(3), CHIT1(3), GFPT2(2), GNE(1), HK1(3) | 193616 | 13 | 11 | 13 | 7 | 6 | 6 | 0 | 0 | 1 | 0.50 | 0.95 |
327 | HSA00903_LIMONENE_ AND_PINENE_DEGRADATION | Genes involved in limonene and pinene degradation | 26 | ALDH3A1(1), CYP2C19(6) | 105065 | 7 | 7 | 7 | 7 | 2 | 3 | 0 | 0 | 2 | 0.50 | 0.95 |
328 | TYROSINE_METABOLISM | 32 | ADH6(1), ALDH3A1(1), AOC2(1), DDC(3), TAT(3), TPO(5) | 167633 | 14 | 13 | 14 | 4 | 3 | 8 | 1 | 0 | 2 | 0.50 | 0.95 | |
329 | GANGLIOSIDE_BIOSYNTHESIS | 8 | ST3GAL4(1) | 10400 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0.51 | 0.95 | |
330 | HSA00260_GLYCINE_ SERINE_AND_THREONINE_ METABOLISM | Genes involved in glycine, serine and threonine metabolism | 45 | AGXT2(3), AOC2(1), DLD(1), GLDC(3), SARDH(3), SARS2(1) | 241655 | 12 | 12 | 12 | 4 | 3 | 6 | 3 | 0 | 0 | 0.51 | 0.95 |
331 | PTC1PATHWAY | The binding of extracellular signaling protein Sonic hedgehog to the Patched receptor (Ptc1) allows progression through G1 and may inhibit the G2/M transition. | 9 | CDC25B(2) | 42795 | 2 | 2 | 2 | 1 | 0 | 1 | 1 | 0 | 0 | 0.51 | 0.95 |
332 | SODDPATHWAY | Some members of the tumor necrosis factor receptor family have cytoplasmic death domains that promote apoptosis when active and are repressed by silencers called SODDs. | 10 | BAG4(1), TNFRSF1A(2), TNFRSF1B(1) | 79887 | 4 | 4 | 4 | 0 | 1 | 1 | 0 | 1 | 1 | 0.52 | 0.96 |
333 | WNT_SIGNALING | Wnt signaling genes | 59 | APC(7), DVL1(1), DVL3(1), FZD2(2), LDLR(3), PPP2R5C(2), PRKCA(3), PRKCE(2), PRKCZ(1), WNT7A(2) | 305380 | 24 | 19 | 24 | 4 | 6 | 12 | 1 | 3 | 2 | 0.52 | 0.97 |
334 | HSA04910_INSULIN_ SIGNALING_PATHWAY | Genes involved in insulin signaling pathway | 131 | ACACA(2), ACACB(6), ARAF(1), BRAF(4), GYS1(1), GYS2(2), INPP5D(4), INSR(2), IRS4(3), KRAS(2), MAPK1(1), MAPK3(1), MKNK2(1), PFKP(2), PHKG1(1), PHKG2(1), PIK3R5(4), PRKAG2(2), PRKCZ(1), PTPRF(4), RAF1(1), RAPGEF1(2), SLC2A4(1), SORBS1(4), SOS1(3), TRIP10(1), TSC2(2) | 837668 | 59 | 45 | 59 | 24 | 12 | 37 | 0 | 5 | 5 | 0.53 | 0.98 |
335 | GCRPATHWAY | Corticosteroids activate the glucocorticoid receptor (GR), which inhibits NF-kB and activates Annexin-1, thus inhibiting the inflammatory response. | 17 | GNAS(2), NOS3(1), RELA(2) | 56669 | 5 | 4 | 5 | 4 | 1 | 4 | 0 | 0 | 0 | 0.54 | 0.98 |
336 | CELL_CYCLE_KEGG | 82 | ATM(4), CDC25B(2), CDH1(1), CDK4(1), EP300(4), HDAC2(1), ORC3L(1), PRKDC(4), RBL1(4), TBC1D8(2) | 325441 | 24 | 21 | 24 | 10 | 4 | 13 | 3 | 2 | 2 | 0.54 | 0.98 | |
337 | SIG_IL4RECEPTOR_ IN_B_LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes | 27 | MAPK1(1), MAPK3(1), RAF1(1), SOS1(3) | 66840 | 6 | 6 | 6 | 1 | 1 | 5 | 0 | 0 | 0 | 0.54 | 0.98 |
338 | PTENPATHWAY | PTEN suppresses AKT-induced cell proliferation and antagonizes the action of PI3K. | 16 | MAPK1(1), MAPK3(1), PTK2(2), SOS1(3) | 80309 | 7 | 7 | 7 | 1 | 1 | 6 | 0 | 0 | 0 | 0.54 | 0.98 |
339 | PS1PATHWAY | Presenilin is required for gamma-secretase activity to activate Notch signaling; presenilin also inhibits beta-catenin in the Wnt/Frizzled pathway. | 12 | APC(7), DVL1(1), NOTCH1(6) | 181534 | 14 | 13 | 14 | 1 | 1 | 9 | 1 | 1 | 2 | 0.54 | 0.98 |
340 | PENTOSE_PHOSPHATE_ PATHWAY | 23 | GPI(3), PFKP(2), PGM1(1), RBKS(1) | 110501 | 7 | 6 | 7 | 0 | 2 | 3 | 0 | 0 | 2 | 0.55 | 0.99 | |
341 | FIBRINOLYSISPATHWAY | Thrombin cleavage of fibrinogen results in rapid formation of fibrin threads that form a mesh to capture platelets and other blood cells into a clot. | 12 | F13A1(1), FGG(1) | 42266 | 2 | 2 | 2 | 1 | 0 | 1 | 0 | 0 | 1 | 0.55 | 0.99 |
342 | DNAFRAGMENTPATHWAY | DNA fragmentation during apoptosis is effected by DFF, a caspase-activated DNAse, and by endonuclease G. | 10 | DFFB(1), HMGB1(1), TOP2A(2), TOP2B(2) | 76164 | 6 | 6 | 6 | 2 | 1 | 4 | 0 | 1 | 0 | 0.56 | 0.99 |
343 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. | 15 | CDK4(1) | 18622 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0.56 | 0.99 |
344 | HSA00220_UREA_CYCLE_ AND_METABOLISM_OF_ AMINO_GROUPS | Genes involved in urea cycle and metabolism of amino groups | 30 | ALDH3A1(1), AOC2(1), CPS1(9), SMS(2) | 161956 | 13 | 12 | 13 | 4 | 3 | 7 | 1 | 0 | 2 | 0.56 | 0.99 |
345 | EGFR_SMRTEPATHWAY | EGF receptor activation inhibits SMRT, a transcriptional co-repressor that interacts with transcription factor complexes and gene silencers. | 10 | EGFR(2), MAP3K1(4), NCOR2(3) | 141099 | 9 | 9 | 9 | 3 | 5 | 3 | 0 | 0 | 1 | 0.56 | 0.99 |
346 | IGF1PATHWAY | Growth factor IGF-1 stimulates growth and inhibits apoptosis by activating the MAP kinase pathway in a variety of cell types. | 20 | MAPK3(1), RAF1(1), RASA1(2), SOS1(3) | 110028 | 7 | 7 | 7 | 1 | 1 | 4 | 0 | 0 | 2 | 0.56 | 0.99 |
347 | HSA00040_PENTOSE_ AND_GLUCURONATE_ INTERCONVERSIONS | Genes involved in pentose and glucuronate interconversions | 25 | UGT1A7(1), UGT2B15(2) | 60362 | 3 | 3 | 3 | 0 | 1 | 1 | 1 | 0 | 0 | 0.56 | 0.99 |
348 | GAMMA_HEXACHLOROCYCLOHEXANE_ DEGRADATION | 31 | ACPP(1), ALPP(2), CYP19A1(3), CYP2B6(1), CYP2C19(6), CYP2F1(1), CYP4F8(2) | 204363 | 16 | 14 | 16 | 9 | 5 | 10 | 0 | 0 | 1 | 0.56 | 0.99 | |
349 | EPOPATHWAY | Erythropoietin, which activates the MAPK pathway, stimulates erythrocyte production and is an effective treatment for anemia. | 19 | EPOR(1), JAK2(3), MAPK3(1), RAF1(1), SOS1(3), STAT5B(1) | 145153 | 10 | 10 | 10 | 1 | 1 | 6 | 0 | 1 | 2 | 0.56 | 0.99 |
350 | HSA00730_THIAMINE_ METABOLISM | Genes involved in thiamine metabolism | 8 | NFS1(1) | 11610 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0.56 | 0.99 |
351 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. | 6 | CFLAR(1) | 11610 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.57 | 1.00 |
352 | CELLCYCLEPATHWAY | Cyclins interact with cyclin-dependent kinases to form active kinase complexes that regulate progression through the cell cycle. | 22 | CDK4(1), RBL1(4) | 89470 | 5 | 5 | 5 | 0 | 1 | 2 | 1 | 0 | 1 | 0.58 | 1.00 |
353 | HSA00252_ALANINE_ AND_ASPARTATE_METABOLISM | Genes involved in alanine and aspartate metabolism | 33 | AARS2(4), AGXT2(3), CAD(2), CRAT(1), DLAT(2), DLD(1), NARS2(3), PC(1) | 273237 | 17 | 14 | 17 | 3 | 3 | 9 | 3 | 1 | 1 | 0.58 | 1.00 |
354 | LIMONENE_AND_PINENE_ DEGRADATION | 12 | ALDH3A1(1) | 37815 | 1 | 1 | 1 | 2 | 0 | 0 | 0 | 0 | 1 | 0.58 | 1.00 | |
355 | BUTANOATE_METABOLISM | 27 | AACS(2), ALDH3A1(1) | 45478 | 3 | 3 | 3 | 3 | 0 | 2 | 0 | 0 | 1 | 0.59 | 1.00 | |
356 | HSA00450_SELENOAMINO_ ACID_METABOLISM | Genes involved in selenoamino acid metabolism | 26 | MARS(1), MAT1A(1), PAPSS2(1), SCLY(1), WBSCR22(1) | 86532 | 5 | 4 | 5 | 2 | 2 | 2 | 0 | 1 | 0 | 0.59 | 1.00 |
357 | HSA03022_BASAL_TRANSCRIPTION_ FACTORS | Genes involved in basal transcription factors | 33 | GTF2H1(1), GTF2IRD1(2), TAF1(7), TAF2(3) | 260875 | 13 | 13 | 13 | 1 | 2 | 5 | 1 | 2 | 3 | 0.59 | 1.00 |
358 | APOPTOSIS | 68 | BAK1(1), CASP10(2), DFFB(1), HELLS(1), IRF2(1), MAP3K1(4), RELA(2), TNFRSF1A(2), TNFRSF1B(1) | 214440 | 15 | 12 | 15 | 5 | 6 | 7 | 0 | 1 | 1 | 0.59 | 1.00 | |
359 | SA_BONE_MORPHOGENETIC | Bone morphogenetic protein binds to its receptor to induce ectopic bone formation and promote development of the viscera. | 4 | BMPR1A(2) | 59383 | 2 | 2 | 2 | 1 | 1 | 0 | 0 | 1 | 0 | 0.59 | 1.00 |
360 | STEROID_BIOSYNTHESIS | 9 | HSD17B4(1) | 20128 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0.59 | 1.00 | |
361 | SHHPATHWAY | Sonic hedgehog (Shh) signaling in the developing CNS induces neuronal proliferation via interaction with the patched (Ptc-1) and smoothened receptors. | 14 | DYRK1A(3) | 36554 | 3 | 3 | 3 | 2 | 0 | 3 | 0 | 0 | 0 | 0.60 | 1.00 |
362 | PROSTAGLANDIN_SYNTHESIS_ REGULATION | 29 | ANXA5(2), PLA2G4A(4) | 93707 | 6 | 6 | 6 | 3 | 1 | 3 | 0 | 1 | 1 | 0.60 | 1.00 | |
363 | ALKALOID_BIOSYNTHESIS_ II | 5 | AOC2(1) | 64563 | 1 | 1 | 1 | 2 | 0 | 0 | 1 | 0 | 0 | 0.60 | 1.00 | |
364 | HSA04140_REGULATION_ OF_AUTOPHAGY | Genes involved in regulation of autophagy | 29 | IFNA16(2), ULK2(1) | 75466 | 3 | 3 | 3 | 0 | 1 | 1 | 1 | 0 | 0 | 0.60 | 1.00 |
365 | CREMPATHWAY | The transcription factor CREM activates a post-meiotic transcriptional cascade culminating in spermatogenesis. | 7 | CREM(1), GNAS(2) | 33851 | 3 | 3 | 3 | 2 | 1 | 2 | 0 | 0 | 0 | 0.61 | 1.00 |
366 | HSA00480_GLUTATHIONE_ METABOLISM | Genes involved in glutathione metabolism | 37 | GSR(2) | 124672 | 2 | 2 | 2 | 1 | 0 | 0 | 0 | 2 | 0 | 0.62 | 1.00 |
367 | TELPATHWAY | Telomerase is a ribonucleotide protein that adds telomeric repeats to the 3' ends of chromosomes. | 15 | EGFR(2), POLR2A(2), PRKCA(3) | 156794 | 7 | 7 | 7 | 4 | 1 | 3 | 0 | 2 | 1 | 0.62 | 1.00 |
368 | CDK5PATHWAY | Cdk5, a regulatory kinase implicated in neuronal development, represses Mek1, which downregulates the MAP kinase pathway. | 12 | MAPK1(1), MAPK3(1), RAF1(1) | 34581 | 3 | 3 | 3 | 1 | 1 | 2 | 0 | 0 | 0 | 0.62 | 1.00 |
369 | HSA04130_SNARE_INTERACTIONS_ IN_VESICULAR_TRANSPORT | Genes involved in SNARE interactions in vesicular transport | 35 | BNIP1(1), STX5(1) | 58901 | 2 | 2 | 2 | 0 | 1 | 0 | 0 | 1 | 0 | 0.62 | 1.00 |
370 | MAPKPATHWAY | The mitogen-activated protein (MAP) kinase pathway is a common signaling mechanism and has four main sub-pathways: Erk, JNK/SAPK, p53, and ERK5. | 85 | BRAF(4), MAP2K5(1), MAP2K6(2), MAP3K1(4), MAP3K11(1), MAP3K12(1), MAP3K14(1), MAP4K3(1), MAPK1(1), MAPK3(1), MAPKAPK5(1), MAX(1), MKNK2(1), PAK1(1), RAF1(1), RELA(2), RPS6KA2(2), RPS6KA4(2), STAT1(1) | 562162 | 29 | 21 | 29 | 12 | 6 | 16 | 0 | 1 | 6 | 0.63 | 1.00 |
371 | NGFPATHWAY | Nerve growth factor (NGF) stimulates neural survival and proliferation via the TrkA and p75 receptors, which induce DAG and IP3 production and activate Ras. | 18 | MAPK3(1), RAF1(1), SOS1(3) | 56510 | 5 | 5 | 5 | 1 | 1 | 4 | 0 | 0 | 0 | 0.64 | 1.00 |
372 | DCPATHWAY | Dendritic cells internalize and present antigen, after which they migrate to lymphocyte-rich tissues and induce T and B cell differentiation. | 21 | CD5(1), IL4(1), TLR9(1) | 39715 | 3 | 3 | 3 | 2 | 0 | 3 | 0 | 0 | 0 | 0.64 | 1.00 |
373 | HSA00280_VALINE_ LEUCINE_AND_ISOLEUCINE_ DEGRADATION | Genes involved in valine, leucine and isoleucine degradation | 44 | ALDH3A1(1), BCAT2(2), DBT(1), DLD(1), HSD17B4(1) | 143986 | 6 | 6 | 6 | 4 | 3 | 1 | 0 | 0 | 2 | 0.64 | 1.00 |
374 | CDC25PATHWAY | The protein phosphatase Cdc25 is phosphorylated by Chk1 and activates Cdc2 to stimulate eukaryotic cells into M phase. | 8 | ATM(4), CDC25B(2) | 102580 | 6 | 6 | 6 | 1 | 1 | 3 | 1 | 1 | 0 | 0.65 | 1.00 |
375 | HISTIDINE_METABOLISM | 24 | ALDH3A1(1), AOC2(1), DDC(3) | 99457 | 5 | 5 | 5 | 2 | 1 | 2 | 1 | 0 | 1 | 0.65 | 1.00 | |
376 | HSA00251_GLUTAMATE_ METABOLISM | Genes involved in glutamate metabolism | 31 | CAD(2), CPS1(9), GFPT2(2), GSR(2) | 216052 | 15 | 13 | 15 | 3 | 3 | 8 | 0 | 2 | 2 | 0.66 | 1.00 |
377 | HSA00030_PENTOSE_ PHOSPHATE_PATHWAY | Genes involved in pentose phosphate pathway | 26 | GPI(3), PFKP(2), PGM1(1), RBKS(1) | 130054 | 7 | 6 | 7 | 1 | 2 | 3 | 0 | 0 | 2 | 0.66 | 1.00 |
378 | CTLPATHWAY | Cytotoxic T lymphocytes induce apoptosis in infected cells presenting antigen-MHC-I complexes via the perforin and Fas/Fas ligand pathways. | 10 | CD3E(1), ITGAL(2) | 38115 | 3 | 3 | 3 | 2 | 1 | 2 | 0 | 0 | 0 | 0.66 | 1.00 |
379 | TUBBYPATHWAY | Tubby is activated by phospholipase C activity and hydrolysis of PIP2, after which it enters the nucleus and regulates transcription. | 7 | CHRM1(1), PLCB1(6) | 122952 | 7 | 6 | 7 | 2 | 3 | 3 | 0 | 1 | 0 | 0.67 | 1.00 |
380 | HSA00440_AMINOPHOSPHONATE_ METABOLISM | Genes involved in aminophosphonate metabolism | 16 | WBSCR22(1) | 30916 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0.67 | 1.00 |
381 | ST_WNT_BETA_CATENIN_ PATHWAY | Beta-catenin is degraded in the absence of Wnt signaling; when extracellular Wnt binds Frizzled receptors, beta-catenin accumulates in the nucleus and may promote cell survival. | 31 | ANKRD6(3), APC(7), DVL1(1), FSTL1(1), LRP1(8), MVP(1), SENP2(1) | 319998 | 22 | 19 | 20 | 3 | 3 | 15 | 2 | 1 | 1 | 0.67 | 1.00 |
382 | HSA05120_EPITHELIAL_ CELL_SIGNALING_IN_ HELICOBACTER_PYLORI_ INFECTION | Genes involved in epithelial cell signaling in Helicobacter pylori infection | 66 | ATP6V0A1(3), ATP6V0A2(5), ATP6V1B1(2), ATP6V1G3(1), ATP6V1H(1), EGFR(2), LYN(1), MAP3K14(1), MET(2), PAK1(1), RELA(2) | 360966 | 21 | 17 | 21 | 6 | 7 | 8 | 1 | 1 | 4 | 0.67 | 1.00 |
383 | TNFR1PATHWAY | Tumor necrosis factor alpha binds to its receptor TNFR1 and induces caspase-dependent apoptosis. | 28 | BAG4(1), DFFB(1), MADD(2), MAP3K1(4), PAK1(1), PRKDC(4), SPTAN1(2), TNFRSF1A(2) | 303523 | 17 | 16 | 17 | 5 | 7 | 7 | 0 | 0 | 3 | 0.67 | 1.00 |
384 | HSA00051_FRUCTOSE_ AND_MANNOSE_METABOLISM | Genes involved in fructose and mannose metabolism | 40 | GMPPA(1), HK1(3), PFKP(2) | 152373 | 6 | 5 | 6 | 0 | 4 | 2 | 0 | 0 | 0 | 0.68 | 1.00 |
385 | HSA04120_UBIQUITIN_ MEDIATED_PROTEOLYSIS | Genes involved in ubiquitin mediated proteolysis | 39 | ANAPC4(2), CUL2(2), SMURF2(1), UBA1(1) | 116083 | 6 | 6 | 6 | 1 | 0 | 4 | 1 | 0 | 1 | 0.68 | 1.00 |
386 | HSA00641_3_CHLOROACRYLIC_ ACID_DEGRADATION | Genes involved in 3-chloroacrylic acid degradation | 15 | ADH6(1), ALDH3A1(1) | 59986 | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 0 | 1 | 0.68 | 1.00 |
387 | HSA00564_GLYCEROPHOSPHOLIPID_ METABOLISM | Genes involved in glycerophospholipid metabolism | 64 | AGPAT4(1), CRLS1(1), GPAM(4), PLA2G4A(4) | 171416 | 10 | 10 | 10 | 10 | 2 | 4 | 1 | 1 | 2 | 0.69 | 1.00 |
388 | O_GLYCAN_BIOSYNTHESIS | 14 | GALNT2(2), GALNT6(3), GALNT7(2), GALNT8(1), ST3GAL4(1) | 121550 | 9 | 9 | 9 | 2 | 1 | 7 | 0 | 0 | 1 | 0.69 | 1.00 | |
389 | HSA04614_RENIN_ANGIOTENSIN_ SYSTEM | Genes involved in renin-angiotensin system | 17 | ACE2(2), CMA1(1), CTSA(1), CTSG(2), THOP1(1) | 90353 | 7 | 7 | 7 | 2 | 2 | 5 | 0 | 0 | 0 | 0.70 | 1.00 |
390 | SMALL_LIGAND_GPCRS | 14 | DNMT1(3), TBXA2R(1) | 61959 | 4 | 4 | 4 | 1 | 0 | 4 | 0 | 0 | 0 | 0.70 | 1.00 | |
391 | RBPATHWAY | The ATM protein kinase recognizes DNA damage and blocks cell cycle progression by phosphorylating chk1 and p53, which normally inhibits Rb to allow G1/S transitions. | 12 | ATM(4), CDC25B(2), CDK4(1) | 117017 | 7 | 7 | 7 | 1 | 2 | 3 | 1 | 1 | 0 | 0.70 | 1.00 |
392 | HSA00590_ARACHIDONIC_ ACID_METABOLISM | Genes involved in arachidonic acid metabolism | 51 | ALOX12B(1), CYP2B6(1), CYP2C19(6), PLA2G4A(4) | 152456 | 12 | 10 | 12 | 6 | 3 | 7 | 0 | 1 | 1 | 0.71 | 1.00 |
393 | EEA1PATHWAY | The FYVE-finger proteins EEA1 and HRS are localized to endosome membranes and regulate sorting and ubiquitination in the vesicle transport system. | 7 | EGFR(2), RAB5A(1) | 41225 | 3 | 3 | 3 | 1 | 1 | 2 | 0 | 0 | 0 | 0.71 | 1.00 |
394 | D4GDIPATHWAY | D4-GDI inhibits the pro-apoptotic Rho GTPases and is cleaved by caspase-3. | 12 | CASP10(2) | 27270 | 2 | 2 | 2 | 1 | 0 | 2 | 0 | 0 | 0 | 0.71 | 1.00 |
395 | IL6PATHWAY | IL-6 binding to its receptor activates JAK kinases and a variety of transcription factors, with effects in neuronal differentiation, bone loss, and inflammation. | 21 | JAK2(3), MAPK3(1), RAF1(1), SOS1(3) | 120867 | 8 | 8 | 8 | 1 | 1 | 5 | 0 | 1 | 1 | 0.72 | 1.00 |
396 | CITRATE_CYCLE_TCA_ CYCLE | 20 | ACO1(1), DLD(1), DLST(1), IDH3A(1), IDH3B(1), PC(1) | 123154 | 6 | 6 | 6 | 0 | 3 | 2 | 0 | 1 | 0 | 0.72 | 1.00 | |
397 | STATIN_PATHWAY_PHARMGKB | 18 | LDLR(3), LRP1(8) | 151522 | 11 | 10 | 9 | 2 | 2 | 7 | 1 | 1 | 0 | 0.72 | 1.00 | |
398 | CDC42RACPATHWAY | PI3 kinase stimulates cell migration by activating cdc42, which activates ARP2/3, which in turn promotes formation of new actin fibers. | 14 | PAK1(1), WASL(1) | 35640 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 0.73 | 1.00 |
399 | REDUCTIVE_CARBOXYLATE_ CYCLE_CO2_FIXATION | 9 | ACO1(1) | 34692 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0.73 | 1.00 | |
400 | VEGFPATHWAY | Vascular endothelial growth factor (VEGF) is upregulated by hypoxic conditions and promotes normal blood vessel formation and angiogenesis related to tumor growth or cardiac disease. | 25 | EIF2B1(1), EIF2B3(1), EIF2B4(1), FLT4(1), NOS3(1), PRKCA(3), PTK2(2) | 175316 | 10 | 9 | 10 | 6 | 1 | 6 | 0 | 1 | 2 | 0.74 | 1.00 |
401 | ERBB3PATHWAY | Neuregulins bind to the receptor tyrosine kinases ErbB3 and ErbB4, surface-localized receptors whose overexpression induces tumor formation. | 5 | EGFR(2), ERBB3(2) | 66028 | 4 | 3 | 4 | 1 | 1 | 2 | 0 | 0 | 1 | 0.74 | 1.00 |
402 | VALINE_LEUCINE_AND_ ISOLEUCINE_BIOSYNTHESIS | 7 | LARS(1), LARS2(2) | 48873 | 3 | 3 | 3 | 0 | 0 | 3 | 0 | 0 | 0 | 0.75 | 1.00 | |
403 | HSA01030_GLYCAN_ STRUCTURES_BIOSYNTHESIS_ 1 | Genes involved in glycan structures - biosynthesis 1 | 109 | B4GALT3(1), B4GALT5(1), CHPF(1), EXT2(1), EXTL1(1), GALNT2(2), GALNT6(3), GALNT7(2), GALNT8(1), GALNTL1(2), GANAB(4), MAN1A1(3), MAN2A1(4), NDST1(3), NDST2(3), OGT(2), ST3GAL4(1), XYLT2(1) | 547464 | 36 | 33 | 36 | 11 | 7 | 24 | 0 | 2 | 3 | 0.75 | 1.00 |
404 | MITOCHONDRIAPATHWAY | Pro-apoptotic signaling induces mitochondria to release cytochrome c, which stimulates Apaf-1 to activate caspase 9. | 19 | BAK1(1), DFFB(1) | 39039 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 0.76 | 1.00 |
405 | HSA04620_TOLL_LIKE_ RECEPTOR_SIGNALING_ PATHWAY | Genes involved in Toll-like receptor signaling pathway | 100 | IFNA16(2), IL1B(1), IRAK1(4), MAP2K6(2), MAPK1(1), MAPK3(1), MYD88(1), PIK3R5(4), RELA(2), STAT1(1), TLR9(1), TOLLIP(1) | 297494 | 21 | 19 | 21 | 9 | 6 | 10 | 2 | 1 | 2 | 0.76 | 1.00 |
406 | HSA00740_RIBOFLAVIN_ METABOLISM | Genes involved in riboflavin metabolism | 16 | ACP6(1), ACPP(1), ENPP3(3) | 66513 | 5 | 5 | 5 | 0 | 2 | 3 | 0 | 0 | 0 | 0.76 | 1.00 |
407 | SA_PTEN_PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. | 16 | MAPK1(1), MAPK3(1), SOS1(3) | 79795 | 5 | 5 | 5 | 1 | 0 | 5 | 0 | 0 | 0 | 0.76 | 1.00 |
408 | HSA00960_ALKALOID_ BIOSYNTHESIS_II | Genes involved in alkaloid biosynthesis II | 18 | AOC2(1) | 93844 | 1 | 1 | 1 | 5 | 0 | 0 | 1 | 0 | 0 | 0.77 | 1.00 |
409 | HSA00620_PYRUVATE_ METABOLISM | Genes involved in pyruvate metabolism | 42 | ACACA(2), ACACB(6), ACSS1(2), ALDH3A1(1), DLAT(2), DLD(1), GRHPR(1), LDHB(1), LDHC(1), PC(1) | 231214 | 18 | 16 | 18 | 4 | 5 | 10 | 1 | 1 | 1 | 0.77 | 1.00 |
410 | FRUCTOSE_AND_MANNOSE_ METABOLISM | 25 | GMPPA(1), HK1(3), PFKP(2) | 177610 | 6 | 5 | 6 | 1 | 4 | 2 | 0 | 0 | 0 | 0.77 | 1.00 | |
411 | TRYPTOPHAN_METABOLISM | 54 | ALDH3A1(1), AOC2(1), CYP19A1(3), CYP2B6(1), CYP2C19(6), CYP2F1(1), CYP4F8(2), DDC(3), GCDH(1), WARS(1) | 284648 | 20 | 16 | 20 | 14 | 5 | 11 | 2 | 0 | 2 | 0.77 | 1.00 | |
412 | HSA00410_BETA_ALANINE_ METABOLISM | Genes involved in beta-alanine metabolism | 25 | ALDH3A1(1), AOC2(1), DPYS(2), SMS(2) | 131399 | 6 | 5 | 6 | 4 | 1 | 3 | 1 | 0 | 1 | 0.77 | 1.00 |
413 | GLYCOLYSIS_AND_GLUCONEOGENESIS | Genes involved in glycolysis and gluconeogenesis | 43 | DLAT(2), DLD(1), GPI(3), HK1(3), LDHB(1), LDHC(1), PC(1), PFKP(2), PGK1(2) | 263510 | 16 | 14 | 16 | 1 | 6 | 8 | 1 | 0 | 1 | 0.77 | 1.00 |
414 | HSA00190_OXIDATIVE_ PHOSPHORYLATION | Genes involved in oxidative phosphorylation | 113 | ATP4A(2), ATP6V0A1(3), ATP6V0A2(5), ATP6V1B1(2), ATP6V1G3(1), ATP6V1H(1), CYC1(2) | 413775 | 16 | 14 | 16 | 6 | 4 | 8 | 0 | 0 | 4 | 0.78 | 1.00 |
415 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. | 15 | CASP10(2), DFFB(1) | 52440 | 3 | 3 | 3 | 1 | 0 | 3 | 0 | 0 | 0 | 0.78 | 1.00 |
416 | PHENYLALANINE_TYROSINE_ AND_TRYPTOPHAN_BIOSYNTHESIS | 9 | PAH(2), TAT(3) | 95872 | 5 | 5 | 5 | 1 | 3 | 2 | 0 | 0 | 0 | 0.78 | 1.00 | |
417 | HSA00380_TRYPTOPHAN_ METABOLISM | Genes involved in tryptophan metabolism | 58 | ALDH3A1(1), AOC2(1), DDC(3), GCDH(1), HSD17B4(1), WARS(1), WBSCR22(1) | 240108 | 9 | 9 | 9 | 8 | 4 | 2 | 2 | 0 | 1 | 0.78 | 1.00 |
418 | ACHPATHWAY | Nicotinic acetylcholine receptors are ligand-gated ion channels that primarily mediate neuromuscular signaling and may inhibit neuronal apoptosis via the AKT pathway. | 13 | PTK2(2) | 31172 | 2 | 2 | 2 | 4 | 1 | 1 | 0 | 0 | 0 | 0.78 | 1.00 |
419 | KREBS_TCA_CYCLE | 30 | DLAT(2), DLD(1), DLST(1), IDH3A(1), IDH3B(1), PC(1) | 145351 | 7 | 7 | 7 | 2 | 2 | 3 | 1 | 1 | 0 | 0.78 | 1.00 | |
420 | ETSPATHWAY | The Ets transcription factors are activated by Ras and promote macrophage differentiation. | 18 | CSF1R(2), DDX20(1), HDAC2(1), NCOR2(3), RBL1(4) | 156588 | 11 | 11 | 11 | 1 | 2 | 6 | 1 | 1 | 1 | 0.78 | 1.00 |
421 | PORPHYRIN_AND_CHLOROPHYLL_ METABOLISM | 26 | CP(1), UGT1A7(1), UGT2B15(2) | 112573 | 4 | 4 | 4 | 1 | 1 | 2 | 1 | 0 | 0 | 0.79 | 1.00 | |
422 | HSA00561_GLYCEROLIPID_ METABOLISM | Genes involved in glycerolipid metabolism | 55 | ADH6(1), AGPAT4(1), ALDH3A1(1), GPAM(4), LIPF(1), PNLIP(5), PNLIPRP1(3), PNLIPRP2(1) | 289522 | 17 | 17 | 17 | 9 | 5 | 7 | 1 | 1 | 3 | 0.79 | 1.00 |
423 | ST_TYPE_I_INTERFERON_ PATHWAY | Type I interferon is an antiviral cytokine that induces a JAK-STAT type pathway leading to ISGF3 activation and a cellular antiviral response. | 8 | PTPRU(3), STAT1(1) | 61202 | 4 | 3 | 4 | 2 | 0 | 4 | 0 | 0 | 0 | 0.79 | 1.00 |
424 | GHPATHWAY | Growth hormone receptors dimerize on ligand binding and activate the JAK2 protein kinase. | 25 | INSR(2), JAK2(3), MAPK1(1), MAPK3(1), PRKCA(3), RAF1(1), SLC2A4(1), SOS1(3), STAT5B(1) | 339345 | 16 | 16 | 16 | 1 | 1 | 10 | 0 | 3 | 2 | 0.79 | 1.00 |
425 | ACTINYPATHWAY | The Arp 2/3 complex localizes to the Y-junction of polymerizing actin fibers that enable lamellipod extension and consequent cell motility. | 18 | NTRK1(5), WASF3(1), WASL(1) | 125978 | 7 | 7 | 7 | 1 | 0 | 5 | 0 | 1 | 1 | 0.79 | 1.00 |
426 | IRINOTECAN_PATHWAY_ PHARMGKB | 17 | ABCC1(4), ABCC2(2), UGT1A7(1) | 102004 | 7 | 7 | 7 | 1 | 3 | 4 | 0 | 0 | 0 | 0.79 | 1.00 | |
427 | IL2PATHWAY | IL-2 promotes proliferation via JAK and MAP kinase and has surface receptors on activated B cells, LPS-treated monocytes, and many T cells. | 22 | MAPK3(1), RAF1(1), SOS1(3), STAT5B(1) | 83668 | 6 | 6 | 6 | 1 | 1 | 5 | 0 | 0 | 0 | 0.79 | 1.00 |
428 | IL4PATHWAY | IL-4 promotes Th2 cell differentiation via a heterodimeric receptor that activates Stat6/JAK and MAP kinase pathways. | 11 | IL4(1) | 22279 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.80 | 1.00 |
429 | BILE_ACID_BIOSYNTHESIS | 27 | ADH6(1), ALDH3A1(1) | 75508 | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 0 | 1 | 0.80 | 1.00 | |
430 | HSA00920_SULFUR_ METABOLISM | Genes involved in sulfur metabolism | 14 | PAPSS2(1) | 41953 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0.80 | 1.00 |
431 | SULFUR_METABOLISM | 9 | PAPSS2(1) | 41953 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0.80 | 1.00 | |
432 | MPRPATHWAY | Progesterone binding to its intracellular receptor activates the MAPK pathway and induces oocyte maturation; binding to membrane receptor inhibits adenylyl cyclase. | 22 | CAP1(1), GNAS(2), MAPK1(1), MAPK3(1) | 102882 | 5 | 5 | 5 | 2 | 0 | 4 | 0 | 1 | 0 | 0.80 | 1.00 |
433 | AKTPATHWAY | Second messenger PIP3 promotes cell survival by activating the anti-apoptotic kinase AKT. | 14 | RELA(2) | 34331 | 2 | 1 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 0.80 | 1.00 |
434 | ST_P38_MAPK_PATHWAY | p38 is a MAP kinase regulated by cytokines and cellular stress. | 35 | CREB3(1), MAP2K6(2), MAPK1(1), MAPKAPK5(1), MKNK2(1) | 197538 | 6 | 6 | 6 | 2 | 0 | 4 | 0 | 0 | 2 | 0.81 | 1.00 |
435 | NEUTROPHILPATHWAY | Neutrophils are phagocytotic leukocytes that destroy foreign cells with reactive oxygen species or enzymatic digestion and express CD11 and CD18. | 8 | ITGAL(2), ITGAM(2), SELL(1) | 73305 | 5 | 5 | 5 | 5 | 2 | 3 | 0 | 0 | 0 | 0.81 | 1.00 |
436 | CACAMPATHWAY | Calcium functions as a second messenger activating the calcium/calmodulin-dependent kinases, which phosphorylate targets such as CREB. | 14 | CAMK2A(2), CAMK2D(1), CAMK4(1), CAMKK1(2) | 150511 | 6 | 6 | 6 | 4 | 3 | 2 | 1 | 0 | 0 | 0.81 | 1.00 |
437 | NUCLEAR_RECEPTORS | 40 | ALK(6), NR0B1(1) | 203944 | 7 | 7 | 7 | 2 | 2 | 3 | 2 | 0 | 0 | 0.81 | 1.00 | |
438 | HSA00640_PROPANOATE_ METABOLISM | Genes involved in propanoate metabolism | 33 | ACACA(2), ACACB(6), ACSS1(2), ALDH3A1(1), LDHB(1), LDHC(1) | 167186 | 13 | 12 | 13 | 6 | 3 | 8 | 0 | 1 | 1 | 0.81 | 1.00 |
439 | TALL1PATHWAY | APRIL and BAFF bind to BCMA and TACI receptors on B cell surfaces, promoting immunoglobulin production and cell proliferation. | 15 | MAP3K14(1), RELA(2) | 77690 | 3 | 2 | 3 | 3 | 1 | 1 | 0 | 0 | 1 | 0.82 | 1.00 |
440 | MRNA_PROCESSING_ REACTOME | 92 | CLK2(1), CLK3(1), DDX20(1), DHX8(1), NXF1(1), POLR2A(2), PRPF3(3), PRPF8(1), SF3A2(1), SFRS4(1), SFRS8(6), SRPK1(2), SRRM1(1), SUPT5H(1) | 523489 | 23 | 20 | 23 | 7 | 5 | 10 | 2 | 4 | 2 | 0.82 | 1.00 | |
441 | ACE_INHIBITOR_PATHWAY_ PHARMGKB | 8 | NOS3(1) | 27524 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0.84 | 1.00 | |
442 | IL2RBPATHWAY | The beta subunit of the IL-2 receptor is required for IL-2 and IL-15 signal recognition and activates JAK kinase on ligand binding. | 34 | CFLAR(1), MAPK1(1), MAPK3(1), RAF1(1), SOS1(3), STAT5B(1) | 145668 | 8 | 8 | 8 | 1 | 1 | 7 | 0 | 0 | 0 | 0.84 | 1.00 |
443 | OXIDATIVE_PHOSPHORYLATION | 60 | ATP6V0A1(3), ATP6V1B1(2), ATP6V1G3(1), ATP6V1H(1), ATP7A(5) | 313664 | 12 | 11 | 12 | 2 | 3 | 5 | 1 | 0 | 3 | 0.84 | 1.00 | |
444 | HSA04742_TASTE_TRANSDUCTION | Genes involved in taste transduction | 48 | ADCY4(3), ADCY8(8), CACNA1A(6), GNAS(2), ITPR3(3), PDE1A(2) | 351707 | 24 | 19 | 24 | 7 | 7 | 12 | 1 | 2 | 2 | 0.84 | 1.00 |
445 | GLYCEROPHOSPHOLIPID_ METABOLISM | 49 | AGPAT4(1), PLA2G4A(4) | 125346 | 5 | 5 | 5 | 4 | 1 | 2 | 0 | 1 | 1 | 0.84 | 1.00 | |
446 | HSA05050_DENTATORUBROPALLIDOLUYSIAN_ ATROPHY | Genes involved in dentatorubropallidoluysian atrophy (DRPLA) | 15 | INSR(2), MAGI1(3) | 113829 | 5 | 5 | 5 | 1 | 2 | 2 | 0 | 1 | 0 | 0.85 | 1.00 |
447 | HSA00720_REDUCTIVE_ CARBOXYLATE_CYCLE | Genes involved in reductive carboxylate cycle (CO2 fixation) | 11 | ACLY(1), ACO1(1), ACSS1(2) | 115416 | 4 | 4 | 4 | 1 | 2 | 1 | 0 | 1 | 0 | 0.85 | 1.00 |
448 | HSA00626_NAPHTHALENE_ AND_ANTHRACENE_DEGRADATION | Genes involved in naphthalene and anthracene degradation | 18 | WBSCR22(1) | 49207 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0.85 | 1.00 |
449 | DNA_REPLICATION_ REACTOME | 42 | MCM10(1), ORC3L(1), POLD1(1), RPA1(1) | 122100 | 4 | 4 | 4 | 8 | 1 | 2 | 1 | 0 | 0 | 0.85 | 1.00 | |
450 | BETA_ALANINE_METABOLISM | 27 | ALDH3A1(1), AOC2(1), DPYS(2), SMS(2) | 158534 | 6 | 5 | 6 | 5 | 1 | 3 | 1 | 0 | 1 | 0.85 | 1.00 | |
451 | VALINE_LEUCINE_AND_ ISOLEUCINE_DEGRADATION | 36 | ALDH3A1(1) | 92158 | 1 | 1 | 1 | 3 | 0 | 0 | 0 | 0 | 1 | 0.86 | 1.00 | |
452 | HSA00970_AMINOACYL_ TRNA_BIOSYNTHESIS | Genes involved in aminoacyl-tRNA biosynthesis | 38 | AARS2(4), CARS(3), LARS(1), LARS2(2), MARS(1), NARS2(3), SARS2(1), VARS(3), WARS(1) | 441020 | 19 | 13 | 19 | 6 | 2 | 9 | 3 | 2 | 3 | 0.86 | 1.00 |
453 | GLYCOSAMINOGLYCAN_ DEGRADATION | 11 | NAGLU(1) | 96394 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0.86 | 1.00 | |
454 | CHEMICALPATHWAY | DNA damage promotes Bid cleavage, which stimulates mitochondrial cytochrome c release and consequent caspase activation, resulting in apoptosis. | 20 | ATM(4), PRKCA(3), PTK2(2), STAT1(1), TLN1(3) | 256285 | 13 | 11 | 13 | 2 | 3 | 6 | 1 | 2 | 1 | 0.86 | 1.00 |
455 | HSA00350_TYROSINE_ METABOLISM | Genes involved in tyrosine metabolism | 56 | ADH6(1), ALDH3A1(1), AOC2(1), DDC(3), TAT(3), TPO(5), WBSCR22(1) | 232638 | 15 | 14 | 15 | 8 | 4 | 8 | 1 | 0 | 2 | 0.86 | 1.00 |
456 | GLYCEROLIPID_METABOLISM | 45 | ADH6(1), AGPAT4(1), ALDH3A1(1), LIPF(1), PNLIP(5), PNLIPRP1(3), PNLIPRP2(1) | 256835 | 13 | 13 | 13 | 6 | 5 | 5 | 0 | 1 | 2 | 0.86 | 1.00 | |
457 | AMINOACYL_TRNA_BIOSYNTHESIS | 21 | CARS(3), LARS(1), LARS2(2), MARS(1), WARS(1) | 173230 | 8 | 8 | 8 | 3 | 1 | 4 | 1 | 1 | 1 | 0.87 | 1.00 | |
458 | FOLATE_BIOSYNTHESIS | 9 | ALPP(2) | 39474 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 0.87 | 1.00 | |
459 | CARBON_FIXATION | 21 | PGK1(2) | 50499 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 0.87 | 1.00 | |
460 | AMINOSUGARS_METABOLISM | 15 | GNE(1), HK1(3) | 165454 | 4 | 3 | 4 | 5 | 3 | 1 | 0 | 0 | 0 | 0.88 | 1.00 | |
461 | HSA00120_BILE_ACID_ BIOSYNTHESIS | Genes involved in bile acid biosynthesis | 38 | ADH6(1), ALDH3A1(1) | 97166 | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 0 | 1 | 0.88 | 1.00 |
462 | HSA03050_PROTEASOME | Genes involved in proteasome | 22 | PSMB3(1), PSMC3(1), PSMD1(1), PSMD13(1) | 140394 | 4 | 4 | 4 | 3 | 1 | 1 | 0 | 1 | 1 | 0.88 | 1.00 |
463 | PROTEASOMEPATHWAY | Ubiquitinated proteins are targeted for proteolytic degradation by the proteasome, where they are unfolded and degraded to small peptides in an ATP-dependent process. | 20 | PSMB3(1), PSMC3(1) | 115152 | 2 | 2 | 2 | 2 | 0 | 1 | 0 | 1 | 0 | 0.88 | 1.00 |
464 | HSA00500_STARCH_ AND_SUCROSE_METABOLISM | Genes involved in starch and sucrose metabolism | 83 | AGL(2), DDX19A(2), DDX4(2), DDX54(2), ENPP3(3), ERCC2(1), GPI(3), GYS1(1), GYS2(2), HK1(3), MGAM(7), PGM1(1), SETX(2), SKIV2L2(3), SMARCA2(4), UGT1A7(1), UGT2B15(2) | 592755 | 41 | 31 | 41 | 18 | 12 | 21 | 2 | 2 | 4 | 0.89 | 1.00 |
465 | HSA00632_BENZOATE_ DEGRADATION_VIA_ COA_LIGATION | Genes involved in benzoate degradation via CoA ligation | 24 | GCDH(1) | 112053 | 1 | 1 | 1 | 5 | 0 | 0 | 1 | 0 | 0 | 0.89 | 1.00 |
466 | HSA00071_FATTY_ACID_ METABOLISM | Genes involved in fatty acid metabolism | 47 | ACSL3(1), ADH6(1), ALDH3A1(1), GCDH(1), HSD17B4(1) | 190998 | 5 | 5 | 5 | 3 | 1 | 2 | 1 | 0 | 1 | 0.90 | 1.00 |
467 | RANKLPATHWAY | RANK is a TNF-type receptor that promotes osteoclast differentiation and consequent bone resorbtion on binding RANK ligand produced by osteoblasts. | 12 | RELA(2) | 56843 | 2 | 1 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 0.90 | 1.00 |
468 | HSA00010_GLYCOLYSIS_ AND_GLUCONEOGENESIS | Genes involved in glycolysis and gluconeogenesis | 64 | ACSS1(2), ADH6(1), ALDH3A1(1), DLAT(2), DLD(1), GPI(3), HK1(3), LDHB(1), LDHC(1), PFKP(2), PGK1(2), PGM1(1) | 421042 | 20 | 16 | 20 | 2 | 8 | 8 | 1 | 1 | 2 | 0.90 | 1.00 |
469 | GLUCONEOGENESIS | 53 | ADH6(1), ALDH3A1(1), DLAT(2), DLD(1), GPI(3), HK1(3), LDHB(1), LDHC(1), PFKP(2), PGK1(2), PGM1(1) | 353919 | 18 | 14 | 18 | 1 | 7 | 8 | 1 | 0 | 2 | 0.90 | 1.00 | |
470 | GLYCOLYSIS | 53 | ADH6(1), ALDH3A1(1), DLAT(2), DLD(1), GPI(3), HK1(3), LDHB(1), LDHC(1), PFKP(2), PGK1(2), PGM1(1) | 353919 | 18 | 14 | 18 | 1 | 7 | 8 | 1 | 0 | 2 | 0.90 | 1.00 | |
471 | HSA00860_PORPHYRIN_ AND_CHLOROPHYLL_ METABOLISM | Genes involved in porphyrin and chlorophyll metabolism | 41 | CP(1), UGT1A7(1), UGT2B15(2) | 177047 | 4 | 4 | 4 | 1 | 1 | 2 | 1 | 0 | 0 | 0.91 | 1.00 |
472 | PYRUVATE_METABOLISM | 37 | ACACA(2), ALDH3A1(1), DLAT(2), DLD(1), GRHPR(1), LDHB(1), LDHC(1), PC(1) | 165830 | 10 | 9 | 10 | 2 | 2 | 6 | 1 | 0 | 1 | 0.91 | 1.00 | |
473 | HSA00062_FATTY_ACID_ ELONGATION_IN_MITOCHONDRIA | Genes involved in fatty acid elongation in mitochondria | 10 | HSD17B4(1) | 46606 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0.91 | 1.00 |
474 | SIG_INSULIN_RECEPTOR_ PATHWAY_IN_CARDIAC_ MYOCYTES | Genes related to the insulin receptor pathway | 49 | BRD4(2), CAP1(1), IRS4(3), MAPK1(1), MAPK3(1), PARD3(3), RAF1(1), RPS6KA2(2), SERPINB6(2), SLC2A4(1), SORBS1(4), SOS1(3) | 364791 | 24 | 19 | 24 | 5 | 6 | 14 | 1 | 2 | 1 | 0.91 | 1.00 |
475 | PROTEASOME | 17 | PSMB3(1), PSMB8(1) | 131622 | 2 | 2 | 2 | 1 | 0 | 1 | 0 | 1 | 0 | 0.91 | 1.00 | |
476 | HSA00340_HISTIDINE_ METABOLISM | Genes involved in histidine metabolism | 41 | ALDH3A1(1), AOC2(1), DDC(3), WBSCR22(1) | 158435 | 6 | 6 | 6 | 4 | 2 | 2 | 1 | 0 | 1 | 0.91 | 1.00 |
477 | DREAMPATHWAY | The transcription factor DREAM blocks expression of the prodynorphin gene, which encodes the ligand of an opioid receptor that blocks pain signaling. | 13 | CREM(1), MAPK3(1), POLR2A(2) | 131919 | 4 | 4 | 4 | 1 | 1 | 2 | 0 | 1 | 0 | 0.91 | 1.00 |
478 | IL10PATHWAY | The cytokine IL-10 inhibits the inflammatory response by macrophages via activation of heme oxygenase 1. | 13 | IL10RA(1), STAT1(1) | 49742 | 2 | 2 | 2 | 3 | 0 | 2 | 0 | 0 | 0 | 0.91 | 1.00 |
479 | HSA05130_PATHOGENIC_ ESCHERICHIA_COLI_ INFECTION_EHEC | Genes involved in pathogenic Escherichia coli infection - EHEC | 51 | CDH1(1), OCLN(1), PRKCA(3), TUBB2C(1), TUBB4(3), WASL(1) | 180717 | 10 | 10 | 10 | 2 | 1 | 6 | 1 | 1 | 1 | 0.91 | 1.00 |
480 | HSA05131_PATHOGENIC_ ESCHERICHIA_COLI_ INFECTION_EPEC | Genes involved in pathogenic Escherichia coli infection - EPEC | 51 | CDH1(1), OCLN(1), PRKCA(3), TUBB2C(1), TUBB4(3), WASL(1) | 180717 | 10 | 10 | 10 | 2 | 1 | 6 | 1 | 1 | 1 | 0.91 | 1.00 |
481 | RARRXRPATHWAY | RXR and RAR suppress transcription in the absence of ligand and, on binding trans- or 9-cis-retinoic acid, are ubiquitinated to allow transcription to proceed. | 14 | NCOR2(3), POLR2A(2) | 131063 | 5 | 5 | 5 | 2 | 2 | 2 | 0 | 1 | 0 | 0.92 | 1.00 |
482 | PHOSPHATIDYLINOSITOL_ SIGNALING_SYSTEM | 82 | ACVRL1(2), BMPR1A(2), CLK2(1), COL4A3BP(3), PIK3C2A(1), PIK3C2B(5), PIK3C2G(1), PLCB1(6), PLCB4(3), PRKCA(3), PRKCE(2), PRKCZ(1), RAF1(1), RPS6KA2(2), RPS6KA4(2) | 599354 | 35 | 31 | 35 | 10 | 9 | 17 | 2 | 4 | 3 | 0.92 | 1.00 | |
483 | N_GLYCAN_BIOSYNTHESIS | 21 | B4GALT3(1), B4GALT5(1), MAN1A1(3) | 138389 | 5 | 5 | 5 | 2 | 3 | 2 | 0 | 0 | 0 | 0.93 | 1.00 | |
484 | G1_TO_S_CELL_CYCLE_ REACTOME | 65 | ATM(4), CDK4(1), CREB3(1), ORC3L(1), RBL1(4), RPA1(1), TNXB(12) | 460649 | 24 | 17 | 24 | 9 | 5 | 13 | 3 | 1 | 2 | 0.93 | 1.00 | |
485 | PROPANOATE_METABOLISM | 31 | ACACA(2), ALDH3A1(1), LDHB(1), LDHC(1) | 128937 | 5 | 5 | 5 | 5 | 0 | 4 | 0 | 0 | 1 | 0.95 | 1.00 | |
486 | HSA00532_CHONDROITIN_ SULFATE_BIOSYNTHESIS | Genes involved in chondroitin sulfate biosynthesis | 17 | CHPF(1), XYLT2(1) | 110692 | 2 | 2 | 2 | 1 | 1 | 0 | 0 | 1 | 0 | 0.95 | 1.00 |
487 | HDACPATHWAY | Myocyte enhancer factor MEF2 activates transcription of genes required for muscle cell differentiation and is inhibited by histone deacetylases. | 30 | INSR(2), MAP2K6(2), PPP3CC(1) | 282413 | 5 | 5 | 5 | 4 | 0 | 2 | 0 | 1 | 2 | 0.96 | 1.00 |
488 | ACETYLCHOLINE_SYNTHESIS | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
489 | BBCELLPATHWAY | Fas ligand expression by T cells induces apoptosis in Fas-expressing, inactive B cells. | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
490 | BLOOD_GROUP_GLYCOLIPID_ BIOSYNTHESIS_NEOLACTOSERIES | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
491 | CYANOAMINO_ACID_ METABOLISM | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
492 | EOSINOPHILSPATHWAY | Recruitment of eosinophils in the inflammatory response observed in asthma occurs via the chemoattractant eotaxin binding to the CCR3 receptor. | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
493 | ERYTHPATHWAY | Erythropoietin selectively stimulates erythrocyte differentiation from CFU-GEMM cells in bone marrow. | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
494 | HSA00031_INOSITOL_ METABOLISM | Genes involved in inositol metabolism | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
495 | HSA00072_SYNTHESIS_ AND_DEGRADATION_ OF_KETONE_BODIES | Genes involved in synthesis and degradation of ketone bodies | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
496 | HSA00300_LYSINE_ BIOSYNTHESIS | Genes involved in lysine biosynthesis | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
497 | HSA00471_D_GLUTAMINE_ AND_D_GLUTAMATE_ METABOLISM | Genes involved in D-glutamine and D-glutamate metabolism | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
498 | HSA00472_D_ARGININE_ AND_D_ORNITHINE_ METABOLISM | Genes involved in D-arginine and D-ornithine metabolism | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
499 | HSA00550_PEPTIDOGLYCAN_ BIOSYNTHESIS | Genes involved in peptidoglycan biosynthesis | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
500 | HSA00627_1,4_DICHLOROBENZENE_ DEGRADATION | Genes involved in 1,4-dichlorobenzene degradation | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
501 | HSA00643_STYRENE_ DEGRADATION | Genes involved in styrene degradation | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
502 | HSA00660_C5_BRANCHED_ DIBASIC_ACID_METABOLISM | Genes involved in C5-branched dibasic acid metabolism | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
503 | HSA00780_BIOTIN_ METABOLISM | Genes involved in biotin metabolism | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
504 | HSA00785_LIPOIC_ ACID_METABOLISM | Genes involved in lipoic acid metabolism | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
505 | HSA00830_RETINOL_ METABOLISM | Genes involved in retinol metabolism | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
506 | IL18PATHWAY | Pro-inflammatory IL-18 is activated in macrophages by caspase-1 cleavage and, in conjunction with IL-12, stimulates Th1 cell differentiation. | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
507 | INOSITOL_METABOLISM | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
508 | LONGEVITYPATHWAY | Caloric restriction in animals often increases lifespan, which may occur via decreased IGF receptor expression and consequent expression of stress-resistance proteins. | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
509 | LYSINE_BIOSYNTHESIS | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
510 | METHIONINEPATHWAY | Catabolic Pathways for Methionine, Isoleucine, Threonine and Valine | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
511 | MTA3PATHWAY | The estrogen receptor regulates proliferation in mammary epithelia via MTA3 activation; loss of either protein is implicated in breast cancer. | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
512 | NEUROTRANSMITTERSPATHWAY | Biosynthesis of neurotransmitters | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
513 | PEPIPATHWAY | Proepithelin (PEPI) induces epithelial cells to secrete IL-8, which promotes elastase secretion by neutrophils. | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
514 | RANPATHWAY | RanGEF (aka RCC1) and RanGFP regulate the GTP- or GDP-bound state of Ran, creating a Ran gradient across the nuclear membrane that is used in nuclear import. | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
515 | SLRPPATHWAY | Small leucine-rich proteoglycans (SLRPs) interact with and reorganize collagen fibers in the extracellular matrix. | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
516 | ST_PAC1_RECEPTOR_ PATHWAY | The signaling peptide PACAP binds to its receptor, PAC1R, which activates adenylyl cyclase and phospholipase C. | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
517 | SYNTHESIS_AND_DEGRADATION_ OF_KETONE_BODIES | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
518 | VOBESITYPATHWAY | The adipose tissue of obese individuals overexpresses a key glucocorticoid-metabolizing enzyme, activating inactive circulating corticosteroids and inducing insulin resistance. | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
519 | HSA00790_FOLATE_ BIOSYNTHESIS | Genes involved in folate biosynthesis | 41 | ALPP(2), DDX19A(2), DDX4(2), DDX54(2), ERCC2(1), SETX(2), SKIV2L2(3), SMARCA2(4) | 337460 | 18 | 17 | 18 | 8 | 4 | 12 | 1 | 0 | 1 | 1.00 | 1.00 |
520 | SIG_PIP3_SIGNALING_ IN_CARDIAC_MYOCTES | Genes related to PIP3 signaling in cardiac myocytes | 63 | CREB3(1), IFI27(1), IRS4(3), MET(2), PAK1(1), PARD3(3), PTK2(2), RPS6KA2(2), SLC2A4(1), SOS1(3), TSC2(2) | 394817 | 21 | 19 | 21 | 4 | 6 | 10 | 1 | 2 | 2 | 1.00 | 1.00 |
521 | HSA00510_N_GLYCAN_ BIOSYNTHESIS | Genes involved in N-glycan biosynthesis | 41 | B4GALT3(1), GANAB(4), MAN1A1(3), MAN2A1(4) | 238470 | 12 | 11 | 12 | 2 | 4 | 7 | 0 | 0 | 1 | 1.00 | 1.00 |
522 | INTEGRINPATHWAY | Integrins are cell surface receptors commonly present at focal adhensions that interact with the extracellular matrix and transduce extracellular signaling. | 35 | ACTN3(2), CAPN1(2), ITGA1(1), MAPK1(1), MAPK3(1), PPP1R12B(1), PTK2(2), RAF1(1), SOS1(3), TLN1(3), VCL(2) | 417636 | 19 | 19 | 19 | 4 | 6 | 9 | 1 | 2 | 1 | 1.00 | 1.00 |
523 | LYMPHOCYTEPATHWAY | B and T cell lymphocytes interact with other cells via transmembrane adhesion proteins such as CD44, which interacts with endothelial cells. | 9 | ITGAL(2), SELL(1) | 66420 | 3 | 3 | 3 | 3 | 1 | 2 | 0 | 0 | 0 | 1.00 | 1.00 |
524 | HSA00980_METABOLISM_ OF_XENOBIOTICS_BY_ CYTOCHROME_P450 | Genes involved in metabolism of xenobiotics by cytochrome P450 | 70 | ADH6(1), AKR1C1(1), ALDH3A1(1), CYP2B6(1), CYP2C19(6), CYP2F1(1), UGT1A7(1), UGT2B15(2) | 313318 | 14 | 11 | 14 | 8 | 3 | 8 | 1 | 0 | 2 | 1.00 | 1.00 |
525 | DEATHPATHWAY | Death receptors such as Fas and DR3, 4, and 5 transduce pro-apoptotic signaling by oligomerizing to activate the caspase cascade. | 32 | CASP10(2), CFLAR(1), DFFB(1), MAP3K14(1), RELA(2), SPTAN1(2) | 201584 | 9 | 8 | 9 | 5 | 2 | 6 | 0 | 0 | 1 | 1.00 | 1.00 |
526 | MCALPAINPATHWAY | In integrin-mediated cell migration, calpains digest links between the actin cytoskeleton and focal adhesion proteins. | 24 | CAPN1(2), CXCR3(1), EGFR(2), ITGA1(1), MAPK1(1), MAPK3(1), MYLK(1), PTK2(2), TLN1(3) | 328549 | 14 | 14 | 14 | 5 | 5 | 7 | 1 | 0 | 1 | 1.00 | 1.00 |
527 | ARAPPATHWAY | ADP-ribosylation factors (ARFs), members of the Ras superfamily, regulate eukaryotic vesicular trafficking and activate phospholipase D's. | 12 | ARFGAP1(1), COPA(4), GBF1(4) | 218539 | 9 | 9 | 9 | 0 | 0 | 6 | 1 | 1 | 1 | 1.00 | 1.00 |
528 | GPCRDB_CLASS_A_RHODOPSIN_ LIKE | 164 | AVPR2(2), CHRM1(1), CXCR3(1), F2RL3(1), GALT(1), HTR1D(1), NPY1R(3), NTSR2(2), RGR(1), RHO(1), TBXA2R(1) | 369060 | 15 | 13 | 15 | 4 | 4 | 10 | 0 | 0 | 1 | 1.00 | 1.00 | |
529 | MSPPATHWAY | Macrophage stimulating protein is synthesized as pro-MSP by the liver and, on proteolysis, binds to monocyte receptor kinase RON to induce macrophage development. | 6 | IL1B(1), MST1(4), MST1R(2) | 175724 | 7 | 7 | 7 | 1 | 1 | 4 | 1 | 1 | 0 | 1.00 | 1.00 |
530 | UCALPAINPATHWAY | Calpains promote formation of integrin adhesion clusters which recruit Rac to enable the formation of mature focal adhesions that do not contain calpain. | 16 | ACTN3(2), CAPN1(2), ITGA1(1), PTK2(2), SPTAN1(2), TLN1(3) | 313961 | 12 | 12 | 12 | 4 | 5 | 4 | 1 | 1 | 1 | 1.00 | 1.00 |
531 | TERTPATHWAY | hTERC, the RNA subunit of telomerase, and hTERT, the catalytic protein subunit, are required for telomerase activity and are overexpressed in many cancers. | 7 | MAX(1) | 27599 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
532 | HSA00020_CITRATE_ CYCLE | Genes involved in citrate cycle (TCA cycle) | 27 | ACLY(1), ACO1(1), DLD(1), DLST(1), IDH3A(1), IDH3B(1), PC(1) | 195091 | 7 | 7 | 7 | 2 | 3 | 3 | 0 | 1 | 0 | 1.00 | 1.00 |
533 | PYRIMIDINE_METABOLISM | 55 | CAD(2), DPYS(2), NT5E(1), POLD1(1), POLQ(6), POLR2A(2), POLR2F(1), RRM1(1) | 446677 | 16 | 15 | 16 | 5 | 3 | 11 | 0 | 2 | 0 | 1.00 | 1.00 | |
534 | ECMPATHWAY | Extracellular matrix induces integrin-mediated FAK phosphorylation in epithelial cells, leading to PI3 and MAP kinase activation and actin reorganization. | 22 | ITGA1(1), MAPK1(1), MAPK3(1), MYLK(1), PTK2(2), RAF1(1), TLN1(3) | 281433 | 10 | 10 | 10 | 5 | 3 | 5 | 1 | 0 | 1 | 1.00 | 1.00 |
535 | RHOPATHWAY | RhoA is a G protein whose active form stabilizes actin structures such as focal adhesions and activates Rock1, which phosphorylates myosin light chains. | 30 | ARHGEF11(7), ARHGEF5(1), MYLK(1), PPP1R12B(1), TLN1(3), VCL(2) | 423935 | 15 | 14 | 15 | 4 | 5 | 6 | 2 | 1 | 1 | 1.00 | 1.00 |
536 | HSA00361_GAMMA_HEXACHLOROCYCLOHEXANE_ DEGRADATION | Genes involved in gamma-hexachlorocyclohexane degradation | 23 | ACP6(1), ACPP(1), ALPP(2) | 113356 | 4 | 4 | 4 | 2 | 2 | 2 | 0 | 0 | 0 | 1.00 | 1.00 |
537 | HSA00602_GLYCOSPHINGOLIPID_ BIOSYNTHESIS_NEO_ LACTOSERIES | Genes involved in glycosphingolipid biosynthesis - neo-lactoseries | 21 | B4GALT3(1), FUT6(2) | 85807 | 3 | 3 | 3 | 0 | 1 | 2 | 0 | 0 | 0 | 1.00 | 1.00 |
538 | HSA03320_PPAR_SIGNALING_ PATHWAY | Genes involved in PPAR signaling pathway | 67 | ACSL3(1), CD36(1), PLTP(1), SLC27A4(2), SORBS1(4) | 261215 | 9 | 8 | 9 | 10 | 3 | 5 | 1 | 0 | 0 | 1.00 | 1.00 |
539 | ALANINE_AND_ASPARTATE_ METABOLISM | 21 | AGXT2(3), CAD(2), CRAT(1), PC(1) | 205479 | 7 | 7 | 7 | 2 | 1 | 5 | 1 | 0 | 0 | 1.00 | 1.00 | |
540 | INSULINPATHWAY | Insulin regulates glucose levels via Ras-mediated transcriptional activation. | 21 | INSR(2), MAPK3(1), RAF1(1), RASA1(2), SLC2A4(1), SOS1(3) | 306528 | 10 | 10 | 10 | 1 | 1 | 6 | 0 | 1 | 2 | 1.00 | 1.00 |
541 | CASPASEPATHWAY | Caspases are cysteine proteases active in apoptosis; caspase-8 and 9 cleave and activate other caspases, while 3, 6, and 7 cleave cellular targets. | 21 | CASP10(2), DFFB(1) | 95842 | 3 | 3 | 3 | 1 | 0 | 3 | 0 | 0 | 0 | 1.00 | 1.00 |
542 | HSA00290_VALINE_ LEUCINE_AND_ISOLEUCINE_ BIOSYNTHESIS | Genes involved in valine, leucine and isoleucine biosynthesis | 12 | BCAT2(2), LARS(1), LARS2(2), VARS(3) | 255722 | 8 | 6 | 8 | 1 | 1 | 5 | 1 | 0 | 1 | 1.00 | 1.00 |
543 | HSA00240_PYRIMIDINE_ METABOLISM | Genes involved in pyrimidine metabolism | 86 | CAD(2), DPYS(2), NT5C2(1), NT5C3(2), NT5E(1), POLD1(1), POLR2A(2), POLR2F(1), RRM1(1), RRM2B(2) | 493873 | 15 | 15 | 15 | 6 | 3 | 9 | 2 | 1 | 0 | 1.00 | 1.00 |
544 | GLOBOSIDE_METABOLISM | 13 | ST3GAL4(1) | 33837 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1.00 | 1.00 | |
545 | KERATAN_SULFATE_ BIOSYNTHESIS | 10 | B4GALT3(1), B4GALT5(1), ST3GAL4(1) | 102123 | 3 | 3 | 3 | 4 | 1 | 2 | 0 | 0 | 0 | 1.00 | 1.00 | |
546 | BLOOD_GROUP_GLYCOLIPID_ BIOSYNTHESIS_LACTOSERIES | 7 | FUT6(2) | 69204 | 2 | 2 | 2 | 1 | 0 | 2 | 0 | 0 | 0 | 1.00 | 1.00 | |
547 | HSA00710_CARBON_ FIXATION | Genes involved in carbon fixation | 23 | PGK1(2) | 70052 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
548 | TRANSLATION_FACTORS | 37 | EEF1A2(1), EIF2B1(1), EIF2B3(1), EIF2B4(1), EIF4A1(1), EIF4G3(2), EIF5(1) | 289002 | 8 | 8 | 8 | 3 | 0 | 5 | 1 | 0 | 2 | 1.00 | 1.00 | |
549 | EIF2PATHWAY | Eukaryotic initiation factor 2 (EIF2) initiates translation by transferring Met-tRNA to the 40S ribosome in a GTP-dependent process. | 9 | EIF5(1) | 37122 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
550 | HSA00601_GLYCOSPHINGOLIPID_ BIOSYNTHESIS_LACTOSERIES | Genes involved in glycosphingolipid biosynthesis - lactoseries | 10 | ST3GAL4(1) | 37265 | 1 | 1 | 1 | 2 | 0 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
551 | ST_JNK_MAPK_PATHWAY | JNKs are MAP kinases regulated by several levels of kinases (MAPKK, MAPKKK) and phosphorylate transcription factors and regulatory proteins. | 38 | DLD(1), MAP2K5(1), MAP3K1(4), MAP3K11(1), MAP3K12(1) | 309823 | 8 | 6 | 8 | 3 | 3 | 3 | 0 | 0 | 2 | 1.00 | 1.00 |
552 | MALATEXPATHWAY | The tricarboxylate transfer pathway shuttles acetyl groups of acetyl-CoA between mitochondria and the cytoplasm. | 8 | ACLY(1), PC(1) | 83967 | 2 | 2 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 1.00 | 1.00 |
553 | BOTULINPATHWAY | Blockade of Neurotransmitter Relase by Botulinum Toxin | 5 | CHRM1(1), CHRNA1(2) | 127293 | 3 | 3 | 3 | 1 | 0 | 3 | 0 | 0 | 0 | 1.00 | 1.00 |
554 | SARSPATHWAY | The SARS coronavirus has a 30kb RNA genome containing rep, a large gene encoding viral protease Mpro. | 10 | LDHB(1), LDHC(1) | 87868 | 2 | 2 | 2 | 1 | 0 | 2 | 0 | 0 | 0 | 1.00 | 1.00 |
555 | IFNAPATHWAY | Interferon alpha, active in the immune response, binds to the IFN receptor and activates Jak1 and Tyk2, which phosphorylate Stat1 and Stat2. | 8 | STAT1(1) | 44466 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
556 | HSA00533_KERATAN_ SULFATE_BIOSYNTHESIS | Genes involved in keratan sulfate biosynthesis | 16 | B4GALT3(1), ST3GAL4(1) | 90065 | 2 | 2 | 2 | 4 | 1 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
557 | MITOCHONDRIAL_FATTY_ ACID_BETAOXIDATION | 15 | ACSL3(1) | 45694 | 1 | 1 | 1 | 2 | 0 | 1 | 0 | 0 | 0 | 1.00 | 1.00 | |
558 | NUCLEOTIDE_METABOLISM | 14 | POLD1(1), RRM1(1) | 92218 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 1.00 | 1.00 | |
559 | GPCRDB_CLASS_A_RHODOPSIN_ LIKE2 | 13 | GPR109B(2) | 102990 | 2 | 2 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 1.00 | 1.00 | |
560 | PGC1APATHWAY | PCG-1a is expressed in skeletal muscle, heart muscle, and brown fat, and is a coactivator for receptors such as glucocorticoid receptor and thyroid hormone receptor. | 23 | CAMK2A(2), CAMK2D(1), CAMK4(1), PPP3CC(1), SLC2A4(1) | 317527 | 6 | 5 | 6 | 3 | 3 | 2 | 0 | 0 | 1 | 1.00 | 1.00 |
561 | 1_AND_2_METHYLNAPHTHALENE_ DEGRADATION | 7 | ADH6(1) | 52969 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1.00 | 1.00 | |
562 | UBIQUITIN_MEDIATED_ PROTEOLYSIS | 23 | NRF1(1) | 54355 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1.00 | 1.00 | |
563 | HSA00531_GLYCOSAMINOGLYCAN_ DEGRADATION | Genes involved in glycosaminoglycan degradation | 17 | HGSNAT(1), HYAL1(3), NAGLU(1) | 273701 | 5 | 5 | 5 | 1 | 0 | 3 | 0 | 1 | 1 | 1.00 | 1.00 |
564 | SALMONELLAPATHWAY | Salmonella induces membrane ruffling in infected cells via bacterial proteins including SipA, SipC, and SopE, which alter actin structure. | 12 | WASL(1) | 56120 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
565 | MONOAMINE_GPCRS | 32 | CHRM1(1), HTR1D(1) | 118295 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 1.00 | 1.00 | |
566 | HSA01032_GLYCAN_ STRUCTURES_DEGRADATION | Genes involved in degradation of glycan structures | 29 | HGSNAT(1), HYAL1(3), NAGLU(1), NEU1(2) | 429709 | 7 | 7 | 7 | 2 | 1 | 4 | 0 | 1 | 1 | 1.00 | 1.00 |
567 | N_GLYCAN_DEGRADATION | 13 | NEU1(2) | 130361 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 1.00 | 1.00 | |
568 | RABPATHWAY | Rab family GTPases regulate vesicle transport, endocytosis and exocytosis, and vesicle docking via interactions with the rabphilins. | 9 | RAB5A(1) | 66336 | 1 | 1 | 1 | 2 | 0 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
569 | PARKINPATHWAY | In Parkinson's disease, dopaminergic neurons contain Lewy bodies consisting of alpha-synuclein and parkin, an E3 ubiquitin ligase that targets glycosylated alpha-synuclein. | 10 | SNCAIP(2) | 135265 | 2 | 2 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 1.00 | 1.00 |
570 | HSA03020_RNA_POLYMERASE | Genes involved in RNA polymerase | 23 | POLR2A(2), POLR2F(1) | 227569 | 3 | 3 | 3 | 1 | 1 | 1 | 0 | 1 | 0 | 1.00 | 1.00 |
571 | RNA_POLYMERASE | 14 | POLR2A(2), POLR2F(1) | 233558 | 3 | 3 | 3 | 1 | 1 | 1 | 0 | 1 | 0 | 1.00 | 1.00 | |
572 | RNA_TRANSCRIPTION_ REACTOME | 37 | GTF2H1(1), POLR2A(2), POLR2F(1) | 318821 | 4 | 4 | 4 | 2 | 1 | 1 | 0 | 1 | 1 | 1.00 | 1.00 | |
573 | HSA00511_N_GLYCAN_ DEGRADATION | Genes involved in N-glycan degradation | 15 | NEU1(2) | 179445 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
574 | HSA00624_1_AND_2_ METHYLNAPHTHALENE_ DEGRADATION | Genes involved in 1- and 2-methylnaphthalene degradation | 22 | ADH6(1) | 100005 | 1 | 1 | 1 | 3 | 0 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
575 | HSA00930_CAPROLACTAM_ DEGRADATION | Genes involved in caprolactam degradation | 13 | HSD17B4(1) | 113260 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 1.00 | 1.00 |
576 | RIBOSOMAL_PROTEINS | 94 | RPS6KA2(2) | 235933 | 2 | 2 | 2 | 1 | 0 | 1 | 0 | 1 | 0 | 1.00 | 1.00 | |
577 | HSA03010_RIBOSOME | Genes involved in ribosome | 67 | RPL22L1(1) | 159500 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1.00 | 1.00 |
578 | ACETAMINOPHENPATHWAY | Acetaminophen selectively inhibits Cox-3, which is localized to the brain, and yields the toxic metabolite NAPQI when processed by CAR in the liver. | 5 | 13689 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
579 | AHSPPATHWAY | Alpha-hemoglobin stabilizing protein (AHSP) prevents precitipation of hemoglobin alpha-subunits. | 12 | 56114 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
580 | ARFPATHWAY | Cyclin-dependent kinase inhibitor 2A is a tumor suppressor that induces G1 arrest and can activate the p53 pathway, leading to G2/M arrest. | 16 | 8028 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
581 | ARGININECPATHWAY | Related catabolic pathways process arginine, histidine, glutamine, and proline through glutamate to alpha-ketoglutamate, which feeds into the citric acid cycle. | 6 | 43096 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
582 | BETAOXIDATIONPATHWAY | Beta-Oxidation of Fatty Acids | 6 | 13788 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
583 | BIOSYNTHESIS_OF_ STEROIDS | 14 | 20532 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
584 | CAPROLACTAM_DEGRADATION | 5 | 82610 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
585 | CHOLESTEROL_BIOSYNTHESIS | 15 | 19326 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
586 | EICOSANOID_SYNTHESIS | 17 | 15055 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
587 | ETCPATHWAY | Energy is extracted from carbohydrates via oxidation and transferred to the mitochondrial electron transport chain, which couples ATP synthesis to the reduction of oxygen to water. | 9 | 55160 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
588 | FATTY_ACID_BIOSYNTHESIS_ PATH_2 | 9 | 46261 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
589 | FBW7PATHWAY | Cyclin E interacts with cell cycle checkpoint kinase cdk2 to allow transcription of genes required for S phase, including transcription of additional cyclin E. | 8 | 5779 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
590 | FOSBPATHWAY | FOSB gene expression and drug abuse | 5 | 29113 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
591 | GLUTATHIONE_METABOLISM | 31 | 97134 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
592 | HEME_BIOSYNTHESIS | 9 | 44493 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
593 | HSA00100_BIOSYNTHESIS_ OF_STEROIDS | Genes involved in biosynthesis of steroids | 24 | 30927 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
594 | HSA00130_UBIQUINONE_ BIOSYNTHESIS | Genes involved in ubiquinone biosynthesis | 8 | 20831 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
595 | HSA00232_CAFFEINE_ METABOLISM | Genes involved in caffeine metabolism | 7 | 29996 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
596 | HSA00363_BISPHENOL_ A_DEGRADATION | Genes involved in bisphenol A degradation | 14 | 42350 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
597 | HSA00460_CYANOAMINO_ ACID_METABOLISM | Genes involved in cyanoamino acid metabolism | 6 | 14908 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
598 | HSA00603_GLYCOSPHINGOLIPID_ BIOSYNTHESIS_GLOBOSERIES | Genes involved in glycosphingolipid biosynthesis - globoseries | 14 | 23437 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
599 | HSA00604_GLYCOSPHINGOLIPID_ BIOSYNTHESIS_GANGLIOSERIES | Genes involved in glycosphingolipid biosynthesis - ganglioseries | 16 | 23437 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
600 | HSA00625_TETRACHLOROETHENE_ DEGRADATION | Genes involved in tetrachloroethene degradation | 7 | 21122 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
601 | HSA00642_ETHYLBENZENE_ DEGRADATION | Genes involved in ethylbenzene degradation | 12 | 47036 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
602 | HSA00791_ATRAZINE_ DEGRADATION | Genes involved in atrazine degradation | 9 | 80286 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
603 | HSA00900_TERPENOID_ BIOSYNTHESIS | Genes involved in terpenoid biosynthesis | 6 | 24700 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
604 | HSA03060_PROTEIN_ EXPORT | Genes involved in protein export | 8 | 17112 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
605 | HSP27PATHWAY | Hsp27 oligomers have molecular chaperone activity and protect heat-stressed cells against apoptosis. | 15 | 10974 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
606 | HYPERTROPHY_MODEL | 17 | 19055 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
607 | IGF1MTORPATHWAY | Growth factor IGF-1 activates AKT, Gsk3-beta, and mTOR to promote muscle hypertrophy. | 19 | 26394 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
608 | KREBPATHWAY | The Krebs (citric acid) cycle takes place in mitochondria, where it extracts energy in the form of electron carriers NADH and FADH2, which drive the electron transport chain. | 8 | 57749 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
609 | MITRPATHWAY | The MyoD/MEF2 transcription factors induce muscle cell differentiation and are repressed by the transcriptional repressor MITR. | 9 | 75154 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
610 | NUCLEOTIDE_GPCRS | 8 | 63941 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
611 | P27PATHWAY | p27 blocks the G1/S transition by inhibiting the checkpoint kinase cdk2/cyclin E and is inhibited by cdk2-mediated ubiquitination. | 12 | 26299 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
612 | RECKPATHWAY | RECK is a membrane-anchored inhibitor of matrix metalloproteinases, which are expressed by tumor cells and promote metastasis. | 9 | 4986 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
613 | SKP2E2FPATHWAY | E2F-1, a transcription factor that promotes the G1/S transition, is repressed by Rb and activated by cdk2/cyclin E. | 9 | 26299 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
614 | TERCPATHWAY | hTERC, the RNA subunit of telomerase, and hTERT, the catalytic protein subunit, are required for telomerase activity and are overexpressed in many cancers. | 6 | 30305 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
615 | TERPENOID_BIOSYNTHESIS | 4 | 14440 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
616 | UBIQUINONE_BIOSYNTHESIS | 15 | 62388 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 |
Notes: (Please see notes under significantly mutated gene table)